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Summary
The epidermis is maintained by proliferation of stem cells and differentiation of 
their progeny. In my PhD thesis I have studied the mechanisms by which these 
processes are compartmentalised.
P-catenin levels determine lineage commitment in the epidermis. I investigated 
the role of p-catenin in patterning of the epidermal stem cell compartment and its 
niche during de novo hair follicle formation. For this I used K14ANP-cateninER 
transgenic mice. I found that the levels of p-catenin activation determine the 
number and location of ectopic hair follicles, showing that fo llic le formation is a 
threshold-response event. To dissect the downstream effects of p-catenin 
signalling, I performed microarray analysis and saw that the Hedgehog pathway is 
upregulated by p-catenin activation. Inhibition of Hedgehog signalling attenuates 
the effects of p-catenin.
The array also revealed that p-catenin regulates the Eph/ephrin protein family. I 
found that several ephrin-B ligands and EphB receptors are expressed in distinct 
zones in mouse skin. In order to study the mechanisms modulating epidermal 
niche patterning I have analysed EphB2, EphB3 and ephrin-Bl null epidermis. 
EphB/ephrin-B signalling controls hair follicle spacing, patterning along the radial 
fo llic le  axis, interfollicular epidermal differentiation and melanocyte localisation. 
Disruption of EphB/ephrin-B signalling disturbs proliferation, uncoupling 
expression of K15, CD34 and clonal growth capacity. In culture keratinocytes that 
differ in EphB/ephrin-B expression segregate from one another, reflecting 
differences in cell shape, motility and integrin expression. EphB3 and ephrin-B1 
are induced on activation of p-catenin and augment p-catenin induced cell 
clustering. Conversely, EphB/ephrin-B signalling negatively regulates p-catenin 
activation. Ephrin-B/EphB signalling is a key determinant of epidermal pattern, 
proliferation and differentiation. In summary, I have elucidated the role of p- 
catenin, Hedgehog and EphB/ephrin-B signalling in regulating epidermal 
proliferation, differentiation and morphogenesis.
Para Sebas, 
padres, mi hermana 
y la familia
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Chapter 1 - Introduction
Aims
During embryonic development and throughout adulthood a tissue is maintained 
by replacing the differentiated or damaged cells by new ones and an interplay of 
pathways is essential to couple differentiation and proliferation to properly 
maintain the homeostasis of this tissue. The main focus of this study is to use the 
skin as an experimental model in which to study hair follicle morphogenesis and 
patterning.
In this Chapter, I w ill describe how the epidermis and its appendages are 
structured, how they develop during embryogenesis and how they are maintained 
through adult life. I w ill also outline recent advances in the characterisation of the 
epidermal stem cell compartment and the hair follicle niche. In addition, I w ill 
also describe the role of the key pathways involved in regulating and patterning 
the epidermal stem cell compartment.
1.1 - Introduction to the epidermis
The epidermis forms the protective outer covering of mammalian skin providing 
protection against environmental insults and dehydration, and is an important 
gateway for sensory input (Millar, 2005). This multilayered epithelium consists of 
the interfollicular epidermis (IFE) and associated adnexal structures, including the 
hair fo llic le  and sebaceous and sweat glands (See Figure 1.1).
1.1.1- Development of the epidermis and its appendages
1.1.1.1 -Establishment of the stratified skin epithelium
Adult epidermis is a stratified squamous multilayered epithelium in which cells at 
the basal layer are m itotically active and produce and secrete the extracellular 
matrix that makes up for the basement membrane (BM) that separates the 
epidermis from the dermis and the suprabasal layers (Blanpain and Fuchs, 2005; 
Watt, 2002). At embryonic day (E) E12, the future epidermis consists of a single 
layer of basal cells of the ectoderm. Between E14 and E17 the stratification 
process starts and by E18 a fully stratified interfollicular epidermis (IFE) is 
completed (See Figure 1.2).
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Figure 1.1 - Structure of adult mouse skin . (A and B) Sections of mouse 
back skin stained with haematoxylin&eosin. The main structures are indicated: 
the interfollicular epidermis (IFE), the anagen hair follicle (HF) in A and telogen 
HF in B and the sebaceous glands (SG). (C) Schematic diagram representing- 
adult skin. This consists of, in the upper side the multilayered epidermis, includ­
ing the IFE and its adnexal appendages the SG, the HF and the sweat gland, next 
the basement membrane and in the innermost side the dermis, including the 
dermal cells, the dermal papilla encased at the base of the HF, the arrector pili 
muscle and the nerve and vascular endings.
Basal cells in the IFE are rich in the a3p1 and a6|M integrins (Watt, 2002). As 
basal cells become committed to differentiate, they withdraw from the cell cycle, 
downregulate integrin expression and they leave the basal layer by moving 
upwards into the first suprabasal layer to start the programme of terminal 
differentiation (Watt, 2002). Three types of suprabasal layers can be distinguished: 
spinous, granular and the stratum corneum (Figure 1.2). Committed cells go 
through the spinous layer and the granular layer where the programme is further 
ongoing and finally they become enucleated and flattened when they reach the 
cornified layer. Finally, squames are shed from the outermost layer, the surface of 
the skin. Cells that move upwards from the inner layers are constantly replacing 
shed cells (Figure 1.2).
Basal cells contribute to stratification by two mechanisms: one loosening its 
contacts w ith the BM and the neighbour cells (Watt and Green, 1982) and the 
second one by orienting the plane of mitotic spindle perpendicular to the BM 
(Lechler and Fuchs, 2005; Smart,1970). Although these two mechanisms were 
first described a long time ago the molecular basis is just beginning to be further 
studied.
1.1.1.2-Hair follicle morphogenesis
The hair fo llic le  is the most prominent miniorgan of the skin and one of the 
features of mammalian species; together with its associated appendages, the 
sebaceous and apocrine glands and the arrector pili muscle, the HF forms the 
main component of the pilosebaceous unit (Schmidt-Ullrich and Paus, 2005). The 
apocrine glands are generated only in non hair-bearing regions. The process of 
hair fo llic le  morphogenesis arises as a result of a very complex interplay between 
epidermis and dermis that starts at E13 (See Figure 1.2 and 1.3 for details) and can 
be divided into three stages: induction, organogenesis and cell differentiation 
(Schmidt-Ullrich and Paus, 2005). The main signalling pathways involved in this 
process are shown in Figure 1.3.
The first stage of the induction of HF formation, starts with a gradient of inductive 
signals originating from the epidermis and the dermis in which the message 'make 
an appendage' is set up by E13 (See Diagram in Figure 1.3). The Wnt/^-catenin
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Figure 1.2.- Development and stratification of the epidermis.
This diagram illustrates the main stages during development, starting from 
a single layer of ectodermal cells covering the embryo at E13. As develop­
ment proceeds, the epidermis progressively is stratified and acquires layers 
of terminally differentiating cells and by E18 a multilayered stratified 
epithelium is formed in which the outer differentiated layers constitute the 
epidermal barrier. E indicates embryonic day. Specific layers are indicated. 
Taken and adapted from Blanpain and Fuchs, 2006.
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pathway has been granted this role by promoting interacting self-organising 
gradients of stimulatory and inhibitory signals leading to the aggregation of 
keratinocytes that form the placode by El 4. The next step, organogenesis, starts 
by E15.5 and consists of the condensation of specialised dermal fibroblasts, which 
have inductive properties, underneath the HF placode and the follicular 
keratinocytes to form the hair germ (Figure 1.3). The crosstalk of pathways 
between the mesenchymal dermal condensate and the ectodermal placode drives 
proliferation of both compartments, which allows for the dermal papilla (DP) to 
be formed and for the downgrowth of the hair placode (Figure 1.3; Schmidt- 
U llrich and Paus, 2005; Blanpain and Fuchs, 2005). Another signal at E16.5 is 
sent from the DP to drive proliferation and elaborate differentiation and in the 
next step, the hair peg is formed (Figure 1.3). Finally, the differentiation stage 
follows, when the peg starts becoming a bulbous peg from El 8.5, the DP 
becoming surrounded by the most distal keratinocytes (Figure 1.3).
The follicle matures as matrix cells begin to proliferate, differentiate and by day 
E18.5 to generate the concentrical layers of keratinocytes that give rise to the hair 
shaft (HS) lineages (hair cuticle, cortex and medulla) and its channel, the Inner 
Root Sheath (IRS) lineages (Hunxley layer, Henley layer and IRS cuticle). The IRS 
is surrounded by Outer Root Sheath (ORS), which is the outermost layer (See also 
Figure 1.4; Hardy, 1992).
There are 4 different types of hair that make up the murine pelage: the major type 
is the primary or tylotrich (guard) hair follicle that constitutes 10 % of the coat 
arising from E14 and containing a pad of Merkel cells. The secondary or non- 
tylotrich includes three hair types: awls (28%) arising from E15.5 and auchenne 
and zig-zag (70%) arising from E17. In addition to the pelage fibres, the vibrissae 
or whiskers are very large and highly innervated HF. These are the first follicles to 
develop, from E12 (Schmidt-Ullrich and Paus, 2005; Hardy, 1992).
Much less is known about the development of the sebaceous gland (SG), which 
buds from the upper ORS as a terminally differentiating structure that resides 
above the bulge. Its development begins late in embryonic development from 
individual keratinocytes that give rise to the sebaceous glands (SG) at around
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Figure 1.3- Signalling map of the critical steps during hair follicle morphogenesis. This diagram illustrates the process of embryonic HF morpho­
genesis and depicts a selection of pathways that are involved. During embryonic development, an inductive field of interacting gradients of activa­
tors and inhibitors is created between a group of basal cells and the underlying mesenchyme. The outcome of these signals allows for p-catenin 
activation to switch on a morphogenic programme to make a hair. This triggers a genetic program that w ill lead to the proliferation of the placode 
and will trigger the dermis to make a dermal papilla (DP). Then the DP sends a message to the developing follicle allowing it to grow and differenti­
ate to generate discrete lineages to ultimately generate the hair shaft. At this stage non-keratinocyte cell types such as melanocytes and haemato­
poietic cells immigrate and the HF is inervated and vascularised. Taken and adapted from Schmidt-Ullrich and Paus, 2005.
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E17.5 and extending into postnatal life. Differentiated sebocytes produce and 
secrete lip id-rich sebum into the hair canal that empties out to the skin surface.
Melanoblasts precursors originate in the neural crest, migrate from the dermis and 
start colonising the developing epidermis from E13. Only at E17.5 they start to 
colonise the developing the HF, when they become differentiated melanocytes 
(Steingrimsson et al., 2005). The last step to become a fully mature hair is to 
generate the pigmentary unit, which w ill produce melanin to give colour to the 
HS. At this time the HF is populated by a wave of T cells and Langerhans cells. In 
addition mast cells also populate the HF and the surrounding dermis. By postnatal 
day (P) P8, the HF becomes morphological mature (Figures 1.3 and 1.4). At this 
stage this m ini organ is ready to perform its function, to generate a hair shaft (HS) 
(Millar, 2002; Schmidt-Ullrich and Paus, 2005).
The process of hair morphogenesis is still poorly understood, and although |3- 
catenin is the inductive signal is not yet clear what induces [3-catenin stabilisation. 
Several key signalling pathways are involved in each of these steps, including 
Wnt/p-catenin, BMP, FGF, EGF, NFKB, Notch and Shh (Schmidt-Ullrich and Paus, 
2005; M illar, 2002; See an outline in Figure 1.3).
1.1.2- Maintenance of the epidermis and its appendages
Adult epidermis is a very dynamic tissue, due to the rapid cell turnover in the IFE, 
HF and SG. Terminally differentiated cells in all regions of the epidermis are 
continually shed from the skin and must be replaced throughout adult life.
The hair cycle: Hair follicles go through cycles of growth. The different phases are 
growth (anagen), destruction (catagen), and rest (telogen) (Figure 1.5; Alonso and 
Fuchs, 2006). When the hair follicle becomes in close contact with the dermal 
papilla (DP), then the dermal papilla cells signal the bulge and then the anagen 
phase starts. The responding cells migrate down and start proliferation and 
expansion to form the bulb, a very dynamic microenvironment or niche, where 
they continue to expand and then migrate upwards as they differentiate into the 
several IRS lineages to finally form the hair shaft (Figure 1.5; Millar, 2002)
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Figure 1.4- Hair follicle lineages. This diagram shows the different hair 
fo llic le (HF) lineages that make up the hair shaft (HS). The HF is encased by a 
basement membrane that separates the basal HF keratinocytes, known as the 
outer root sheath (ORS) population with the dermal fibroblasts. At the base of 
the fo llic le  there is the highly proliferative compartment including the matrix 
population. This population differentiates to form concentric rings of differenti­
ating cells that w ill give rise to the HS lineages, its channel composed of cells of 
the inner root sheath (IRS) lineages and the companion layer. HF contain seba­
ceous glands whose function are to release sebum from the differentiated sebo­
cytes and keep the hair canal and the skin lubricated. Cell types and hair 
lineages are classified by colours. Taken and adapted from Blanpain and Fuchs, 
2006 and Niemann and Watt, 2002.
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Figure 1.5- The Flair Follicle Cycle.
This diagram shows the different stages of 
the hair follicle cycle. When matrix cells 
(purple) exhaust their proliferative capacity 
or the stimulus required for hair growth 
stops, the follicle enters a destructive phase 
(catagen) that results in the degeneration of 
the lower two thirds of the hair follicle. The 
upper part remains as a pocket of cells 
surrounding the old hair shaft (club hair). 
The base of the pocket is the permament 
portion of the follicle that remains through 
the whole hair cycle and it is known as the 
bulge, where the stem cells reside. After the 
stage of catagen the hair follicle enters a 
quiescent stage (telogen) in which the 
dermal papilla (DP) is in close contact. 
Then the DP signals to the bulge stem cell 
and the hair follicle enters a new wave of 
regeneration and hair growth (Anagen). The 
first telogen lasts for 1 day and the second 
telogen lasts for approximately 3 weeks, 
after this the hair cycle is asynchronous. The 
dates for the first two cycles are indicated 
and P indicates postnatal day. Taken and 
adapted from Blanpain and Fuchs, 2006 
and Alonso and Fuchs, 2006.
(Alonso and Fuchs, 2006). This phase is followed by a regression phase in which 
the hair fo llic le  degenerates (Catagen), leading to a resting-phase (telogen). (Figure 
1.5; Alonso and Fuchs, 2006).
1.2- Defining a stem ceil compartment
The definition of a stem cell must be on a functional basis. Although this question 
remains contentious after more than 30 years of debate, some consensus has been 
achieved. The prevailing view is that stem cells are cells sitting at the top of the 
lineage hierarchy with the capacity for unlimited or prolonged self-renewal and 
are multipotent, this is, can proliferate to produce at least one type of highly 
differentiated cell types of a given tissue in vivo (Potten, 1997 and Watt and 
Hogan, 2000).
At very early stages of development, a population of pluripotent stem cells 
originating in the inner cell mass of the blastocyst, known as embryonic stem (ES) 
cells produce all the tissue types that make up the adult organism during 
development. Whereas in adulthood, a population of multipotent cells, known as 
adult stem cells are responsible for the renewal and repair of adult tissues, such as 
the blood, the lining of the gut and the epidermis (Watt and Hogan, 2000).
It is important to bear in mind that making functional definition brings some 
difficulties, as the functional capabilities of the cells can only be assessed by 
testing their abilities, which themselves may alter their characteristics during the 
assay procedure. Another problem faced in defining a stem cell population is that 
the definition can only be relative compared with other cell types (Potten, 1997). 
For instance, as suggested by Potten, et al. a stem cell would be defined as: 
a) an undifferentiated cell (i.e. lacking certain tissue specific marker), b) capable 
of proliferation, c) able to self maintain the population, d) able to produce a large 
number of differentiated and functional progeny, e) able to regenerate the tissue 
after injury. These options may be used in a flexible manner. Ideally, these 
requirements should be satisfied in order to define a population of stem cells 
(actual stem cell); in practice, experimental limitations exist. For instance, stem 
cells not expressing these capabilities at a given time, although they possess these
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capabilities (potential stem cells) (Potten, 1997). Alternatively, it has been 
suggested that rather than considering stem cells as undifferentiated cells, it may 
be more productive to think of them as appropriately differentiated for their 
specific niches, with perhaps the ability to display more potential phenotypes in 
alternate niches (Watt and Hogan, 2000a).
After a long debate, several consensus definitions for terms used in the stem-cell 
biology field have been proposed (Smith, 2006). Defining a stem cell as a cell 
that can continuously produce unaltered daughters and also has the ability to 
produce daughter cells that have different, more restricted properties and Tissue 
stem cell is defined as a cell derived from, or resident in, a fetal or adult tissue, 
w ith potency limited to cells of that tissue. These cells sustain turnover and repair 
through life in some tissues (Smith, 2006).
When a stem cell divides can give rise to a stem cell daughter and to a non-stem 
cell daughter that divides a few times before the onset of terminal differentiation. 
These cells are known as transit amplifying cells (TACs) and their role is to 
increase the number of terminally differentiated cells produced by each stem-cell 
division (Watt et al., 2006). Although we think of stem and transit amplifying cells 
as discrete populations, instead there might be gradients of cell behaviour, the 
transit amplifying cell compartment being in the middle between a cell that has 
maximum self-renewal capacity and zero differentiation probability, to one that 
has completed terminal differentiation and can never divide again (Niemann and 
Watt, 2002).
In the next sections I w ill introduce what is known about the epidermal stem cell 
compartment.
1.2.1-Epidermal stem cells
The renewal of the epidermis and its appendages depends on a reservoir of stem 
cells that is constantly maintained throughout adult life (Figure 1.6). This 
population of multi-potent stem cells self-renew and generate daughter progenitor 
cells, the transit amplifying cells (TACs), that undergo a limited number of cell 
divisions and finally differentiate into hair, interfollicular epidermis (IFE) and
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Figure 1.6- Stem cell locations and relationship in mammalian epidermis.
(A) There is strong evidence for the existence of stem cells in the hair follicle bulge 
(blue). Stem cells are known to be present in the basal layer of the interfollicular epider­
mis (green); however it is not clear whether they are clustered (as shown to the right of 
the hair follicle) or distributed singly (shown to the left). There is a third progenitor popu­
lation in the sebaceous gland (red). Cells depicted in bright light green are cells that have 
not yet initiated terminal differentiation; they comprise transit amplifying cells and cells 
that have withdrawn from the cell cycle and become committed to terminal differentia­
tion. IFE: interfollicular epidermis; SG: sebaceous gland; HF: hair follicle; HS: hair shaft; 
IRS: inner root sheath; DP: dermal papilla. (B) Models of lineage relationships within the 
epidermis. Discrete stem-cell populations coexist, together constituting a multipotent 
stem-cell compartment. The relationship between the 3 stem cell compartments is not 
fu lly understood. Stem cells self renew and they give rise to intermediate populations 
(transit amplifying or progenitor cells) that go through several rounds of proliferation and 
they enter the programme of terminal differentiation giving rise to the sebocyte, HF and 
IFE lineages.
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sebaceous lineages, constantly keeping the integrity of the tissue (Figure 1.6; 
(Niemann and Watt, 2002; Watt, et al.2006). At present, it is unclear whether 
transit-amplifying cells have multi lineage differentiation potential or whether they 
are lineage-restricted, like for example the committed progenitors in the 
haematopoietic system (Watt et al., 2006).
1.2.2- Experimental definitions of epidermal stem cells
1.2.2.1 -Label retention
Epidermal stem cells and transit-amplifying cells were first identified according to 
their different proliferative characteristics (Niemann and Watt, 2002; Fuchs, et 
al.2004; Owens and Watt, 2003; Watt et al., 2006). In the normal epidermis, stem 
cells are quiescent and tend not to divide, but in response to tissue damage or to 
being placed in culture they are capable of sustained self-renewal. By contrast, 
transit-amplifying cells are actively dividing in vivo, but in culture they undergo 
terminal differentiation within a few rounds of division. Therefore, the 
experimental criteria to identify an epidermal stem cell are based on 
distinguishing it from its more differentiated progeny. A stem cell has higher 
proliferative capacity yet divides infrequently, it lacks expression of markers of 
terminal differentiation and expresses specific cell markers (Flake, 2000; Wagers 
and Weissman, 2004). Since epidermal stem cells divide infrequently, they can be 
visualised as Bromodeoxyuridine (BrdU) DNA label-retaining cells (LRC) 
(Bickenbach, 1981; Braun et al., 2003). Therefore, a DNA label (such as 5-bromo-
2-deoxyuridine [BrdU]) is used as an in vivo stem cell marker.
LRC are generated in the skin by administering repeated doses of BrdU injections 
at a stage (P10) in which epidermal cells are highly proliferative, so cells in S 
phase w ill take up the label during this pulse period. After a chase period the fate 
of the cells that incorporate the label can be followed (for details see the Materials 
and Methods Chapter). After the chase period, cells that have proliferated w ill 
dilute and loose the label whereas slow-cycling cells w ill retain the label 
(Bickenbach, 1981). In the skin, LRC reside in three confined "niches": 1) 
clustered in the bulge of the hair fo llicle scattered in the 2) sebaceous glands and 
in 3) the basal layer of the IFE (see Figures 1.6 and 3.4; (Bickenbach, 1981); 
(Braun et al., 2003;Watt et al., 2006). The limitation of the method is that 100%
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efficiency of labelling cannot be obtained (Lopez-Rovira et al., 2005; Bickenbach, 
1981).
1.2.2.2- In vitro clonal growth
We can identify a stem cell by its ability to form and maintain colonies in culture 
(Flake, 2000; Watt et al., 2006). Early studies by Barrandon and Green showed 
that when keratinocytes are plated at clonal density can form three types of 
colonies: holoclones (highly proliferative colonies of undifferentiated small round 
cells that can be passaged for a long term), paraclones (abortive colonies of 
terminally differentiated flat cells) and meroclones (small colonies with a 
heterogeneous population that stop dividing after short passages) (Barrandon and 
Green, 1985). In addition, cells expressing high levels of pi integrin give rise to 
holoclones in culture Qones and Watt, 1993)
LRC in the bulge, the permanent portion of the follicle can divide in vivo (Braun et 
al., 2003). When they are plated in culture at clonal density, these can yield more 
and larger colonies, resembling the holoclones, than other portions of the hair in 
vitro (Taylor et al., 2000; Oshima et al., 2001; Ghazizadeh and Taichman, 2001). 
Recent studies have shown that the double positive CD34/a6 integrin bulge 
population have a high in vitro clonal capacity, giving rise to large proliferative 
colonies (Tumbar et al., 2004; Morris et al., 2004).
1.2.2.3- Surface markers
For a long time, identification of molecular markers of epidermal stem cells had 
been through a candidate approach. For instance, the p1 integrin subunit was the 
first human IFE stem cell marker to be characterised (Jones and Watt, 1993). In 
recent years, the epidermal biology field has advanced tremendously by the 
isolation of bulge stem cells based on their expression of surface markers. This has 
allowed the identification of novel markers by global gene expression profiling. 
Mouse bulge markers identified by a candidate approach include CD34, keratin 
15 (K15) and the a6 and |31 integrin subunits (Lyle et al., 1998; Trempus et al., 
2003; Fuchs et al., 2004; Tumbar et al., 2004; Morris et al., 2004; Cotsarelis, 
2006). Genes enriched in the bulge identified by microarray analysis include 
genes that maintain quiescent and undifferentiated states, genes that regulate cell
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adhesion, and genes that mediate communication with other cell types, including 
melanocytes (Tumbar et al., 2004; Morris et al., 2004).
An important issue in skin biology is the correlation and parallels between mouse 
and human skin in particular for clinical applications. Therefore, the identification 
of markers that are enriched in human bulge cells is of key importance. A recent 
study has started addressing this issue by comparing genes upregulated in the 
bulge of mouse and human hair follicles (Ohyama et al., 2006; Cotsarelis, 2006). 
For instance, K15 is a bulge marker in both species, however in human follicles 
CD34 is expressed below the bulge. The Wnt pathway inhibitors, Dkk3 
(Dickkopf3) and W ifi (W nt-inhibiting factor 7) are expressed in both the mouse 
and human bulge. A new bulge marker in both species is the CD200 ligand, 
which has a role in communication with the immune system (Ohyama et al., 
2006). The characterisation studies of mouse bulge markers were performed 
selecting populations FACS sorting according to the expression of markers 
(Tumbar et al., 2004; Morris et al., 2004).
A novel aspect of the studies of human bulge markers is that the cells were 
isolated by laser capture micro dissection so cells were compared on the basis of 
their spatial location rather than relying on existing markers (Ohyama et al., 
2006). Very recently, new human epidermal stem cell markers have been 
identified by generating single cell cDNA libraries from cells expressing high 
levels of melanoma chondroitin sulphate proteoglycan (MCSP) (stem cells) and 
expressing high levels of Delta (transit-amplifying cells) (Lowell et al., 2000; Legg 
et al., 2003). This has led to the identification of Lrigl as a marker of stem cells in 
human interfollicular epidermis (Jensen and Watt, 2006).
As mentioned previously, a very important aspect to consider is whether the 
characteristics that define the stem cell population under study are intrinsic or 
depend on cues from the microenvironment. For instance, there are two distinct 
CD34 bulge populations depending on whether they are in contact with the basal 
layer (a6 integrin positive) or not (a6 integrin negative), they show similar in vivo 
potency, yet they have distinct gene expression profiles (Blanpain et al., 2004). 
However, other in vivo stem cell markers are maintained when bulge cells are
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cultured (Claudinot et al., 2005).
Very recently, Fuchs and co-workers have established a distinct population of 
unipotent progenitors that maintains exclusively the SG (Horsley et al., 2006). 
This population is localized in the bridge connecting the SG and the HF. Its 'ID ' 
profile is characterized by Blimpl expression and keratin 5 expression and it is 
distinct from the more differentiated sebaceous progeny (PPARy and Nile Red 
positives) or the proliferative outer layer (Ki67 positive). Lineage marking analysis 
of Blimp positive cells shows that under steady-state conditions this population 
feeds the renewal of lost differentiated sebocytes and this unipotent population 
originates from the CD34/a6 integrin bulge population (Horsley et al., 2006). 
Further analyses are needed to give more insights about the profile of this newly 
identified population and what their potency in vivo is. This study has opened a 
door into an area of skin biology that still is in its infancy.
1.2.2.4- In vivo potency
In order to maintain both the stem cell and the differentiating cell compartments, 
epidermal stem cell progeny must exhibit asymmetry of fate. This can be 
represented as a stem cell giving rise to another stem cell and a differentiated cell. 
Asymmetry of fate can be achieved on a population basis or at the level of 
individual cell divisions (Watt and Hogan, 2000). In the population model, a stem 
cell gives rise to daughter cells that have a finite probability of being either stem 
cells (50%) or committed progenitors (50%). This strategy might facilitate 
responses to physiological changes. When cell divisions are asymmetric, a stem 
cell always divides to produce one stem cell daughter and one non-stem cell 
daughter. The emerging belief is that the three different LRC reservoirs in the skin 
can give rise to any epidermal lineage, but under normal circumstances they are 
restricted by the local microenvironment, the stem cell niche, to give rise to a 
more limited repertoire of differentiated cells (Figure 1.6; Owens and Watt, 2003). 
When the epidermis is damaged, it can be completely regenerated by bulge stem 
cells; conversely, contact with dermal papilla cells can induce the interfollicular 
epidermis to form hair follicles and sebaceous glands (Niemann and Watt, 2002; 
Watt et al., 2006).
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Until very recently it has been strongly argued that the bulge was the only 
reservoir of stem cells. However, recent studies have elegantly demonstrated that 
this notion is no longer valid (Levy et al., 2005; Claudinot et al., 2005 and Ito et 
al., 2005). Levy et al. have shown that cells expressing Shh in the embryonic 
epidermis establish a lineage distinction between what w ill become, the hair 
fo llic le and the surrounding epidermis: cells of the adult bulge are derived from 
the follicular epidermis, but cells of the interfollicular epidermis are not (Levy et 
al., 2005).
Claudinot et al. have shown that thousands of hair follicles can be generated from 
the progeny of a single cultured epidermal stem cell. However, the keratinocytes 
used for transplantation were marked and this revealed that the interfollicular 
epidermis adjacent to labelled follicles remained unlabelled over many months 
(Claudinot et al., 2005).
In the third study, Ito et al. ablated bulge cells by using the K15 promoter to 
express a thymidine kinase suicide gene. Bulge ablation led to complete loss of 
the hair fo llic le but survival of the interfollicular epidermis. Using lineage-marking 
to fo llow  the fate of cells in which the K15 promoter is active, Ito et al. also 
showed that bulge cells do not normally contribute to the interfollicular 
epidermis. Following damage to the epidermis, bulge-derived cells contributed to 
the interfollicular epidermis, but this was temporary and the cells were 
subsequently lost (Ito et al., 2005). This observation is in agreement with the fact 
that transplanted bulge stem cells home to the bulge (Claudinot et al., 2005). 
These studies show that interfollicular and bulge stem cells constitute two distinct 
populations.
There is already evidence demonstrating that two distinct stem cell populations 
exist w ithin the bulge (Blanpain et al., 2004). In addition, clonal labelling has 
revealed distinct populations of self-renewing cells that feed individual lineages at 
the base of the hair follicle, and distinct clonal organisation along both the 
proximo-distal and radial axes of the follicle (Legue and Nicolas, 2005). Further 
studies w ill be needed to unveil the stem cell hierarchy within the HF, IFE and SG
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populations.
1.3- The Stem cell niche
1.3.1 -Definition and experimental characterisation
Since 1978, when Schofield proposed the 'niche hypothesis' as a description of 
the physiologically limited microenvironment that supports stem cells (Schofield, 
1978), many investigators have become interested in first identifying the presence 
of niche in a variety of tissues and more recently in characterising the nature of 
the niche (Li and Xie, 2005). The definition is still the same after almost 30 years. 
Niche is a 'specific location in a tissue whose microenvironment enables stem 
cells to reside for an indefinite period of time and produce progeny cells with self- 
renewing capacities (Nystul and Spradling, 2006). Niches exhibit a complex 
architecture and they use diverse regulatory pathways (Nystul and Spradling, 
2006).
Identification of the signals that regulate stem cell differentiation is fundamental 
for the understanding of cellular diversity. It is becoming evident that both the 
extracellular cues from the niche and the cell autonomous or intrinsic genetic 
characteristics control stem cell function (Li and Xie, 2005). These intrinsic 
regulators include proteins involved in determining asymmetric cell divisions, 
nuclear factors controlling gene expression, chromosomal modifications in stem 
and committed daughter cells, and biological clocks that might set up the number 
of rounds of division within the TAC population (Watt et al., 2006; Watt and 
Hogan, 2000). Stem cell niches provide extracellular and intracellular key 
components that determine the lineage commitment and stem cell self-renewal. 
Neighbouring cells secrete factors required for differentiation and self-renewal. 
Cell-cell interactions mediated by integral membrane proteins are also required to 
direct other signals that control stem cell fate (Li and Xie, 2005).
1.3.2-The hair follicle niche: a city with many 'inhabitants'
The hair fo llic le  is a multi-cellular niche, harbouring several cell types and 
populations that reside and interact with each other within the niche, and has 
even been named the 'bone-marrow' of the skin (see Figure 1.7; Schmidt-Ullrich
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and Paus, 2005). The HF represents a prototypic neuroectodermal-mesodermal 
interaction system that is provided by three stem cell sources: epithelial, neural 
crest and mesenchymal (Schmidt-Ullrich and Paus, 2005). The interaction of 
these different cell types starts during embryonic development and persists 
through adulthood, as they are all required to maintain the HF functioning (Millar, 
2005). In the HF niche there are also other stem cell populations: such as 
melanocyte stem cells that reside in the bulge region (Nishimura et al., 2004). 
Interestingly, their interaction with bulge keratinocytes and secreted factors in the 
niche are key regulators of the melanocyte fate and function (Millar, 2005). In 
addition, two studies have shown that the DP constitutes a niche for progenitor 
cells, known as adult skin derived precursors (SKIPs) (Figure 1.7; Fernandes et al.,
2004). Further studies w ill be important to unveil further the molecular basis of 
the interaction between these populations and keratinocytes and their relationship 
with epidermal stem cells.
Many advances have been made in attempting to unveil the nature of the niche. 
The isolation studies of bulge and their neighbour cells outlined in earlier 
sections, gave a profile of genes including inhibitors of cell cycle, differentiation 
and promoters of high adhesion making the bulge a proliferation, and 
differentiation restricted environment (Fuchs et al., 2004; Tumbar et al., 2004). 
For example, the expression of the W nt inhibitors Dkk3 (Dickkopf3) and W ifi 
(W rit-inhibiting factor 1) in the bulge underscores the importance of genes that 
maintain stem cells in a non-proliferative state and the inhibition of the Wnt 
pathway, which is crucial for lineage commitment in epidermis.
Recently, the molecular signature of the several cell populations resident in the 
bulb, the growth-promoting niche in mature hair follicles has been revealed. 
Rendl and colleagues have combined multicolour tagging with cell specific 
promoters and surface marker labelling to distinguish between ORS, matrix, 
dermal fibroblasts, dermal papilla and melanocytes (Figure 1.4 and 1.7; Rendl et 
al., 2005). For instance, not only several cell types interact with each other but 
also they express differentially components of key signalling pathways for lineage 
determination. An example is how the Wnt pathway components are distributed
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among these populations: the matrix cells (Wnt10, Wnt11, Wnt5A, Wnt4, Axin2), 
the ORS (Wnt4, WntIO), the dermal papilla cells (Wnt5A, Wnt11, W if i,  Srfp2, 
Frzb, Fzd2, Nkd2, Axin2) and the melanocytes (Dkk3, Nkd1, Nik, Axin2, Wnt4, 
W if i ).
In addition, a part of local regulatory pathways, the HF niche is also highly 
innervated and vascularised and also respond to various hormonal and immune 
signals (Schmidt-Ullrich and Paus, 2005; Figure 1.7). The hormonal and immune 
regulation is tightly linked to the hair cycle, making the HF niche one of the 
unique sites in the body with immune privilege and a peripheral centre for stress 
(Paus et al., 2005; Paus et al., 2006; Arck et al., 2006). This suggests that the local 
niche is under a more global control form of systemic regulation that controls the 
hair and its appendages (Arck et al., 2006).
1.3.3- Pathways modulating the nature of the HF niche
Several pathways are important in regulating the epidermal stem cell 
compartment, but I w ill only focus on those related to my Thesis. These include 
the Wnt, Hedgehog, Notch and Eph/ephrin pathways and their downstream 
effectors. In addition, I w ill also include work from our laboratory that has 
highlighted the importance of integrins, Racl and Myc on how the nature of the 
niche regulates the fate of stem cells.
The niche is important both for population asymmetry and for invariant 
asymmetry in skin. One way to achieve an asymmetric division is to orient the 
plane of mitosis so that one cell remains in the basal (undifferentiated) layer and 
the other in the suprabasal (differentiating) layer. It has recently been shown that 
in the developing epidermis such vertically oriented mitoses involve asymmetric 
location of a protein complex containing protein kinase C (PKC)£, Par3 
(partitioning defective 3) and LGN-lnscuteable (Lechler and Fuchs, 2005). The 
asymmetric location of this protein complex depends on integrins and cadherins, 
and does not occur in p63~/_ epidermis (Koster et al., 2005; Koster et al., 2006). 
This study further shows how adhesion of stem cells to the extracellular matrix 
(ECM), mainly through integrins is also crucial for regulating stem cell behaviour.
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Although the role of asymmetric divisions in progenitor differentiation in adult 
oesophagus is known (Seery and Watt, 2000), the role in adult IFE remains 
controversial.
Integrin signalling is involved in controlling cell growth, differentiation, migration 
and survival, either on its own or by cross talking with growth factor signalling 
(Giancotti and Ruoslahti, 1999). Although integrin-mediated adhesion to the 
extracellular matrix negatively regulates terminal differentiation of cultured 
keratinocytes, epidermal deletion of integrins in vivo does not lead to a stem cell 
depletion phenotype (Lopez-Rovira et al., 2005).
This has led to a search for pleiotropic effectors of integrins and other cell surface 
receptors such as Rho GTPases that might be required to maintain the stem cell 
compartment and niche in vivo .
For instance, Rac1 regulates cell adhesion and growth factor responsiveness, 
factors involved in niche remodelling and its deletion leads to a failure to 
maintain the interfollicular epidermis, hair follicles and sebaceous glands, 
resulting in stem cell depletion (Benitah et al., 2005). Upon deletion of Rac1, 
there is an initial, transient increase in proliferation and c-Myc expression, 
followed by loss of proliferating cells and by the onset of terminal differentiation 
(Benitah et al., 2005). It turns out that Rad exerts its effects by negatively 
regulating Myc, through PAK2 phosphorylation of Myc (Benitah et al., 2005). 
Activation of Myc causes cells to exit from the epidermal stem cell compartment 
and stimulates differentiation into interfollicular epidermis and sebaceous glands. 
Interestingly, one way in which Myc acts is by Miz1-dependent repression of cell 
adhesion genes, including the a6 and |31 integrin subunits (Gebhardt et al., 2006), 
thus impacting on the nature of the stem cell niche. Although overexpression of 
Myc triggers terminal differentiation, ablating Myc from the epidermis results in 
insufficient expansion of the stem cell compartment (Zanet et al., 2005).
In addition, other Rho GTPases also play important roles in the epidermis. RhoA 
signalling suppresses differentiation of cultured keratinocytes, as does the Rho 
effector CRIK (citron kinase) (Grossi et al., 2005). Rho and CRIK might act by
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affecting integrin and Notch signalling (Grossi et al., 2005). Recent studies show 
that deletion of Cdc42 results in progressive hair loss and formation of epidermal 
cysts (Wu et al., 2006), reminiscent of the consequences of blocking P-catenin 
signalling (Niemann and Watt, 2002). This shows that Cdc42 is an important 
regulator of hair progenitor cell differentiation.
Other factors that are important in triggering stem cell proliferation are Tert, the 
catalytic subunit of telomerase (Flores et al., 2005), which promotes bulge stem 
cell mobilisation in the absence of changes in telomere length, and P-catenin 
stabilisation, which promotes the transition from quiescent stem cell to 
proliferating transit-amplifying cell in the bulge (Lowry et al., 2005). The changes 
in Rac1, Myc, Tert and P-catenin activity that are found in epithelial tumours 
(Fuchs et al., 2004; Benitah et al., 2005; Flores et al., 2005) would be consistent 
with the hypothesis that signals from the niche lead to increased stem cell 
proliferation predisposing the epidermis to cancer.
1.4- The Wnt pathway a key regulator of lineage 
commitment in epidermis
There are increasing numbers of pathways involved in the homeostasis and 
development of the skin, combining changes in gene expression with dynamic 
changes in cell adhesion and migration. The key signalling pathways involved in 
lineage commitment, include Wnt/p-catenin, BMP, FGF, EGF, NFKB, Notch and 
Shh. In this section I w ill give an overview of the Wnt pathway (Figure 1.8).
1.4.1- Outline of the Wnt pathway
Several members of the Wnt pathway, ligands, receptors and their antagonists are 
dynamically expressed in all the compartments of the skin (Millar, 2002, 2003; 
Reddy et al., 2001; Reddy et al., 2004) as shown by expression analysis and 
profiling of the distinct populations (Millar, 2003; Rendl et al., 2005). Wnt ligands 
activate three different signalling branches (Figure 1.8; Ciani and Salinas, 2005): 
canonical W nt w ith p-catenin as the main downstream effector (Figure 1.8 A), the 
planar cell polarity (PCP) which modulates cytoskeleton via interaction with the 
family of Rho GTPases (Figure 1.8 B) and calcium W nt pathway which
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Figure 1.7- The hair follicle niche. This diagram illustrates the large array of cell 
types that co-exists and composes the hair follicle stem cell niche. Each cell type is 
explained by the colour code. There are two distinct niches in the hair follicle; one 
located in the permanent portion of the hair follicle, the bulge, where stem cells reside 
and the second niche is in the lower portion of the hair follicle, the bulb, where prolif­
eration and differentiation take place.
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modulate intracellular calcium and gene transcription via NF-AT (Figure 1.8 C). In 
this Introduction I w ill focus in the p-cateninAVnt branch.
1.4.2- The canonical Wnt pathway
p-catenin is a key effector of the W nt signalling pathway and a structural 
component of the adherens junctions, linking cadherins to the actin cytoskeleton, 
which plays a role during development of many tissues (Nelson and Nusse, 2004; 
Moon et al., 2002; See diagram in Figure 1.8 A). In the absence of W nt signalling, 
the level of P-catenin in the cytoplasm that is not complexed with cadherins is 
rapidly phosphorylated in its N terminal region by glycogen synthase kinase 3p 
(GSK-3P) and ubiquitinated. In the presence of a Wnt signal, GSK-3P is inhibited, 
resulting in accumulation of cytoplasmic p-catenin, which is then able to 
translocate to the nucleus and interact with members of the TCF/Lef family and to 
regulate transcription of target genes (Nelson and Nusse, 2004; See Figure 1.8 A).
1.4.3- Canonical W nt pathway and lineage commitment in skin
At the start of my Thesis, there was considerable evidence that the Wnt pathway 
regulate epidermal lineage selection (Figure 1.9). When P-catenin is conditionally 
deleted in the skin during embryogenesis there is no hair formation, and if the 
deletion occurs after birth the hair is lost after the first hair cycle (Huelsken et al.,
2001). When Dickkopf-1, an inhibitor of Wnt action, is ectopically expressed, the 
development of hair follicle is completely abolished (Andl et al., 2002). When the 
W nt pathway is blocked by a dominant negative form of Left mice have a 
progressive hair loss, develop epidermal cysts with interfollicular differentiation 
and they also develop tumours with sebaceous differentiation (Figure 1.9; 
(Niemann et al., 2002; Merrill et al.2001). Epidermal expression of constitutively 
active p-catenin during embryogenesis leads to hyperproduction of hair follicles 
and development of tumours similar to human pilomatricomas and 
trichofolliculomas (Figure 1.9; Gat et al., 1998). Transient activation of P-catenin 
in adult epidermis induces telogen follicles to enter anagen and the formation of 
ectopic hair follicles (Figure 1.9; Van Mater et al., 2003; Lo Celso et al., 2004). 
The levels of P-catenin activation are crucial for lineage commitment in skin; high 
levels favour hair morphogenesis and blocking the pathway leads to inhibition of
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Figure 1 .8 -The main branches of Wnt signalling pathway. (A) The ca no n i­
cal o r W n t/p -ca te n in  pathway. Binding of W nt to the Frizzled and low-density lipopro­
tein receptor 5 (LRP5) or LRP6 complex activates Dishevelled (DVL). Signalling through FZ 
require C-protein activation. Activation of DVL results in inhibition of glycogen synthase 
kinase 3p (GSK3p) and accumulation of p-catenin in the cytoplasm by inducing dissassem- 
bly o f the destruction complex that is formed by adenomatosis polysis coli (APC), Axin and 
(GSK3p). Subsequently, P-catenin translocates to the nucleus where it activates transcrip­
tional mediated T-cell specific transcription factors (TCF)/lymphoid-enhacing factor 
(LEF).(B) In the planar cell polarity (PCP) pathway, FZ functions through G-proteins to 
activate DVL, which in turn, signals Rho GTPases (Rho, Rac or both). Activation of Rac 
signals through c-Jun amino (N)-terminal kinase (JNK). (C) In the W nt/calcium  pathway, 
activation o f DVL induces the release of intracellular calcium and activation of protein 
kinase C (PKC) and calcium/calmodulin-dependent protein kinase II (CamKII). This path­
way has been im plicated in cell fate and cell movement. NF-AT, nuclear factor of activated 
T cells. Taken and adapted from Ciani and Salinas.2005.
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appendage formation (Figure 1.9; Gat et al., 1998; Huelsken et al., 2000; Merrill 
et al., 2001; Niemann et al., 2002; Andl et al., 2002; Van Mater et al., 2003; Lo 
Celso et al., 2004).
Although p-catenin is the key effector of W nt signalling in the epidermis, a closely 
related protein, plakoglobin, has many similar properties. Recent studies have 
shown that epidermal overexpression of plakoglobin mimics the effects of 
overexpressing p-catenin, but plakoglobin cannot completely rescue the 
phenotype of p-catenin ablation (Teuliere, et al.2004). This might be related to the 
dual role of both proteins in adhesion and transcription (Brembeck et al., 2006).
1.4.4-Revealing the modulators and partners of P-catenin
In the epidermis the activity of p-catenin is regulated in a very complex way, 
because the W nt pathway interacts at many levels with other signalling pathways, 
such as BMP (Jamora et al., 2003; Jamora et al., 2005; Yuhki et al., 2004) Notch 
(Nicolas et al., 2003; Iso et al., 2003) and Hedgehog (Millar, 2002; Michno et al., 
2003; St-Jacques et al., 1998; Niemann et al., 2003).
The balance between the cell adhesion and the transcriptional activities of P- 
catenin is key in determining the activation of the pathway. It w ill be very 
important to elucidate new factors regulating the different pools of P-catenin as 
they exert different functions (Brembeck et al., 2006), and it is likely to constitute 
a very important form of regulation. In this line, two recent reports started 
demonstrating this idea. In one Wu et al. showed that Cdc42 modulate hair 
progenitor differentiation by modulating p-catenin turnover. Cdc42 plays a role in 
preventing P-catenin degradation by phosphorylating GSK3P and Axin, two 
negative regulators of P-catenin stabilization (Wu et al., 2006). This is dependent 
on an association among Cdc42, PKC£, Par6 and Par3 (Wu et al., 2006), an 
important complex for asymmetric division in skin (Lechler and Fuchs, 2005). In 
the other very recent study, Ganwen et al. show that the Smad antagonist Smad7 
determines the lineage choice between HF and SG by modulating Wnt/p-catenin 
signals. The mechanism is also modulation of the levels of P-catenin by 
interacting with p-catenin and targeting it to degradation via a novel mechanism 
dependent on Smurf2 (Han et al., 2006).
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Another important aspect w ill be to elucidate alternative transcriptional partners 
of p-catenin in skin and to study the intersection between W nt and other 
pathways.
1.5- Patterning during development
The simplest pattern observed during development is the spacing pattern. This 
involves the maintenance of regular distance between neighbouring cells. 
Examples in which this patterning is observed include teeth, skin appendages, 
scales and limbs (Wolpert, 1998; Wolpert L; Beddington R, 1998). The formation 
and maintenance of boundaries is a key feature of tissue patterning and results 
from the outcome of a complex interplay of several pathways leading to 
differences in cell adhesion and repulsion, cell migration and proliferation and 
determining whether a boundary w ill form and separate distinct cell populations 
or not (Sela-Donenfeld and Wilkinson, 2005; Pasquale, 2005). The Drosophila 
imaginal disk is the classical model to study patterning (Saburi and McNeill,
2005). In mammals, the limb and feather development are two models that have 
been widely used to investigate what are the mechanisms that regulate growth 
and patterning and how they are integrated. These pathways include previously 
mentioned HH, WNT, TGFp, BMP, and FGF along with their transducers and 
modulators. These appear to constitute a kind of ancient 'genetic toolbox' that is 
constantly being used in most of the developmental programmes that make up 
tissues (Capdevila and Izpisua Belmonte, 2001). The final result depends on the 
activity and integration of particular downstream effectors or 'realisator genes' 
that are expressed (or active) in a particular organ or structure, giving as a result 
the formation of different structures, i.e. a limb or a hair follicle (Capdevila and 
Izpisua Belmonte, 2001). Spatially organised cues can function in a graded 
manner to specify cell movement and cell fate. This can be a mechanism that 
links cell differentiation and patterning (Pasquale, 2005).
1.5.1- Patterning appendages/ lessons from feather development
Feather development has been dissected in great detail. Some parallels can be 
drawn between hair follicles and feather morphogenesis. In chickens, skin 
morphogenesis occurs in successive stages (Yu et al., 2004). Firstly, the skin forms
45
distinct regions, known as macropatterning and secondly, the skin appendages 
with particular shapes and sizes form in each region, known as micropatterning 
(Chang et al., 2004; Yu et al., 2004). The spacing of feather buds involves signals 
from the epidermis to the underlying mesenchyme. The dermis is the main factor 
determining skin appendage size and spacing. Several Wnt members are 
dynamically expressed during feather morphogenesis (Chang et al., 2004). Wnt 
signalling determines the formation skin regions (macropatterning) and of 
appendages in chicken skin and the shape of individual feathers (micropatterning) 
(Chang et al., 2004; Yu et al., 2006).
It appears that a positive adjacent ectodermal (horizontal) or dermal (vertical) 
regulator is concentrated locally, providing the initial signal. This leads to the 
formation of a circumscribed placode of functionally distinct keratinocytes (Chang 
et al., 2004). Additionally, members of the Shh, FGF, foilistatin, BMP and Eph 
(EphA4) signalling are expressed during feather bud formation, similar to limb 
development (jung et al., 1998; Wolpert, 1998; McKinnell et al., 2004a; 
McKinnell et al., 2004b; Yu et al., 2004). The fact that both activators (Shh, FGF, 
Follistatin, EphA4) and inhibitors (BMP) are expressed in the forming feather, 
favours a model for achieving periodic patterning in which the two signals diffuse 
at different rates. A periodic pattern can form, the activators having higher 
potency but a shorter range of action, whereas the inhibitors diffuse further and 
act over a long range. Through positive feedback (i.e. follistatin expression) and 
lateral inhibition (BMP, Notch signalling), the competition leads to evenly spaced 
structures (Jung et al., 1998; McKinnell et al., 2004a; McKinnell et al., 2004b). 
Although feathers and hairs evolved independently, recent studies demonstrate 
remarkable convergence evolution of their stem cell compartment (Yu et al., 
2004; Yue et al., 2006); the location of feather stem cells determines feather 
symmetry and is, in turn determined by the activity of Wnt3A (Yue et al., 2006).
1.6- Ephrin/Eph family
In recent years the role of the family of Eph receptors and their Ephrin ligands 
have started to account for their role in cell sorting in vascular remodelling and in 
epithelial systems (Pasquale, 2005). This family of Ephrin ligands and receptors is 
divided into two sub-types: A and B; ephrin-A ligands are tethered to the plasma
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membrane, whereas ephrin-B ligands are transmembrane proteins (See Figure 
1.10). Generally EphA receptors interact with ephrin-A ligands and EphB 
receptors with ephrin-B ligands. W ithin each class, the receptor-ligand pairs have 
different affinities and tend to be very promiscuous. EphA4 constitutes an 
exception, as it not only binds to ephrin-A ligands, but also ephrin-B2 and ephrin- 
B3 (Pasquale, 2005).
1.6.1- Eph/ephrin signalling
Interaction between ligand and receptor requires cell-cell contact as both are 
anchored to the plasma membrane. Eph and ephrins can signal bidirectionally 
(Figure 1.10): this is known as forward signalling in the receptor expressing cell, 
and reverse signalling in the ligand expressing cell (Kullander and Klein, 2002; 
Pasquale, 2005). The first step is the formation of an Eph receptor/ephrin cluster. 
Eph/ephrin complexes can progressively aggregate into larger clusters, depending 
on the density of receptors and ligands found on the cell surface (Pasquale, 2005). 
Ligand binding and receptor clustering lead to Eph receptor protein 
autophosphorylation at the tyrosine residues located in the cytoplasmic tail and at 
the distal tip of the tail there is a PDZ-binding motif. This acts as docking site for 
SH2 domain proteins and PDZ domain containing proteins, respectively, 
including guanine nucleotide-exchange factors of Rho GTPases and signalling 
adaptors. Examples are: Nek, RasGAP, Fyb, Src, Yes, P85-PI3K, Grb2, Abl, 
SHEP1, Ephexin, Syntenin, P ick l, Grip, AF-6, Dvl (See Figure 1.10; Kullander and 
Klein, 2002; Pasquale, 2005)
Although ephrin-B ligands lack catalytic function they become phosphorylated by 
Src kinases upon receptor binding and clustering. They also contain a PDZ- 
binding motif (Figure 1.10) that allow for the recruitment of adaptor proteins and 
cytoskeletal regulators. Examples are: Src/Fyn/yes, Fyn, Grb4, Syntenin, Pickl, 
Grip, Grip2, FAP-1, PDZ-RGS, PHIP, PTP-BL, Dvl (Kullander and Klein, 2002; 
Noren and Pasquale, 2004; Pasquale, 2005). In addition, if Eph receptors and 
ephrins are expressed in the same cells, they can act as heterophilic cell adhesion 
molecules. However, the physiological significance of these lateral interactions 
remains to be established (Pasquale, 2005).
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Figure 1.9- Wnt/p-catenin pathway is critical for lineage commitment 
in mammalian skin . This diagram is a summary of several early studies that illus­
trate the role of P-catenin activation in lineage commitment. (A) Constitutive activa­
tion of P-catenin leads to the formation of tumours of hair origin known as trichofol- 
liculomas (see Gat et al., 1998; Lo Celso et al., 2004). (B) In wild-type skin a pulse 
of P-catenin activation leads to HF to enter the anagen growth phase (Lo Celso et 
al., 2004; Van Mater et al., 2003). (C) When P-catenin is blocked by knockout 
(Huelsken et al.,2001) or by inhibitor overexpression (Andl et al.,2004) a single 
epithelium forms without appendages or if the deletion occurs later in development 
the appendages degenerate and are lost. (D) The P-catenin/ Lef 1 interaction is 
crucial for HF development. When this is blocked HF are lost and instead there is 
formation of SG and IFE cysts and development of sebaceous tumours (Niemann et
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The Eph/Ephrin pathway converges with other well-known tyrosine kinases 
signalling and ECM modulators pathways and modulate adhesion, proliferation 
and cytoskeleton dynamics (Kullander and Klein, 2002; Noren and Pasquale, 
2004). For instance, it has been shown in vitro that Eph/ephrin signalling can 
either activate or inhibit integrin signalling; inhibit ERK/MAPK pathway and 
modulate cytoskeletal dynamics via modulation of the activities of Rho GTPases 
(Rho, Cdc42 and Rac) (Kullander and Klein, 2002; Noren and Pasquale, 2004; 
Poliakov et al., 2004; Poliakov and Wilkinson, 2006).
In addition, recent studies start to point the importance of the intersection of 
Eph/ephrin signalling with other signalling pathways such as canonical Wnt, 
Planar Cell Polarity (PCP) and Notch signalling pathways, important in multiple 
processes in morphogenesis and patterning during development (Noren and 
Pasquale, 2004; Poliakov et al., 2004; Poliakov and Wilkinson, 2006).
1.6.2- Eph/ephrin signalling and patterning
Eph receptors and their Ephrin ligands have been shown to control boundary 
formation by either promoting repulsion or adhesion and attraction (Figure 1.10; 
(Xu et al., 1999; Mellitzer et al., 1999; Batlle et al., 2002; Cooke et al., 2005). 
There are several mechanisms resulting in cell repulsion including endocytosis of 
the adhesive Eph/ephrin complexes from the cell surface, proteolytic cleavage of 
ephrin ligands or by inactivation of cell-cell and cell-ECM adhesion molecules by 
Eph receptors. Mechanisms leading to promotion of adhesion and attraction 
include the result of a poor activation of pathways promoting cell separation, the 
activity of phosphatases if they are recruited to terminate signalling before cells 
are separated. In addition to mediating mechanical cell-cell adhesion, Eph/ephrin 
signalling can activate pathways that promote cell adhesion to the ECM, 
membrane ruffling and axon extension. Finally, the degree of clustering might 
also change the balance of opposing signals that regulate the cytoskeleton, cell­
cell and cel I-substrate adhesion (Pasquale, 2005). Eph/ephrin signalling in 
addition to determine the position of a cell it also influences on the shape, cell 
migration, proliferation and differentiation status of a cell (Pasquale, 2005; 
Poliakov et al., 2004).
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R E P U L S IO N
A D H E S IO N
IN V A S IO N
Several studies have shown that EphB/ephrin-B signalling is sufficient to block cell 
mixing and it is required for boundary formation. A good example of the 
involvement of Eph/ephrin signalling in the formation of sharp interfaces during 
development is the segmentation of rhombomeres in the hindbrain (Sela- 
Donenfeld and Wilkinson, 2005). The formation of rhombomers also relies on 
activation of Eph/ephrin signalling by modulation of adhesive or migratory 
properties of cells. Eph/ ephrin molecules are expressed complementarily in 
rhombomeres and cells from an odd-numbered mix preferably with cells from the 
same or another odd-numbered rhombomere. Interestingly, Xu et al showed that 
mosaic activation of Eph receptors leads to sorting of the cells to boundaries in 
odd-numbered rhombomeres. Mosaic activation of ephrin ligands result in sorting 
to boundaries in even-numbered rhombomeres (Xu et al., 1999). Analyses in 
zebrafish cell cap assays revealed that the bi-directional signalling through 
ephrin-B2 and EphB2 restricts cell intermingling, while unidirectional signalling 
through either the ligand or the receptor prevent cell communication (Mellitzer et 
al., 1999).
Further evidence supporting this notion has come from more recent studies in the 
developing limb and the small intestine (Compagni et al., 2003; Batlle et al.,
2002). The expression of EphB receptors and ephrin-B1 ligand is complementary 
in the developing limb. In addition, mosaic expression of ephrin-B1 shows that 
ephrin-BI expressing cells segregate from ephrin-B1 null cells. This suggests a 
role of ephrin-B1-EphB interaction signalling in the segregation of chondrocytes 
(Compagni et al., 2003).
Analyses of the intestinal architecture revealed that there are opposing gradients 
of expression along the crypt-villus axis of the receptors EphB2/EphB3 and the 
ligands ephrin-B2/ephrin-B1 (Batlle et al., 2002). These allow cell positioning to 
regulate progenitor fate. Progenitors sit on top of the Paneth cells at the bottom of 
the crypt, where there are high levels of receptor expression and where p-catenin 
is active. As the proliferative cells start migrating upwards they start the 
programme of differentiation and they downregulate the expression of receptors 
and instead they start expressing high levels of the ligands. In addition, they show 
that W nt signalling modulates the expression of Eph/ ephrin molecules and thus 
can regulate the balance of stem cell renewal versus differentiation and fate
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determination in a spatially regulated manner (Batlle et al., 2002; van de 
Wetering et al., 2002). Analysis of mutant mice reveal that the EphB/ephrin 
signalling prevents intermingling of proliferating cells into the zone of 
differentiating cells (Batlle et al., 2002).
1.7- Patterning in the epidermis and HF
Little is known about how pattern is controlled in mammalian skin: both the 
placing of individual hair follicles within the epidermis, and patterning of 
undifferentiated cells along the hair follicle outer root sheath or inner root sheath 
during development and how these are maintained during the hair cycle. The 
molecular basis for follicle pattern formation is not yet fully understood. The 
regulatory pathways involved in morphogenesis, such as, FGF, Wnt, BMP, 
hedgehog, are likely to play a role in determination of the pattern. In addition, 
homeobox transcription factors previously described as key regulators in limb 
patterning (Capdevila and Izpisua Belmonte, 2001) are also expressed in gradients 
in distinct compartments of the follicle and are likely to play a role (Hardy, 1992). 
A very recent example has started giving some clues as to how the primary hair 
fo llicle pattern might be set during embryogenesis by looking at the Edar/BMP 
pathway (Mou et al., 2006). The Edar/BMP had been shown previously to be key 
for primary hair development by inhibiting responsiveness (Schmidt-Ullrich et al.,
2006). In this study, Mou et al., from a culture system suggest a model in which 
Edar determines the localisation of stabilised P-catenin, thus where the follicle 
w ill be formed, by inducing a feedback loop between the dermis expressing 
BMP4/7 (inhibitor of HF) and the epidermis expressing CTGF (BMP4/7 inhibitor) 
(Mou et al., 2006). Further molecular and in vivo analyses are needed to 
understand how these and other pathways involved in HF morphogenesis are 
intersecting to generate HF pattern. It is likely that the pattern is set out as a 
complex interplay of pathways rather than a single one on its own.
In addition, not only we need to solve how the pattern is set up during embryonic 
development, but also how is maintained during the hair cycle. Regulation of 
pattern during anagen development is likely to include pathways involved in cell­
cell interaction, migration and invasion such as cadherins, integrins, GFs and their 
downstream counterparts.
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Aims
In this Thesis I set out:
1- To optimise and use the whole mount technique to obtain quantitative and 
spatial information about epidermal stem cells and their progeny without 
relaying on sections.
2- To study how p-catenin induces ectopic hair follicle formation in adult 
epidermis.
3- To us a model of inducible ectopic hair follicle formation, control p-catenin 
signal timing, strength and duration and analyse the impact of the p-catenin 
signal on the stem cell compartment and how this impacts hair follicle 
formation.
4- To identify pathways that intersect with p-catenin.
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Chapter 2- Materials and Methods
2.1- K14ANp-cateninER mice
2.1.1- Experimental treatment of mice
The D2 and D4 lines of K14ANp-cateninER transgenic mice were generated as 
described previously (Lo Celso et al., 2004). The Clare Hall Animal Unit carried 
out all animal care and breeding. All mouse husbandry and experimental 
procedures were conducted in compliance with the protocols established by the 
Cancer Research UK animal ethics committee, following the Home Office 
regulations. All mice were killed with C 0 2 following Humane killing regulations 
under The Animal Act 1986, Home Office.
K14AN|3-cateninER mice were maintained heterozygote and kept in C5-7BL/6 
background.
For my experiments I used mice that were 6-8 weeks old, and therefore in the 
resting phase of the hair cycle (Stenn and Paus, 2001). Wild-type, non-transgenic 
littermates were used as controls. The ANp-cateninER transgene was activated by 
topical application of 4-hydroxytamoxifen (40HT; Sigma) dissolved in acetone. 
40H T  was purchased from Sigma either 99% pure Z-isomer (biologically active) 
or minimum 70% pure Z-isomer. The doses indicated always refer to the amount 
of Z-isomer, and were always applied to the skin in a maximum of 200pl. Tail 
skin was treated by applying 40H T  with a paintbrush (0.5, 1.5 or 3 mg per mouse 
every second day). For back skin treatment (0.5, 1.5 or 3 mg per mouse) 40H T 
was applied with a Gilson micropipette to a clipped area of dorsal skin.
In order to study the interaction between p-catenin and Shh pathways, mice 
received daily topical applications of Cyclopamine (Biomol, 50 p,M in ethanol), 
and Im g 40H T  once per week (D2 line) or every second day (D4 line). 40H T 
was applied 30 minutes after Cyclopamine.
Typically, each experiment was designed so that each condition group was 
analysed in triplicate, this is, and 3 animals were used per condition.
For each experiment two controls were always included. These were transgenic 
mice treated with vehicle alone, in this case it was acetone, named Untreated. A
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second group of w ild  type mice treated with 40H T  or cyclopamine alone, named 
W ild type treated.
2.1.2- Genotyping procedure
2.1.2.1 -DNA extraction
For genotyping the Clare Hall Animal Unit (CRUK, London, UK) took a small ear 
snip from each animal. Each ear snip was incubated in 50pl of ear buffer 
containing 50mM Tris-HCI pH 8.0, 20mM NaCI, 0.1% SDS supplemented with 
2.5 pi of 25mg/ml proteinase K (Sigma) solution at 55°C for one hour, vortexed, 
and incubated at 55°C a further two hours. 150pl of dH20  were added and the 
tubes were incubated for 10 min at 95°C and subsequently briefly centrifuged to 
collect condensate from the lid. The DNA content per sample was measured by 
spectrometry using a Nano Drop reader (Nano Drop Technologies) in order to 
optimise the PCR reaction.
2.1.2.2- PCR reaction
The following primers (supplied by DNA Technology AIS) were used for 
genotyping PCR of K14AN|3-cateninER mice: p-cat [ATGCTGCTGGCTATGGTC 
AG] and for ER [GCACACAAACTCTTCACC]. In a 50pl reaction, 1pl of each 
primer (25pM) was added to 25pl of 2xPCR master mix (Promega), 1pl of DNA 
preparation and 22pl of dH20 . The following PCR conditions were used: 1 cycle 
[94°C, 1min], 32cycles [94°C, 30sec], [50°C, 30sec], [72°C, 1min] and 1 
cycle [72°C, 7min]. 10pl of the PCR product were run on a 2% agarose TAE gel 
following standard procedures (Sambrook, 1989). The PCR product of the 
transgene ANp-cateninER was a 0.6kb fragment.
2.2- Eph mice
Ephrin-B1-deficient animals were generated in Ralf Adams laboratory (London 
Research Institute,CRUK, London, UK) by breeding conditional (Lox/+ or Lox/Lox) 
mutants to PGK-Cre transgenic animals (Compagni et al., 2003). Homozygous 
EphB2 and EphB3 null mice were bred by Ralf Adams laboratory as described 
previously (Orioli et al., 1996). Wild-type mice of the same background and age,
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or EphB2 and EphB3 heterozygous or Cre-negative littermates were used as 
controls. I also examined mice in which the EphB2 cytoplasmic domain has been 
replaced by a p-galactosidase gene (Henkemeyer et al., 1996). This mice line was 
also kept and bred by Ralf Adams laboratory.
2.2.1-Genotyping procedure
All mice strains were genotyped by the Ralf Adams laboratory as previously 
described (Compagni et al., 2003); (Henkemeyer et al., 1996); (Orioli et al., 
1996).
2.3- BrdU labelling
2.3.1- Pulse for labelling S phase cells
To achieve short-term labelling of cells undergoing DNA synthesis, adult mice 
received an intraperitoneal injection of lOOmg/kg body weight 5-bromo-2'- 
deoxyuridine (BrdU; Sigma) 1 hour prior to sacrifice.
2.3.2- Generation of LRC in vivo
To generate label-retaining cells (LRC), the protocol described by Bickenbach and 
colleagues (Bickenbach, 1981) was used. Ten-day-old mice were injected with 
50mg/kg bodyweight 5-bromo-2'-deoxyuridine (BrdU; 20 j^I of 12.5 mg/ml BrdU) 
every 12 hours for a total of four injections to label mitotic cells. An extremely 
high percentage of keratinocytes incorporate the BrdU label because the 
epidermis is hyperproliferative in 10-day-old mice (Lopez-Rovira et al., 2005). 
Normally, mice were maintained for a minimum of 70 days after the final BrdU 
injection in order to detect LRC. In some experiments, the localisation of cells 
containing the BrdU label was assessed after a chase period of less than 70 days. 
Braun et al have shown that 28 days is the minimum chase period required to 
detect LRC in mouse skin (Braun et al., 2003). For an outline of the experimental 
design see Figure 3.3 and 3.4).
2.4-Antibodies
The primary antibodies used in this study are listed in Table 2.1. The secondary 
antibodies used were anti-goat, anti-rabbit, anti-mouse or anti-rat (H+L) IgG Alexa
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633, 488, 594 conjugated secondary antibodies and they were purchased from 
Molecular Probes.
2.5-Tissue sections immunofluorescence
2.5.1-Tissue processing for paraffin sections
To collect skin for paraffin sections, the back of the mouse was shaved before 
removing the skin and stretching out onto a backing card (dermal side down). In 
order to get a good cross-section of the skin, it is important that the direction of 
the hair shafts is parallel to the card. Small rectangles of skin, (tail, back, whiskers, 
ears) were cut out and placed into neutral buffered saline overnight before 
transferring to a 70 % ethanol solution. The CRUK Histopathology Unit mounts 
the supported skin in paraffin blocks. 5mm sections are then cut from the blocks 
using a microtome and mounted onto glass slides.
2.5.2-Paraffin tissue sections staining
Sections were deparaffinised by washing twice in Xylol followed by rehydration 
through four washes in isopropanol solutions of decreasing concentration (100 %, 
96 %, 75 %, 50 %) by the Histopathology Unit.
Standard staining procedure
Typically, a staining would be performed 3 times on 3 independent samples. For 
each set of stainings a section is always included with a secondary antibody only 
as a negative control. The normal protocol would include a first step of antigen 
retrieval: tissue sections would be microwaved in 10 mM sodium citrate (pH 6.0) 
for 5-20 minutes, incubated for another 15 minutes in the hot solution and rinsed 
in 1xPBS. If the protein to be analysed was a transcription factor then a 
subsequent step of permeabilisation was required. Sections were either incubated 
in a 0.3% TritonX-100/PBS solution for 5-10 minutes or for Ki67 and BrDU 
staining in 2 M HCI at 37°C, washed in borate buffer, and digested in 0.01% 
trypsin in 0.05 M Tris buffer for 3 minutes at 37°C. After antigen retrieval, sections 
were usually blocked in a freshly prepared Super Block Buffer, consisting of 2% 
bovine serum albumin, 5% fetal calf serum and 2.5% fish skin gelatin in PBS, for 
2 hours. After blocking sections were incubated with the primary antibody in
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Super Block solution at 4°C overnight. The next day sections were rinsed three 
times for 10 minutes each with PBS/0.2% Tween.
For immunofluorescence staining, secondary antibody conjugated to a 
fluorophore (see secondary antibodies list) was incubated with the section, for 45 
minutes at room temperature. A counter stain would be included in order to 
visualise and localise he protein under study. For this, sections were incubated 
with Phalloidin (either conjugated to TRITC (red channel), FITC (green channel), 
633 (blue channel) to visualise polymerised actin (Sigma) and DAPI to stain nuclei 
(Molecular Probes) simultaneously in dH20  for 10 minutes. Sections were rinsed 
with dH20  and then carefully dried and mounted in Mowiol (Calbiochem) or 
Vectashield (Vector).
Immunostained sections were kept at 4°C protected from the light.
For immunohistochemistry, the DAKO visualisation systems were used.
Sections were deparaffinised by washing twice in Xylol followed by rehydration 
through four washes in isopropanol solutions of decreasing concentration (100 %, 
96 %, 75 %, 50 %) by the Histopathology Unit. Next, sections would be blocked 
with H20 2 for 5min. The following steps would be the same as described above. 
After incubation w ith the primary antibody and subsequent washings, sections 
were incubated with HRP conjugated secondary antibodies and then reacted with 
DAB substrate according to the manufacturer's instructions. Following incubation 
with the secondary antibody sections were washed twice in PBS and incubated 
for 30 min at room temperature with streptABComplex/HRP (DAKO) prepared 
according to the Manufacturer's instructions. Slides were washed twice again in 
PBS and then developed in di-amino-benzydine The DAB solution was either 
supplied already prepared or it was prepared by adding one tablet of DAB to one 
tablet of hydroxyurea in a total volume of 10ml dH20 . After 3 washes in dH20  
sections were dehydrated and counterstained with haematoxylin and mounted by 
the CRUK Histopathology Unit.
When labelling sections of mouse skin with mouse primary antibodies, Mouse on 
Mouse kit (Immunofluorescence or Immunohistochemistry kits, Vector 
Laboratories) was used according to the Manufacturer's instructions. This kit
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worked well for both immunofluorescence and immunohistochemistry 
procedures.
2.5.3-Cryosections sections
To prepare frozen sections of mouse skin, small rectangles of skin sample were 
placed on nitrocellulose membrane for support and subsequently in a plastic 
mould containing O.C.T compound (BDH) and then frozen on dry ice. Frozen 
blocks were stored at -70°C before cutting 6-1 Opm sections with a cryomicrotome 
(Reichart-Jung) and mounting onto slides (Superfrost Plus, BDH).
When staining sections I followed the method described for paraffin sections from 
the blocking step onwards.
2 .6-  Whole mount preparation
The method to prepare mouse tissue was developed by Uffe Jensen and Kristin 
Braun (Braun et al., 2003; Jensen et al., 1999) by modifying a method originally 
described to prepare human epidermal whole mounts (Jensen e t al., 1999).
To prepare whole mounts of mouse tail epidermis, a scalpel was used to slit the 
tail lengthways. Skin was peeled from the tail, cut into pieces (0.5x0.5 cm2) and 
incubated in 5 mM EDTA in PBS at 37°C for four hours. Forceps were used to 
gently peel the intact sheet of epidermis away from the dermis and the epidermal 
tissue was fixed in 4% formal saline (Sigma) for 2 hours at room temperature. 
Fixed epidermal sheets were stored in PBS containing 0.2% sodium azide at 4°C 
for up to 8 weeks prior to labelling.
2.6.1 -Immunolabelling of tails skin whole mounts
Typically, every staining w ill be performed a minimum of 3 times on 3 
independent samples. For an experimental outline see Figures 3.1 and 3.3.
Epidermal sheets were blocked and permeabilised by incubation in PB buffer for 
30 minutes. PB buffer consists of 0.5% skim milk powder, 0.25% fish skin gelatin 
(Sigma) and 0.5% Triton X-100 in TBS (0.9% NaCI, 20 mM HEPES, pH 7.2). 
Primary antibodies were diluted in PB buffer and tissue was incubated overnight 
at room temperature with gentle agitation. Epidermal whole mounts were then
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washed for at least 4 hours in PBS containing 0.2% Tween 20, changing the buffer 
several times. Incubation with secondary antibodies was performed in the same 
way. Samples were rinsed in distilled water and mounted in Gelvatol (Monsanto, 
St Louis, MO) containing 0.5% 1,4-Diazabicyclooctane (DABCO) (Sigma) or with 
Vectashield mounting medium (Vector).
A negative control was always included and these would determine the settings 
for confocal microscopy analysis (For an example see figure 3.3).
To detect BrDU or transcription factors, after permeabilisation and prior to 
incubation with primary antibodies, epidermal sheets were incubated for 20-30 
minutes in 2M HCI at 37°C.
2.6.2- Visualisation of sebocytes in tail whole mounts
Lipid-containing cells, including sebocytes, were detected by performing Nile Red 
staining on frozen sections. A stock solution of Nile Red (x1000, 10pg/ml in 
methanol) was normally diluted 1/1000 in PBS. Whole mounts were incubated in 
1x Nile Red for 15 minutes and washed with PBS or washing buffer for up to 4 
hours to remove excess stain. Then cells were mounted and visualised by 
confocal microscopy. When I performed Nile Red staining together with antibody 
immunolabelling, I first carried out the normal procedure for antibody labelling 
and immediately after the secondary staining I added the Nile Red for 15 minutes 
and washed with washing buffer for up to 4 hours to remove excess stain. When I 
performed double labelling I always used a secondary antibody conjugated with 
633 fluorophore to avoid bleed through between the green (488) and the red 
(594) channels.
2.6.3-Visualisation of apoptotic cells in tail whole mounts
Apoptotic cells were detected in epidermal sheets by using the DeadEndTM 
Fluorometric TUNEL System (Promega). Prior to performing the TUNEL assay 
whole mounts were immunolabelled with a keratin 14 antibody in order to
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visualize basal cells. The analysis were performed in 3 independent samples 
(0.5x0.5cm2/each). FITC positive cells then would be counted under a 
microscope.
2.6.4-Melanocyte visualisation in tissue sections and whole mounts
To visualise melanocytes, epidermal sheets were incubated with 0.2% L-Dopa 
diluted in dH20  at 37° C in the dark for 6h to overnight. L-Dopa was handled 
under the fume hood to avoid inhalation or skin contact. Solutions were prepared 
freshly each time, always under the fume hood.
Before mounting slides were rinsed with dH20  several times and mounted with 
Mowiol (Calbiochem) or Vectashield (DAKO).
Epidermal sheets harvested from albino mice were used as a negative control of 
each experiment.
Paraffin sections were dewaxed prior to L-Dopa labelling. Before mounting they 
were de-hydrated. A light counter stain with Hematoxylin was also performed to 
facilitate visualisation of the epidermal structures.
2.6.5-Optimisation of the whole mount labelling
When 1 performed immunolabelling with a new antibody I always used the 
standard whole mount immunolabelling procedure with a different range of 
antibody concentrations. However, if a staining did not work properly I 
customised the protocol for the antibody staining. The following steps were 
modified in order of importance when changing the procedure: 1- Order, 2- 
Temperature, and 3-Agents and 4- Incubation time.
1- Order: Start with permeabilisation, followed by immunolabelling and 
fixing at the end.
2- Temperature: Perform all procedures at 4°C (including fixation, 
permeabilisation and staining).
3- Fixative agents: The following options would be tried: No fixation. 
Different concentrations of formaldehyde (i.e. 4%, 0.4%). Different 
concentrations of fresh paraformaldehyde (i.e. 4%, 0.4%). This proved to 
be the most adequate. Try methanol, acetone or methanol/acetone (1/1) for
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30 min to overnight at 4°C. Bouin's fixative 2hours at room temperature. 
Zinc containing fixative overnight at 4°C.
4- Permeabilising agents: PB buffer with 0.5% Triton-X100, or with 0.05% 
Triton-X100 or 0.5% Saponin; or PBS with 0.5% Saponin.
5- EDTA treatment: Decrease the incubation time or use Dispase (Invitrogen) 
instead as previously described (Rendl et al., 2005).
6- Use Phosphor free buffers: for phospho antibodies.
2.6.6- Protocol for visualising Eph and ephrins in skin sections and 
whole mounts
When ephrin-B/ EphB immunolabelling was performed on tail whole mounts a 
modified version of the protocol described by Batlle et al. was used (Batlle et al.,
2002).
Whole mounts were processed normally and fixed with 4% paraformaldehyde for 
2 hours at 4°C. However, they were developed using a combination of a HRP 
conjugated secondary antibody (ENVision®System-HRP (DAB) from DAKO) and 
Tyramide-FITC (Molecular Probes) following the manufacturers instructions.
When ephrin-B/EphB immunolabelling was performed in back skin DAB substrate 
was used in the developing step, as described for the protocol of 
immunohistochemistry.
Knockout tissue and omission of primary antibodies were always used as negative 
controls.
2.6.7-X-gal staining in whole mounts
Tail whole mounts were fixed with 4% PFA for 1 hr at room temperature. The 
following stock solutions were prepared and combined as shown to give 10 ml X- 
gal substrate solution.
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Solution [Stock] [Working] [For 10 ml]
K3Fe(CN)6 0.5M 5mM 100 ml
K4Fe(CN)6 0.5M 5mM 100 ml
MgCI2 0.5M 2mM 40 ml
Nonidet P40 10% 0.02% 20 ml
Sodium deoxycholate 5% 0.01% 20 ml
IxPBS 10x 1 x 1 ml
X-Gal 40mg/ml 1 mg/ml 250 ml
dH2Q 8.47 ml
Whole mounts sheets were incubated with the substrate solution in wells of a 
24/well plate on a rocking table at 37°C for 6 hours to overnight. The reaction was 
terminated by fixing the whole mounts again for 4 hours at 4°C with 4% 
formaldehyde solution. Whole mounts were mounted with Mowiol and kept at 
4°C.
2.6.8- Confocal microscopy of epidermal sheets
Images were acquired using a Zeiss LSM 510 confocal laser scanning microscope 
(Carl Zeiss) with an argon laser at 488nm and 568nm and a helium-neon laser at 
633nm. Approximately 30 optical sections of each epidermal sheet were captured 
with a typical increment of 1-3 pm. Scans are presented as z-projections. 
Objectives used were Zeiss 10/NA0.45, Zeiss 20/NA 0.75 and Zeiss 40/NA 1.2. 
The samples were scanned from the dermal side towards the epidermal surface to 
a total thickness of 40-80 pm, which encompassed the epidermis from the hair 
follicle bulb to the basal layer of interfollicularepidermis. For comparison, images 
of different conditions labelled with the same antibodies were taken using the 
same settings.
For each set of staining omission of the primary would be always included as a 
negative control. This would be used for determining the setting of the confocal 
microscope as it would show the background staining given by the secondary 
antibody.
Typically, one analysis would start by taking several low power images (x10) of 
each epidermal sheet. This would allow visualisation of large areas of tissue and
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would be performed for all the mice and conditions of the experiment. Next, 
closer images would be taken (x20), first comparing several follicles and 
epidermal units w ithin on sample. Next, these would be compared with other 
samples. These steps would help assessing the analysis of patterns of expression 
or changes rising in different conditions or genotypes (See Figure 3.3).
Typically, mice of the same background, sex, and age would be compared. These 
factors must always be taken into account when performing analysis. In addition, 
changes during the hair cycle could only be analysed between littermates during 
the synchronous stage of the hair cycle.
2.6.9-Whole mount quantification
In order to perform quantifications in whole mounts, normally 30-50 units per tail 
were scored in three separate mice for each experimental condition.
2.7- Immunofluorescence staining of cultured cells
Cells were cultured on tissue culture plastic microscope slides (Nunc) or on glass 
coverslips (Chance Propper Ltd.) prepared by the CR-UK Washing Room. The cell 
medium was aspirated and cells were washed once with IxPBS. Cells were fixed 
with 4% paraformaldehyde for 20 minutes, rinsed twice with PBS and kept at 4°C 
until used. Cells were permeabilised either with cold acetone or 0.3% Triton X- 
100 for 5 minutes. Then, they are blocked for 1 hour with 4% BSA. Primary 
antibody incubation was performed overnight at 4°C. Secondary antibodies were 
incubated for 30 minutes at room temperature. Cells were incubated with 
Phalloidin-TRITC (1/500) to visualise polymerised actin (Sigma) and DAPI 
(1/10000) to stain nuclei (Molecular Probes) simultaneously in dH20  for 15 
minutes, prior to mounting cells were rinsed with dH20 .
For each set of staining omission of the primary would be always included as a 
negative control.
2.8-Cultivation of Mouse Epidermal Keratinocytes
2 .8 .1 -Cells
Primary adult epidermal keratinocytes or spontaneously immortalised 
keratinocytes lines were used for experiments. Both types of cells were normally 
cultured on a feeder layer of J2-3T3 cells (Rheinwald and Green, 1975).
The Methods I describe are based on (Silva-Vargas et al., 2005) for primary cells 
and (Romero et al., 1999) for immortalised cells.
2.8.2- Cell solutions distributors
Calcium-free F12 and calcium-free DMEM are bought from Invitrogen. Adenine 
can be purchased from Sigma Aldrich Co. Ltd. Penicillin, streptomycin, trypsin 
(0.25%), and (0.02% EDTA) can be obtained from Invitrogen. A suitable supplier 
of foetal calf serum (FCS) and newborn calf serum (NCS) is PAA Laboratories. 
Hydrocortisone and Cholera enterotoxin are purchased from Merck Biosciences 
(UK) Ltd. Epidermal growth factor (EGF) is purchased from Peprotech EC Ltd. 
Insulin and Mitomycin C are purchased from Sigma Aldrich Co Ltd. Mikrozid is 
purchased from Schulke & Mayer UK Ltd. Dimethyl sulfoxide (DMSO) is obtained 
from VWR International Ltd. Collagen I coated dishes are purchased from BD 
Biosciences.
2.8.3-Cell culture solutions and media 
Solutions
Trypsin-EDTA: For passaging cells, mix 1 part 0.25% trypsin and 4 parts 0.02% 
EDTA. 0.25% trypsin is used to isolate keratinocytes from adult mouse skin. 
Phosphate-buffered saline (PBS): To make 1 litre, dissolve 0.2g KCI, 0.2g KH2P04, 
8.0g NaCI, and 2.16g Na2HP04. 7H20  in 900 ml distilled water. Adjust pH to 
7.4, add distilled water to 1-litre final volume, autoclave, and store at room 
temperature.
Mitomycin C in PBS: Prepare a stock solution of 0.4 mg/ml in PBS, filter sterilize 
and store in aliquots at -20°C.
Hydrocortisone: Prepare a 5-mg/ml stock in absolute ethanol. Store at -20°C. 
Cholera enterotoxin: Prepare a 10'5 M stock in distilled water. Store at 4°C.
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EGF: Prepare at 100-pg/ml stock in FAD medium + 10% FCS. Store at -20°C. 
Insulin: Prepare a 5-mg/ml solution in 5 mM hydrochloric acid. Store at-20°C.
2.8.4-Culture media for keratinocytes
2.8.4.1 - FAD medium preparation
The basic medium consists of three parts of calcium-free DMEM and one part 
calcium-free F12 supplemented with 1.8 x 10*4 M adenine (Calcium-free FAD), 
100 lU/ml penicillin, and 100 ng/ml streptomycin. Store at4°C.
Calcium-free FAD is supplemented with 10% batch-tested FCS. The serum 
batches that are optimal for keratinocytes tend to be completely unsuitable for 
fibroblastic cells or hybridomas. FCS is stored at -20°C before use.
Calcium-free FAD + FCS are further supplemented with a HICE cocktail, 
consisting of hydrocortisone (0.5ng/ml), insulin (5 ng/ml), cholera enterotoxin (10' 
10 M), and EGF (10 ng/ml) (all final concentrations).
Complete medium, or low-calcium FAD/Complete (calcium-free FAD + FCS + 
HICE) is stored at 4°C and used within 2 weeks.
2.8.4.2-Keratinocyte Serum Free medium ( KSFM)
KSFM was obtained from GIBCO-lnvitrogen and was used when culturing 
keratinocytes in a feeder-free system. KSFM basal medium was supplemented 
with 0.2 ng/ml recombinant human Epidermal Growth factor (EGF) and 30 mg/ml 
Bovine Pitutary Extract. When this medium was used for Wnt3a or Eph/ephrin-Fc 
stimulation assays no supplements were added.
2.8.4.3-Culture medium for 3T3 J2 feeder cells
J2 cells were cultured in DMEM supplemented with 100 lU/ml penicillin, 
100pg/ml streptomycin, and 10% calf serum.
Stock feeders were normally passaged at 1:5/1:10 weekly and the culture medium 
was changed every 2 days.
2.8.5-Preparing J2 feeder Layers for keratinocyte cultivation
4 pg/ml mitomycin C was added to confluent flasks of 3T3 J2 and incubated for 2 
hr at 37°C. This irreversibly inhibits proliferation of the J2 cells. At the end of the
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incubation period cells are rinsed with 0.02% EDTA, and then harvested in 
trypsin-EDTA. J2 from a 75 cm flask are used to provide feeders for three 25cm2 
dishes or three 60cm2 dishes. If possible, it is better to seed the feeders prior to the 
keratinocytes, so that they can attach properly.
2.8.6-Primary mouse keratinocyte isolation and culture
2.8.6.1- Isolation of mouse keratinocytes
Keratinocytes can be isolated from either the dorsal or tail skin. Mice are killed 
following U.K. Schedule I of the 1986 Animal Act. The hair of the back is shaved, 
and then skin is excised from the rest of the body with the aid of scissors and 
forceps and stored on ice until use for up to few hours. The following steps are the 
followed under sterile conditions.
1)- Wash the skin for approximately Im in  in 10% Betadine (iodine) solution in 
sterile water agitating constantly.
2)- Wash skin 2x in 70% ethanol solution for approximately 10 seconds each.
3)- Complete washing by immersing the skin in sterile PBS for 10 seconds to 
remove excess ethanol.
4)- Transfer the tissue to a 100-mm-diameter petri dish, dermis facing upwards. 
Using sterile scalpel and forceps, remove excess fat and muscle.
5)- Transfer the skin to a fresh dish containing 0.25% trypsin so that the tissue 
floats with the epidermis-side up.
6)- Incubate the tissue at 32° C or 37° C for two hours. Alternatively, tissue may 
be left to digest overnight at 4° C.
7)- Scrape epidermis away from dermis using a scalpel and forceps.
8)- Cut pieces of epidermis into small (1x1 mm) pieces using two scalpels, and 
dice tissue into very fine pieces using a scalpel.
9)- Suspend epidermal slurry in 10ml complete FAD medium, and filter through 
70pm nylon mesh (Falcon) into a 50ml conical tube. Repeat this process several 
times to ensure that a single cell suspension is formed.
10)- Centrifuge isolated keratinocytes at 1200rpm, 5 minutes to pellet isolated 
cells, and discard supernatant. Resuspend pellet in complete FAD medium.
11) Count the number of cells in the supernatant with haemocytometer using 
Trypan blue dye to exclude dead cells from the count.
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12)- Resuspend ceils at desired concentration in complete FAD medium.
13)- Seed cells onto the confluent J2-3T3 feeder layer at desired density.
14)- Feed the cells with fresh complete FAD medium three times per week. 
Cultures are typically grown for 14 days.
For the generation of each line, adequate experimental controls should also be 
prepared.
2.8.6.2- Passage of Keratinocytes
It is important to passage keratinocytes before they reach confluence, as they hard 
to disaggregate once large numbers of differentiated cells accumulate.
In order to passage keratinocytes, first aspirate the medium. Rinse the cultures 
several times with 0.02% EDTA and remove the remaining feeder cells by gentle 
aspiration, as they are EDTA sensitive. Next, add 0.25% trypsin to the culture dish 
and incubate at 37°C for about 10 minutes. This w ill allow the keratinocytes to 
detach. Add medium containing serum to inactivate the trypsin. Transfer the cells 
by pippeting to a tube and centrifuge at 900 rpm for 3 min at RT.
Aspirate the supernatant and resuspend the pellet in completed FAD medium. 
Count cells using a haemocytometer, and resuspend in complete medium at 
desired density. Seed the single keratinocyte suspension onto confluent, 
mitomycin-treated J2 3T3 feeders.
For standard culture of all primary epidermal keratinocytes or immortalised lines I 
used the complete FAD medium without calcium (named Medium Calcium) with 
the exception of the ANp-cateninER D2 and D4 keratinocyte lines that were 
cultured with complete FAD medium including calcium (named High Calcium).
2.9-Mouse Keratinocyte immortalisation
Spontaneously immortalised keratinocyte lines were generated by serial passaging 
as described in Romero, et al.1999. These were cultured with a feeder layer, 
essentially as described in the previous section. In early passages cells were 
passaged at 1:1 ratio. After 6-10 passage cells were passaged at a 1:5 ratio.
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2.10- Keratinocyte clonal growth assays
For clonal growth assays, 103 -  5 x 103 primary adult keratinocytes were plated on 
pre-coated collagen I coated 35 mm dish containing confluent J2 feeder layer. 
Medium was changed every other day. After 14 days the cultures were fixed with 
4 % paraformaldehyde and stained with 1% Rhodamine B. Colonies were defined 
as clusters of 5 or more keratinocytes.
2.11 - Keratinocyte motility
To examine cell motility in the absence of proliferation, spontaneously 
immortalised keratinocytes were plated without feeder layer on collagen coated 
35 mm glass-bottom Petri dishes (MatTek). Prior to analysis, cells were first rinsed 
with pre-warmed Versene and then treated with Mitomycin C for 2 hours.
To analyze motility, cells were cultured in complete FAD medium. The cells were 
kept humidified at 37°C with 5% C 0 2. Fields of cells were monitored and 
recorded by low-light video microscopy, at a 10 min lapse interval on inverted 
Olympus microscopes IM or 1MT-2 equipped with 10x NA 0.25 or 4x NA 0.1 
phase-contrast objective lenses and driven by Broadcast Animation Controllers 
(BAC 900; EOS Electronics [AV], Ltd.) and fitted with monochrome charge- 
coupled device cameras and video recorders (models M370 CE and PVW-2800P, 
respectively; Sony). Recordings were digitized and the sequence of all frames was 
run on a PC. Experiments were performed at least 3 independent times.
2.12- Keratinocyte Retroviral infection
Retroviral supernatants were generated by transient transfection of Phoenix 
packaging cells and stable infection of AM12 cells. Phoenix cells (5x106) were 
plated in a 10 cm dish, incubated for 24 hr, and then transfected by calcium- 
phosphate precipitation with 20 pg of the retroviral plasmid pBABE-EGFP (Lowell 
et al., 2000) for15 hr at 37°C. After 48 hr, the virus-containing medium was 
filtered (0.45pm filter, Millipore) and supplemented with 4pg/ml polybrene 
(Sigma) (first supernatant). Viruses were collected for an additional 8 hr as before 
(second supernatant). One plate of Phoenix cells produced sufficient virus for one
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to two plates of target cells. The packaging cell line AM12 were infected two 
rounds of incubation culture with retroviral supernatant produced by the Phoenix 
cells. After 2days, the selection step with was started. GFP positive cells were 
selected by a combination of puromycin resistance (2pg/ml puromycin, Sigma- 
Aldrich).
Immortalised mouse keratinocyte lines were plated at 105 cells/cm2 and cultured 
for 2 -3days until they reached 60% confluency. Keratinocytes were infected by 
two rounds of incubation culture with previously filtered retroviral supernatant 
from the infected and selected AM12 packaging cells for 7 h rinsed two times with 
PBS, and placed in keratinocyte medium. After 2 days the selection with was 
started. GFP positive cells were selected by a combination of puromycin 
resistance (2 pg/ml puromycin, Sigma-Aldrich and FACS sorting.
2.13- Keratinocyte sorting experiments
Mixing experiments were performed at close to confluent cell densities on 
collagen coated dishes with J2-3T3 feeders (Lowell et al., 2000). 105 or 104 GFP 
labelled cells were combined with 104 or 105 unlabelled cells per 60 mm dish. 
Each condition was performed at least in triplicate. The cultures were fixed 5 days 
after plating and labelled with Phalloidin to detect polymerised actin.
Analysis of these experiments would include the analysis of several fields of each 
sample. There is variability between experiments so it is important to perform 
several times.
2.14- FACS and flow cytometry
For two colour FACS analysis, keratinocyte suspensions prepared from adult skin 
were incubated with FITC or biotin conjugated primary antibodies for 30 min on 
ice and then washed twice for 10 min at 4°C. The subsequent incubation with 
streptavidin PE (BD Bioscience) was performed in the same way. The cell viability 
was assessed by 7AAD staining (BD Bioscience). Cells were analysed with a FACS 
Vantage sorter (Silva-Vargas et al., 2005); (Morris et al., 2004), after gating out 
dead cells and cells with high forward and side scatter.
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Omission of the primary antibody, single stainings , unstained and an adequate 
isotype control should always be performed.
2.15- Ephrin/Eph stimulation assays
Recombinant ephrin-B1-Fc, ephrin-B2-Fc, EphB2-Fc or EphB3-Fc (R&D systems) 
was pre-clustered with 0.2 pg of goat anti-human IgG (Jackson Laboratories) per 1 
mg Eph/ephrin for 30 min at room temperature. Keratinocytes were treated with a 
final Eph/ephrin concentration of 2 pg/ml.
Keratinocytes were plated on collagen-coated surfaces at the desired cell density 
and transferred to basal FAD medium three hours prior to treatment with 
recombinant EphB and ephrin-B proteins. One hour prior to treatment cells were 
incubated with 20 pg/ml human IgG (Antibodies Inc.) in order to block any FC 
receptor present on the keratinocytes. Eph/ephrin stimulation was carried out at 
37°C for between 10 min and overnight, depending on the experiment.
Each condition is performed in triplicate.
2.16- Wnt pathway activation assays
TOPFLASH activity was measured by a luciferase assay in the presence or
absence of Wnt3A or Wnt5A (R&D) in basal KSFM (GIBCO). The CRUK Protein
Facility purified recombinant mouse Wnt3A or Wnt5A as described previously
(W illert et al., 2003)and (Mikels and Nusse, 2006), respectively).
In order to perform luciferase assays, keratinocytes were transfected with the
Lipofectamine 2000 method. Cells were transiently transfected with the following
constructs: pRL (Renilla luciferase control, Promega), Topflash or Fopflash (firefly
luciferase) (van de Wetering et al., 1997). 0.5x 105 keratinocytes were plated in
quadruplicate in 24-weII plates and left overnight to settle on KSFM with additives
at 37°C. The next day 0.5pg of DNA were transfected per well (0.08 pg pRL and
0.12pg Topflash or Fopflash) following the manufacturer's instruction. Cells were
incubated with the transfection mixture overnight on KSFM. The next day cells
were incubated either with Wnt3A or Mock (buffer alone) or in combination with
recombinant EphFc. When Eph treatment was combined with Wnt stimulation,
the second day I incubated the cells with human IgG for 2hours in order to block
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any Fc receptors. Then, cells were rinsed and the recombinant EphFc were added 
for 1 hour. The last step was to add the Wnt3A or 40H T accordingly. These were 
left for 24 hours prior analysis.
Cell lysis was performed using passive lysis buffer from the Dual-Luciferase 
Reporter Assay Kit (Promega). Cells were washed twice with PBS, 200pl of 1x 
buffer were added to each well and lysis was performed using a rubber cell 
scraper. Lysates were collected in eppendorf tubes, put on dry ice with ethanol, 
and then subjected to four freeze/thaw cycles. The clear lysates were transferred 
to fresh tubes and either stored at -20°C or used immediately for luciferase 
analysis. Ren ilia and firefly luciferase activities were detected in enzymatic 
reactions prepared using the Dual-Luciferase Reporter Assay Kit (Promega) 
according to the Manufacturer's instructions. 10pl of each lysate were analyzed 
using a BioOrbit 1251 luminometer connected to an automated capillary system 
that automatically added the two luciferase substrates to the lysates. Ren ilia 
luciferase activity was used to normalise the data for transfection efficiency.
2.17- Cell lysis and Western blotting
2.17.1 - Protein isolation
Cells were lysed in RIPA buffer (50 mM Tris-HCI pH 7.4, 1% NP40, 0.25 % 
sodium deoxycholate, 150 mM NaCI, 1 mM EGTA). To analyse the soluble pool 
of p-catenin, keratinocytes were lysed in hypotonic buffer at 4°C (20 mM Tris-HCI 
pH 7.5, 1 mM MgCI2, 1 mM sodium orthovanadate, 25 mM p-glycerophosphate 
with protease inhibitors) and centrifuged at 600 g for 10 min to remove nuclei. 
The supernatant was centrifuged at 100,000 g for 1 hr at 4°C; the particulate 
fraction was discarded and the soluble fraction was used for analysis.
2.17.2- BCA protein assay
The concentration of protein in samples was determined using a BCA protein 
assay kit (Pierce). The kit is based upon the Biuret reaction involving the reduction 
of Cu2+ ions to the Cu1+ (cuprous) ion by protein in alkaline medium. Chelation of 
the cuprous ion to bicinchoninic acid (BCA) molecules provides a sensitive 
colorimetric detection method with the reaction product exhibiting a strong
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absorbance at 562nm. The absorbance is linear over a 20-2000 mg/ml protein 
concentration range. A protein standard curve was produced from 0 to 2 pg/ pi 
protein by making dilutions of a 2 mg/ ml BSA solution (Pierce) into PBS 
according to the Manufacturer's instructions. Protein samples to be assayed were 
diluted 1:4 to 1:5 in PBS to minimise interference of lysis buffer detergent and 
supplements with the reaction and also to place the protein concentration within 
the standard curve. The assay was set up on a 96-well plate (DYNEX 
Technologies) according to the Manufacturer's instructions and all standards and 
samples were assayed in triplicate wells. The plate was incubated at 37°C for 30 
min and the absorbance at 562nm was then read on a Titertek Multiscan 
MCC/340 MKII spectrophotometer. The protein concentration of each sample was 
determined against the standard curve.
2.17.3- Immunoprecipitation of Eph and ephrin proteins
To detect Eph and ephrin proteins from cell lysates I had to perform 
immunoprecipitation (IP) of the Eph and ephrin proteins and then immunoblot 
with the same antibody. This step increased the western blot (WB) quality.
The day before, cells were plated on Collagen I pre-coated dishes at near to 
confluency density and they were further incubated with KSFM media without 
additives in order to starve cells.
Cells were harvested and lysed with a cell scrapper in ice-cold IP buffer that 
consisted in (0.15 M NaCI; 0.05 M Tris; 5mM EDTA; 0.5% NP-40; including a 
cocktail of protease inhibitors: PMSF 200pg/ml final concentration and Aprotinin 
25pg/ml) and leave on ice for 30 minutes. Put aside a small volume (50 |xl for 
total lysate control sample and 50 pi for protein concentration measurements). 
Centrifuge at 12000 rpm for 15 minutes at 4°C and transfer the supernatant to a 
new tube. For IP, 1Opl of primary goat antibody (all the anti-ephrin/eph antibodies 
used were raised in goat from R&D Systems) were added (Stock 100pg/ml) and 
cell lysates were incubated rocking for 2 hours to overnight at 4°C. Then 50 pi of 
Protein G slurry were added and further incubated for 2 hours at 4°C, if the IP was 
performed with a rabbit antibody, I used Protein A instead. Centrifuge at slow 
speed 1200 rpm for a minute at room temperature. Aspirate supernatant and add
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wash by adding 1ml ice-cold PBS, centrifuge and aspirate 3 times. Boil and add 
sample buffer to the beads. Store at -20°C.
2.17.4- Laemmli sample buffer
2x Laemmli sample buffer (reducing) comprised 125mM Tris-HCI, pH6.8, 2% 
SDS, 20% glycerol, 0.02% bromophenol blue and 10% (v/v) p-mercaptoethanol 
(Sigma). The sample buffer was aliquoted and stored at-20°C.
2.17.5- SDS-PAGE
A vertical mini-gel electrophoresis apparatus (Atto) was used. Gels were prepared 
between the glass plates using the method of Laemmli (Laemmli, 1970). Table 2.1 
describes the gel compositions. Immediately after pouring the resolving gel 
solution, 0.5 ml of dH20  was carefully applied to ensure a level interface as well 
as to eliminate an air-acrylamide interface. Gels were allowed to polymerise at 
room temperature for approximately 30 min. The dH20  layer was discarded from 
the top of the resolving gel and the stacking gel solution was then poured. An 8 or 
12 well comb was inserted to create wells and the gel was left to polymerise. 
After the gel had set, the comb was removed and the wells were flushed with 
SDS-PAGE running buffer which comprised 50mM Trizma base, 384mM glycine 
and 0.1% SDS.
Equal amounts of protein from each sample (typically 10-20pg total protein) were 
diluted into Laemmli sample buffer and placed in a 100°C hot block for 5 min 
before being briefly spun down in a bench top centrifuge and applied to the wells 
using capillary pipette tips. 10pl pre-stained rainbow molecular weight markers 
(Amersham) were added to 10pil Laemmli sample buffer, boiled for 5 min and 
loaded into one of the wells. Samples were electrophoresed at 120V until the dye 
front had run off the bottom of the gel and the gel was then removed and 
prepared for Western blot.
2.17.6- Preparation of SDS-PAGE gels 
Stock solutions
40 % acrylamide mix (37.5:1 acrylamide to bis-acrylamide ratio) (Amresco), 3M 
Tris-HCI, pH 8.8 (BDH), 10%  SDS in dH20 , 2M Tris-HCI, pH 6.8 (BDH), APS
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10%  ammonium persulphate (Bio-Rad) in dH20 , aliquots stored at -20°C, 
TEMED N,N,N',N'-tetramethylethylenediamine (Bio-Rad).
Resolving gels (15 ml)
% GEL 40 % Acrylamide mix 3M Tris-HCI, pH 8.8 10 % SDS dH20 APS TEMED
8 % 3 ml 1.9 ml 0.15 ml 9.8 ml 0.15 ml 9 ml
10% 3.75 ml 1.9 ml 0.15 ml 9.05 ml 0.15 ml 6 ml
12 % 4.5 ml 1.9 ml 0.15 ml 8.3 ml 0.15 ml 6 ml
15 % 5.625 ml 1.9 ml 0.15 ml 7.715 ml 0.15 ml 6 ml
Stacking gel (10 ml)
Solutions 40 % Acrylamide mix 3M Tris-HCI, pH 8.8 10%  SDS dH20 APS TEMED
1.275 ml 0.1 ml 0.625 ml 7.85 ml 0.1 ml 10 ml
2.18- Western blotting
After electrophoresis, proteins were transferred onto PVDF membrane (Millipore), 
which had been pre-wet in absolute methanol. Mini-Trans Blot Cells (Bio-Rad) 
were used to transfer the protein and were set up according to the Manufacturer's 
instructions. Transfer took place at 4°C overnight at 30 volts. The blot was then 
rinsed briefly in TBS containing 0.1 % Tween-20 (TBST) before blocking with 5 % 
Marvel milk powder (99 % fat free, Premier Brands UK Ltd.) dissolved in TBST for 
at least 1 hour at room temperature.
2.18.1- Transfer buffer
The transfer buffer for Western blotting was made up freshly each time: 8.75g 
Trizma base and 43.5g glycine were dissolved in 500 ml dH20  to which was 
added 15 ml of a 10 % SDS solution. The buffer was made up to 1.2 I before the 
addition of 300 ml of methanol and was then thoroughly mixed.
2.18.2- Probing blots with antibodies and ECL detection
Blocked membranes were incubated with primary antibody typically diluted in 
5 % milk powder solution in TBST. Some antibodies (according to manufacturers 
instructions) were diluted in 5 % BSA in TBST. Incubation with primary antibody 
was at 4°C overnight with gentle agitation. After 3 x 20-30 min washes with TBST, 
the blots were incubated for 1 hour at room temperature with HRP-coupled
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secondary antibody (Amersham) diluted 1:5000 in 5 % milk, TBST. Membranes 
were then washed 3 or 4 times with TBST again. To detect bound HRP, a 
chemiluminescence kit was used according to the Manufacturer's instructions 
(ECL, Amersham). X-ray films (Kodak) were exposed in autoradiography cassettes. 
Densitometry of bands produced on films was carried out using NIH Image v1.58.
2.19- Oligonucleotide arrays and data analysis
2.19.1- RNA preparation
Back skin samples were prepared for RNA isolation using a combination of 
methods previously developed in the lab (Arnold and Watt, 2001 )and (Owens et 
al., 2003). The portion of dorsal skin that had been previously clipped and where 
the treatment was applied was cut into 4 pieces of about 1 cm2 of size. These were 
put into cryo-vials and flash frozen in liquid nitrogen. Processing of the skin to 
obtain RNA was performed with care using standard RNA techniques (for 
standard references on molecular biology see (Sambrook, 1989). The square of 
dorsal skin from each mouse was weighted so that they were around 50mg. They 
were then placed into 12ml of TRI reagent (Helena Biosciences) in a 50ml 
polypropylene tube (Nalgene) and homogenised at room temperature for 1 min 
using a Polytron homogenizer set to a high speed. The tubes were left at room 
temperature for 5 min and then kept on ice until the next step. 1.2ml 1-bromo-3- 
chloropropane (BDP, Helena Biosciences) was then added to each tube, mixed by 
shaking very vigorously for 15 sec and incubated at room temperature for 15 min. 
The samples were centrifuged at 11400rpm in a Beckman J-20 centrifuge for 
30min at 4°C. The upper, aqueous phase containing the RNA was carefully 
removed into brand new polypropylene tubes (Nalgene). 12ml isopropanol were 
added and the samples were mixed by vortexing. Samples were placed at -20°C 
for one hour to precipitate the RNA, which was then pelleted by spinning again at 
11400rpm in a Beckman J-20 for 30min at 4°C. The isopropanol was discarded 
appropriately and the pellet was left to dry and then resuspended in RNase-free 
dH20 . For a second run of RNA purification, I used the Qiagen RNeasy Mini 
Columns according to the Manufacturer's instructions and resuspended in 100pl 
of RNase-free dH20 . The RNA was quantified by spectrometry and the quality
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controlled by running samples on formaldehyde/agarose/ethidium bromide gels 
following the standard procedure (Sambrook, 1989).
2.19.2- cDNA and cRNA preparation
Double-stranded cDNA was generated from 10 pg total RNA using Superscript 
Double Strand cDNA Synthesis Kit (Invitrogen) according to the Manufacturer's 
instructions, with a T7-polyT primer (Affymetrix). The cDNA was purified using 
the GeneChip Sample Cleanup Module (Affymetrix) and used to generate 
biotinylated cRNA by in vitro transcription using the Enzo BioArray High Yield 
Transcript Labelling Kit (Affymetrix). cRNA was purified using the GeneChip 
Sample Cleanup Module (Affymetrix) following the Manufacturer's instructions 
and quantified as described before. 25 pg of cRNA were fragmented in 
Fragmentation buffer provided with the GeneChip Sample Cleanup Module by 
incubating it at 94°C for 35 min exactly in a heating block.
The quality of cDNA, cRNA and fragmented cRNA was checked by running an 
aliquot of each on formaldehyde/agarose/ethidium bromide gels. The molecular 
weight markers used were 0.24-9.5 Kb RNA Ladder (Invitrogen) for cDNA and 
cRNA, and RNA Century Size Markers (Ambion) for the cRNA.
2.19.3- Microarrays hybridization and scanning
The hybridization and scanning of the arrays were performed by the Cancer 
Research UK Affymetrix Facility located in the Paterson Institute for Cancer 
Research, Manchester (UK). 10 pg of fragmented cRNA were hybridized to the 
GeneChip Mouse Expression Set 430 (A and B chip) oligonucleotide arrays 
(Affymetrix), comprising 45037 probe sets. Complete annotations and spotting 
patterns can be found online at http://www.affymetrix.com. The hybridization was 
performed following the Manufacturer's instructions using an Affymetrix 
GeneChip Instrument System. The arrays were washed and stained with 
streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip 
scanner.
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2.19.4- Normalization and Filtering of the Array Data
Unsealed raw data were loaded from a text file on Genespring (Version 6.1, 
Silicon Genetics). Measurements less than 0.001 were set to 0.001. The 
normalization was set as follow: per chip normalization to the 50th percentile, 
per gene normalization to the median.
Spearman correlation was used to generate a condition tree and cluster all the 
chips as a quality control. As a result, one replicate for the conditions wt7 and 
wtO (B chip) were removed.
All the data that passed the quality control were filtered using the Genespring 
advanced filtering tool. I identified probes with present or marginal flags in at 
least one out of 6 conditions, t test p value less than 0.05 in at least one 
condition, standard deviation less than 1.45 in at least 2 out of 6 conditions, and 
a change in relative expression levels of at least 2-fold in the 40HT-treated 
transgenic samples compared to untreated transgenic and all the wild-type 
samples.
Unsealed raw data were analyzed using GeneSpring™ software (Silicon Genetics, 
version 6.1). Normalized data were filtered to select for genes showing a fold 
change greater than 3 with t-test p-values less than 0.05 and a standard deviation 
less than 1.45 upon activation of the transgene.
2.19.5- Normalization and filtering of the array data
Unsealed raw data were loaded on Genespring (Version 6.1) with measurements 
less than 0.001 set to 0.001, per-chip normalization to the 50th percentile and 
per-gene normalization to the median. A condition tree based on Spearman 
correlation was used to cluster all the chips as a quality control. All the data from 
the chips that passed the quality control were filtered using the Genespring 
advanced filtering tool. We identified probes with present or marginal flags, t-test 
p-value less than 0.05, standard deviation less than 1.45 and a change in relative 
expression levels of at least 3-fold in the 40H T treated transgenic samples 
compared to untreated transgenic and the all the wild-type samples.
Most of the 103 upregulated genes could be classified into distinct functional 
groups (Table 1 A). Proteins involved in signalling or transcription were the largest 
category (29.1%), followed by proteins involved in cellular metabolism (15.5%)
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and keratins (14.6%). Representative genes in each group are listed in Table 1B, 
with their fold induction indicated in brackets.
The lists shown in this study contain no repeated probes and only the known 
genes.
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Antibody Specificity Species Originator Dilution
AC40 Actin Mouse Sigma
OBT0030 Bromodeoxyuridine Rat Oxford
Biotechnology
1:100
p-catenin Mouse BD 1:100
C20 c-Myc Rabbit Santa Cruz 1:100
CDP Rabbit gift from M. 
Busslinger
1:600
RAM34 CD34 Rat BD Pharmingen 1:50
Dishevelled 2 Rabbit 1:100
AF473 EphrinBI Goat R&D 1:50
Ephrinb2 Goat R&D 1:25
EphB2 Goat R&D 1:25
BAF 432 EphB3 Goat R&D 1:25
EphB4 Goat R&D 1:25
Ab 4389 EphA4 Rabbit Abeam 1:100
MC-20 Estrogen receptor Rabbit Santa Cruz 
Biotechnology
1:100
ab7523 Gli 1 Rabbit Abeam 1:100
Gli 2 Rabbit gift from R. 
Toftgdrd
1:50
MB 1.2 pi integrin Rat gift from B Chan 1:100
Keratin 17 Rabbit gift of P. Coulombe 1:100/1:500
AF 64 Keratin 14 Rabbit Covance 1:5000
LHK15 Keratin 15 Mouse gift from I. Leigh 1:100/1:50
NCL-Ki67p Ki67 Rabbit Novocastra 1:600
01902-D c-kit Rat Pharmingen 1:10
2012 Lef1 Mouse Upstate 1:100
C-19 N-Myc Rabbit Santa Cruz 1:100
nestin 130 Nestin Rabbit gift from R. McKay 1:100
ab12053 Sox4 Rabbit Abeam 1:50
GOH3 a6 integrin Rat BD Biosciences 1:100
05-591 pAkt Rabbit Biosource 1:100
Keratin 10 Rabbit MK10DAKO 1:2500
Caspase 14 Rabbit Abeam 1:500
keratin 6 Rabbit Babco 1:5000
11796 PSMAD2/3 Goat Santa Cruz 1:250
Ly-6A/E Seal Rat BD 1:250
2B8 c-Kit (CD 117) Rat BD 1:50
Sox2 Sox2 Rabbit Gift from R 
Lovellbadge
1:500
AB5603 Sox2 Rabbit Chemicon 1:250
AB5772 Sox3 Rabbit Chemicon 1:100
AB5811 Sox13 Rabbit Chemicon 1:100
Table 2.1- List of selected primary antibodies used in the work 
presented in this Thesis.
2.20- List of selected suppliers
Abeam, Cambridge,UK.
Acros organic, Netherlands.
Affymetrix Inc. Santa Clara, California, USA.
Ambion Inc. Austin, Texas, USA.
Amersham Biosciences, Amersham, Buckinghamshire, UK.
Amresco, Solon, Ohio, USA.
Antibodies Inc.; Davis, California,USA.
Atto, supplied by BioRad.
Beckman Instruments, Palo Alto, California, USA.
BD Biosciences, Erembodegen, Belgium.
BD PharMingen, San Diego, California, USA.
BDH Laboratory Supplies Inc. Hemel Hempstead, Hertfordshire, UK. 
Becton-Dickinson, Lincoln Park, New Jersey, USA.
Biochrom, Berlin, Germany.
Biomol International, LP.Hamburg, Germany.
Biorad Laboratories Inc. Hemel Hempstead, Hertfordshire, UK. 
Boehringer Mannheim UK Ltd. Lewes, East Sussex, UK.
Calbiochem -  Novabiochem (UK) Ltd. Nottingham, UK.
Carl Zeiss Ltd. Welwyn Garden City, Hertfordshire, UK.
Chemicon (Millipore), Harrow, Middlesex,UK.
DAKO A/S, Glostrup. Denmark.
Difco aboratories, Manston, Wisconsin, USA.
DNA Technology AIS, Aharus, Denmark.
Eppendorf, Histon, Cambridge, UK.
Falcon, part of Nunc A/S, Roskilde, Denmark.
Fischer Scientific, Loughborough, Leicestershire, UK.
Gibco BRL/Life Technologies Ltd. Paisley, Renfrewshire, UK.
Helena Biosciences, Sunderland, Tyne & Wear, UK.
IBL, Hamburg, Germany.
ICN Pharmaceuticals Ltd. Thame, Oxon, UK.
Imperial Laboratories (Europe) Ltd. Andover, Hampshire, UK. 
Invitrogen, Paisley, UK.
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Jencons, Leighton Buzzard, Beds, UK.
Jackson Laboratories, Maine,USA.
Merck Biosciences, Darmstadt, Germany.
Millipore, Harrow, Middelsex, UK.
Molecular Probes, Leiden, Netherlands.
Monsanto Chemicals, Springfield, Massachusetts, USA.
Nalgene Nunc International, Rochester, New York, USA.
Novagen, Madison, Wisconsin, USA.
New England Biolabs (NEB). New York, USA.
Nunc A/S, Roskilde, Denmark.
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Chapter 3- Characterisation of patterning in 
tail epidermis
Aims
An interesting question in biology is how patterning arises during development 
and how it is maintained throughout adulthood. The epidermis constitutes an 
ideal model to start unveiling this question. The epidermis is a highly 
compartmentalised tissue, which contains domains where proliferation and 
differentiation are inhibited, in which stem cells reside and domains where the 
lineage choice of the stem cell progeny occurs. Patterning allows for coupling of 
differentiation and proliferation by separating progenitor populations from their 
more differentiated progeny. In this Chapter I sought to define further the 
compartments of tail epidermis and characterise markers of LRC and their 
committed progeny.
3.1- Introduction to the tail whole mount system to assess 
patterning in epidermis
The tail whole mount system is a technique that although is dated to the 1800s 
(Schweizer and Marks, 1977), it was being further developed in our laboratory at 
the time I joined the laboratory (Braun et al., 2003). The work that l performed 
that contributed to its further development is presented in this Chapter.
Whole mounts of several parts of the furry body can be prepared, however the 
hair follicles of the tail are quite large compared to those in the back and the IFE 
is thicker. This makes the skin of the tail quite resistant as it remains intact and 
can be peeled off the dermis and thus ideal to work with. The diagram in Figure
3.1 shows a step-wise protocol that is described in detail in the Materials and 
Methods section. The benefit of this system is that allows of 3-D visualisation, 
screening of large areas and quantification of changes occurring or patterns in the 
epidermis. In wild-type skin the hair follicles are arranged in rows and clustered 
in groups of three (triplets) (see Figure 3.2). Each follicle has a pair of prominent
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sebaceous glands. In order to make quantification consistent, we defined one 
triplet and the adjacent interfollicular epidermis as one epidermal unit (See red 
dotted line in Figure 3.2).
A typical experiment is depicted in Figure 3.3.
For each set of staining omission of the primary would be always included as a 
negative control. This would be used for determining the setting of the confocal 
microscope as it would show the background staining given by the secondary 
antibody.
Typically, the analysis of a tail skin whole mount would start by taking several 
low power images (x10) of each epidermal sheet. This would allow visualisation 
of large areas of tissue and would be performed for all the mice and conditions of 
the experiment. Next, closer images would be taken (x20), first comparing several 
follicles and epidermal units within on sample. Next, these would be compared 
with other samples. These steps would help assessing the analysis of patterns of 
expression or changes rising in different conditions or genotypes (See Figure 3.3). 
Typically, mice of the same background, sex, and age would be compared. These 
factors must always be taken into account when performing analysis. In addition, 
changes during the hair cycle could only be analysed between littermates during 
the synchronous stage of the hair cycle.
The observations and the results obtained in tail whole mounts should be backed 
up by analysis of conventional histology of tail skin and also compared with back 
skin.
3.2- LRC compartment
One characteristic of stem cells is that they are slow-cycling cells with a high 
proliferative capacity. Taking advantage of this feature, they can be detected by 
labelling the tissue at a stage in which is highly proliferative, this is, so that cells 
w ill take up the label (Bickennbach, 1981; Braun et al., 2003). In mouse, the skin 
is highly proliferative around 10 days after birth (P10) (Figure 3.4 A, B). After a 
chase period of minimum of 40 days, only the slow-cycling cells w ill retain the 
label (see Figure 3.4 A and C). The more proliferative cells w ill dilute the label 
after a few divisions. I used this assay to detect the label retaining cells (LRC) in 
epidermis. At P50, LRC were clustered in the permanent portion of the hair
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follicle, known as the bulge (See Figure 3.4). There were a few scattered LRC in 
the SG and in IFE (See Figure 3.4 C and D). There were no big differences 
between a chase period of 40 days or 60 days (See Figure 3.4 C and D). When I 
joined the laboratory this technique was being developed and I contributed to the 
optimisation of this technique to screen for new bulge LRC markers (Braun et al.,
2003) and markers of differentiation and signalling pathways involved in lineage 
commitment that w ill be described in the Chapter.
3.3- Characterisation of the epidermal stem cell 
compartment in situ: 'Candidate-approach' screen of stem 
cell markers
Since the whole mount technique allows us to visualise and characterise the stem 
cell compartment of mouse tail epidermis in situ, we can use this approach in 
combination with LRC experiments to locate slow cycling cells and to assess the 
expression of several putative stem cell and differentiation markers by 
immunolabelling (Figure 3.5). The whole mounts are analysed by confocal 
microscopy.
3.3.1- Well-known bulge markers
On a candidate-approach basis, we carried out a screen for several putative stem 
cell markers in this system (see Figure 3.5). In particular, we have shown that 
keratin 15 is expressed in label-retaining cells in the tail epidermis confirming that 
is a good stem cell marker like in the back (Figure 3.5 E,H,J,K; Lyle et al., 1998; 
Braun et al., 2003). It was later confirmed by studies of Morris, Costarelis and 
colleagues that keratin 15 expression is a bonafide marker of bulge stem cells that 
under steady-state conditions replenish the hair follicle lineages (Morris et al.,
2004).
Based on the literature, I also assessed in this system, known markers of bulge 
stem cells like the HSC and HF marker CD34 (Trempus et al., 2003). I confirmed 
that CD34 is expressed in LRC of the bulge of mouse tail follicles (Figure 3.5 
D,G).
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Figure 3.1 - Tail skin whole-mount labelling technique .
This diagram shows the steps carried out to isolate and process tail 
epidermis from tail skin (See Materials and Methods for detailed 
explanation). This technique allows visualisation in 3-D of basal 
cells from sebaceous glands (SG), hair follicle (HF) and interfollicu- 
lar epidermis (IFE). The whole-mount shown was immunolabelled 
for Ki67 (red) and (31 integrin (green) and visualised by confocal 
microscopy.
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Figure 3.2 - Tail skin whole-mount allows quantification of 
large areas. Whole mount of wild type epidermis immunolabelled 
with anti-keratin 14 antibody was processed with LSM software and 
the color shown is the saturation of the original image. Hair follicles 
in tail epidermis are arranged in staggered rows of triplets. Dashed 
red line indicates the epidermal units which w ill be used as a measure 
for quantification in later chapters. Scale bar: 100 pm.
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Tcf-3 has been reported to be expressed in the bulge, where it acts as a repressor 
of the Wnt pathway (DasGupta and Fuchs, 1999; DasGupta et al., 2002; Merrill 
et al., 2001). I have confirmed in this system that this is indeed a good marker 
(Figure 3.5 E).
pSMAD2 was revealed in a screen for bulge markers (Tumbar et al., 2004), and 
the immunolabelling shows that is expressed in the bulge of tail follicles (Figure
3.5 F). When I did double labelling with BrDU, I could see that a large proportion 
of the cells pSMAD2 positive were CD34 positive (Figure 3.5 G) and keratin 15 
positive (Figure 3.5 H).
3.3.2- Candidate bulge markers
Based on the literature, I also assessed in this system, markers of stem cells 
reported from other adult tissues, like the neural stem cell markers, such as the 
transcription factor Sox2 and the intermediate filament protein, nestin (Marvin et 
al., 1998;Li etal., 2003; D'Amourand Gage, 2003).
Nestin is expressed in cells resident of the bulb normally clustered and a second 
population of single cells with a dendritic morphology can also be found along 
the ORS (Figure 3.9 B). Flowever, I was not able to confirm the expression of 
nestin in the bulge keratinocytes that was previously reported (Li et al., 2003).
P63 was also a good candidate, as it is critical for the stratification of epithelia 
(Koster et al., 2004). The antibody recognises all the 7 isoforms and labelled all 
cells in ORS, SG and IFE, so it was discarded further as a good bulge marker 
(Figure 3.5 D).
In the case of Sox2, LRC at the top of the bulge, express high levels of cytoplasmic 
Sox2 (Figure 3.5 I, L, M). These cells are keratin 15 and CD34 negative. (See 
Figure 3.5 l,L,M). Interestingly, the keratin 15 positive population of the HF is only 
formed after postnatal day 5 (Figure 3.5 K).
After I completed this screen, two groups reported the identification and genetic 
profiling of bulge LRC (Tumbar et al., 2004 and Morris et al., 2004). In agreement 
with my findings they reported that label retaining cells in the bulge express 
keratin 15 and that CD34 is a good marker to isolate bulge LRCs.
Their studies provide new markers that w ill be tested in the future.
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Figure 3.3- Stepwise protocol of tail skin whole mount analysis. Typically, each staining w ill be performed a minimum of 3 times on 3 
independent samples. For each set of staining omission of the primary would be always included as a negative control. This would be used for deter­
mining the setting of the confocal microscope as it would show the background staining given by the secondary antibody. For comparison between 
experimental conditions, images of different conditions labelled with the same antibodies were taken using the same settings. Typically, the first step 
of the analysis would start by taking several low power images (x10) of each epidermal sheet. This would allow visualisation of large areas of tissue 
and would be performed for all the mice and conditions of the experiment. The second step w ill consist in taking closer images at higher magnifica- 
^  tion (x20), first comparing several follicles and epidermal units within on sample. Next, these would be compared with other samples. These steps 
would help assessing the analysis of patterns of expression or changes rising in different conditions or genotypes.
Since the screen was performed, a new population positive for the thymic 
progenitor cell surface marker MTS24 has been described which is above the 
keratin 15/CD34 double positive population that resembles the Sox2 population 
(Nijhof et al., 2006).
3.4-Visualisation of lineage commitment in tail epidermis 
3.4.1 -Patterning in the IFE
The epidermis of the tail is highly patterned, as can be appreciated in whole 
mount preparations. In w ild type skin, hair follicles are arranged groups of three 
(triplets) and are organised in rows, such that the hair follicle triplets in one row 
are staggered relative to those in the rows on either side (See figure 3.2). Single 
scattered LRC positive cells are also localised in IFE (Figure 3.4 C, D). After
comparing various samples, their localisation does not appear to follow a fixed
pattern, however they are normally confined to the parakeratotic scale region. In 
addition, within tail IFE two types of differentiation can be distinguished (see 
Figure 3.6; Lopez-Rovira et al., 2005). The IFE that encircles each hair follicle 
triplet, known as the parakeratotic scale, expresses caspase 14 (Figure 3.6 A) but 
does not express keratin 10 (Figure 3.6 B). The remainder of the tail IFE is keratin 
10 positive and caspase 14 negative (Figure 3.6 A, B). When looking at a section 
of tail skin the areas devoided of basal keratin 10 expression demark the
parakeratotic scale area (Figure 3.6 C and D).
Interestingly, when looking at dermis whole mounts a similar pattern of 
expression like parakeratotic scales is found when immunolabelling with several 
basement membrane markers like collagen IV (Manuela Ferreira, personal 
communication).
3.4.2- Patterning along the follicle in tail epidermis
Patterning is also observed along the length (proximo-distal axis) of individual hair 
follicles, including the sebaceous glands (Figure 3.7) with different expression 
domains that correspond to areas in which either differentiation or proliferation 
are inhibited (like the bulge) or differentiation and proliferation are promoted (like 
the bulb).
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I focused on the markers that have discrete domains of expression in the follicle. 
For instance, Sox2 expression specifically labels an area above the conventional 
bulge defined by CD34 expression (see Figure 3.7 A,B/C/D/E). The infundibulum 
is specifically labelled with antibodies to phosphorylated Akt in telogen follicles 
(Figure 3.7 B) as previously reported (Alonso et al,.2005). The lipophilic dye Nile 
Red provides a specific marker of sebocytes (Figure 3.7 F), while CDP and FABP 
are highly expressed in the bulb of anagen follicles (Figure 3.7 C, H). 
Interestingly, the expression of the Planar Cell Polarity protein, Dishevelled2, also 
marks the bulb (Figure 3.7 I).
3.5-The proliferation pattern in tail epidermis
As previously mentioned in Figure 3.4, quiescent cells are visualised by label 
retention after a long chase period (30 days) and they are located in the bulge 
portion of the HF and scattered in the SG and IFE (Figure 3.4 and 3.8 A). The 
proliferative compartment can be visualised by immunolabelling S-phase cells 
with a 1h pulse of BrDU. In addition Ki67 can be used as a marker of actively 
cycling cells. A large number of proliferating cells can be seen in the basal layer 
of IFE, in the outer layers of the SG and at the base of the hair follicle, the bulb, in 
anagen follicles (Figure 3.8 B-D). We can also visualise proliferative cells with a 
marker for lipid rafts, which normally are enriched in highly proliferative cells 
(Figure 3.8 E and F; Gniadecki and Bang, 2003).
3.6- Cell types resident in the HF
As described in the Introduction, the skin niche is very complex and multiple cell 
types coexist. I analysed several of these populations in tail epidermis (Figure 3.9 
A-F). I analysed Neural crest derivatives such as Nestin positive cells (Figure 3.9
A), which are known to include a progenitor population of the dermal papilla 
(Fernandes et al., 2004) and melanocyte stem cells (positive for c-Kit) (Figure 3.9
B). Nestin positive cells are not keratinocytes as they are negative for keratin 14 
(Figure 3.9 C). Keratin 16, marker for Merkel cells, the skin mechanoreceptors, 
defines a row of three or four cells on either side of the upper part of the bulge 
(Figure 3.9 D). Differentiated melanocytes can be visualised by L-Dopa staining,
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Figure 3.5 - Screen for bulge markers. A candidate approach to search 
for markers of the bulge compartment of tail epidermis was performed using 
the whole mount system. (A-M) Examples of some of the proteins tested are 
shown. (A-M) Whole-mounts of wild type epidermis immunolabelled with 
antibodies to the proteins shown. Asterisks indicate non-specific staining in 
sebaceous glands. Epidermis in K is from P8 mouse. Epidermis in other 
panels is from adult mice. Scale bars: 100 pm.
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Figure 3.6- Patterning within the interfollicular epidermis
(A-B)Tail epidermal whole mounts of w ild type skin immunolabelled 
with anti-caspase 14 antibody (A) or anti-keratin 10 antibody (B). (C) 
Tail skin section immunolabelled for keratin 10. Arrows indicate the 
boundaries of the parakeratotic scale (keratin 10 negative).(D) Section 
of tail skin stained with Haematoxylin and Eosin. (E) is an enlarge­
ment of the box in D, which correlates to the parakeratotic scale. 
Scale bars: 100 pm.
and in tail epidermis are localised at the bulb of hair anagen follicles and in the 
parakeratotic scale area of IFE (Figure 3.9 E).
Several types of immune cells reside within the epidermis and the dermis (Stenn 
and Paus, 2001), including Langherhans cells which I visualised by expression of 
the DEC205 marker (Figure 3.9 F).
3.7- Sox2-GFP a tool to analyse stem cells in mouse skin
A transgenic line driving GFP under the promoter of Sox2 was obtained from Dr 
Fred Gage (Salk Institute, San Diego, USA). The GFP expression allows isolation 
of the Sox2 population to characterise it in vitro and in vivo. It is very encouraging 
to see that GFP expression confirms the staining observed with the antibody (see 
Figure 3.10 A and B). This population is negative for the known bulge marker 
CD34 (Figure 3.10 C). FACS isolation of GFP positive cells show that Sox2 
positive cells are very rare and represent a 0.02% of total keratinocytes (Figure 
3.10 D). FACS analyses confirmed that they are negative for CD34 and only 
0.015% of the Sox2 population is positive for a6 integrin (Figure 3.10 D). It w ill 
be very interesting to analyse how this population changes in situations in which 
the nature of the niche is altered.
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Figure 3.7 - Patterning along the distal-proximal axis of the hair 
follicle. (A-l) Wild-type whole-mounts were immunolabelled with antibodies 
to the proteins indicated. Scale bars: 100 pm.
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Figure 3.8 - Proliferation within tail epidermis (A-F) Tail whole 
mounts of w ild type epidermis immunolabelled with antibodies to the 
proteins shown. (A) LRC were generated by 4 BrdU injections as shown in 
Figure 3.3A. After 30 days chase, Label Retaining Cells (LRC), quiescent 
cells are located clustered in the bulge, and a few scattered in the IFE and 
SG. (B-D) Proliferative cells are located in IFE, the bulb of HF and periph­
ery of the SG. (E-F) Cholera Toxin labelling reveals the transit amplifying 
compartment which are the proliferative cells. Dotted lines in E demarcate 
HF and SG. Arrows indicate LRC in A, proliferative cells in B,D and Lipid 
rafts in F. HF in E are in telogen and in F are in anagen. Scale bars: 100 g 
m.
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Figure 3.9 - Neural crest cells and immune cells reside in skin
(A) Wild-type whole-mounts were immunolabelled with antibodies to the 
proteins indicated (A-D,F) or stained with L-Dopa (E). Scale bars: TOO pm.
V  /C&34
Sox2-GFP
Figure 3.10- The Sox2-GFP reporter mice as a tool to study Sox2 
positive cells (A) Immunolabelling of tail wholemount with an anti-Sox2 anti­
body. (B) GFP expression driven by the Sox2 promoter. In B locations of seba­
ceous glands (SG), bulge (BG) and interfollicular epidermis (IFE) are indicated. (C) 
Double labelling of Sox2 (red) and CD34 (green). (D) Tail keratinocytes were 
isolated from Sox2-GFP transgenic animals and immunolabelled with antibodies 
to a6 integrin and FACS sorted. The FACS profile shows the GFP and a6 integrin 
populations. Arrows in A and B show the Sox2 population. Scale bars: 100 pm.
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3.8- Conclusions
The work presented in this introductory Chapter contributed to the development 
of the whole mount technique (Braun et al., 2003). I confirmed the location of 
LRC, Keratin 15 and CD34 positive cells and found new markers including Sox2, 
Nestin and pSMAD2. In addition, I also found markers of different regions of IFE 
and markers for different locations along the HF. I developed markers for non- 
keratinocyte cell populations in epidermis. Finally, I have showed that Sox2-GFP 
mice can be used to mark a new population of cells above the bulge in HF.
Chapter 4- (5-catenin drives HF morphogenesis 
in tail epidermis
Aims
The first response of the skin to P-catenin activation is the entry of hair follicles 
into the anagen growth phase and subsequently ectopic hair follicles are formed. 
Sustained P-catenin activation leads to the formation of tumours of hair follicle 
origin, resembling trichofolliculomas (See Figure 1.9; Gat et al.1998, Van Mater, 
et al.2003, Lo Celso et al., 2004). These studies show that P-catenin activation 
determines lineage commitment in the epidermis; however, they also raise several 
questions that I wanted to address in this chapter.
The aim of my Thesis was to investigate how P-catenin activation leads to ectopic 
hair formation.
It is not known what is the effect of different levels of P-catenin activation and 
whether cells would exhibit a graded response to increasing P-catenin activation 
or HF induction would be a threshold response. The first issue I investigated was 
the effect of titrating p-catenin signalling.
It was previously shown that cells in all regions of the epidermis (HF, SG, IFE) are 
competent to respond to P-catenin, however, it is unclear whether responsiveness 
is restricted to the stem cell compartment or whether committed progenitors can 
also be reprogrammed to induce hair follicles even though they are lineage 
restricted. The second issue I analysed was the effect of P-catenin on the bulge 
stem cell LRC compartment and what was the contribution to hair follicle 
formation.
Thirdly, I wanted to study whether P-catenin induced HFs are capable of 
reconstructing a follicle niche including keratinocytes and non-epithelia! cells that 
are normally resident in the hair follicle.
To explore these issues I used K14ANP-cateninER mice that were previously 
generated in the laboratory (Lo Celso et al., 2004). For this, I collaborated with 
Cristina Lo Celso who helped me in the handling and the treatment of mice. I 
performed all the analysis of the experiments described unless stated. While
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previous analysis was performed in dorsal skin, I mainly focused on the effect of 
P-catenin activation and on de novo hair follicle formation in tail skin, taking 
advantage of the whole-mount system described in Chapter 3.
4.1-Introduction to the K14AN(i-cateninER transgenic 
model
The K14ANp-cateninER inducible transgenic mice were previously generated in 
the laboratory (Lo Celso et al., 2004). In this model, the keratin 14 promoter 
targets expression of an inducible p-catenin in the basal layer of the epidermis, 
the outer root sheath (ORS) of the hair follicle and the outer layers of the 
sebaceous glands (Figure 4.1 A and E). The N-terminus of mutant P-catenin has 
been removed and therefore the mutant cannot be degraded via GSK3P mediated 
phosphorylation The C-terminus is fused to a mutant estrogen receptor (ER) (see 
Figure 1.8 and 4.1 A). Without 40H T treatment, the mutant protein is complexed 
with heat shock proteins and localised to the membrane complexed with E- 
cadherin, at adherens junctions (Lo Celso et al., 2004; Zhu and Watt, 1999). 
Upon 40HT treatment, the transgenic protein is released from heat-shock 
proteins and it translocates to the nucleus (Figure 4.1 B-D) where it complexes 
with transcription factors, such as members of the Tcf/Lef family (Ciani and 
Salinas, 2005; Nelson and Nusse, 2004). With this model, p-catenin activity in 
normal adult mouse epidermis is induced by 4-OHT treatment and thus the onset 
and duration of p-catenin activation can be controlled (Lo Celso et al., 2004).
Two different transgenic lines were used in this study, a low copy number line 
called D2 and a high copy number called D4. These lines have different levels of 
ANp-cateninER transgene, the D4 keratinocytes expressing twice as much when 
assessed by western blot of immortalised keratinocytes (Silva-Vargas et al., 2005). 
The level of transgenic p-catenin in D4 keratinocytes is similar to the level of 
endogenous P-catenin (Silva-Vargas et al., 2005). Although all basal cells (keratin 
14 positive) express the transgene in tail epidermis, there is heterogeneity in the 
expression levels, with higher levels detected in the sebaceous glands, compared 
to IFE or ORS. In the IFE there are patches of higher
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Figure 4.1- The AN(3-cateninER transgenic model. (A) Schematic diagram of the 
transgenic cassette.The trangene expression is driven by the keratin 14 (K14) promoter. The 
transgene is fused to a mutated form of the estrogen receptor (ER™). (B,C) Z-stack of 20x 
confocal images of tail epidermis whole-mounts immunostained with anti- Keratin 14. (B) 
Untreated (Unt) trangenic mouse or (C) treated for 21 days with 40HT. Note that upon 
40HT treatment the hair re-growths and ectopic follicles are formed from IFE and SG. (D-F) 
ER immunofluorescence of skin, either untreated (Unt) (D) or treated (E,F) for 24 h with the 
40HT doses shown. (D) In untreated skin, the transgene is localised to cell-cell borders. 
Upon 40HT treatment the transgene partially relocalised to the nucleus (E-F). (G) Compari­
son of relative levels on ANp-cateninER by immunoblotting with anti-ER or, as a loading 
control, anti-actin antibody. Panels (D-G) were provided by Cristina Lo Celso. In (C) ectopic 
follicles originating from SG (arrows) and from IFE (arrowheads) are indicated. Scale bars: B 
and C 100 pm, D-F 50 pm.
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expression (Silva-Vargas et al., 2005). This variation has not been commented on 
previously, although it appears to be a feature of all mice in which the K14 
promoter is used to target transgene expression.
All mice used were 6 to 8 weeks old, so that the HF were in telogen and the skin 
looks pink. After 40H T treatment, the wild-type skin would remain always pink 
without hair regrowth and the transgenic skin would gradually start getting dark 
and hairy. The changes in transgenic skin represented the entrance of hair follicles 
into anagen, when melanogenesis is activated (Hardy, 1992).
As previously mentioned in the Materials and Methods Chapter, in all the 
experiments presented in this Chapter for each condition there were three mice 
per group. The analysis of the harvested skin was performed as described in 
Chapter 3 (See Figure 3.3).
4.2- Titration of P-catenin activation in vivo: from HF 
morphogenesis to tumorigenesis
4.2.1-From morphogenesis to tumorigenesis
In order to exploit this inducible system and to achieve different levels of p- 
catenin activation I did not only used the two lines of K14ANP-cateninER mice: 
D2, with 12 copies of the transgene, and D4, with 21 copies (Lo Celso et al., 
2004), but also varied the doses of 40H T applied to the skin.
In these studies I used three concentrations: 0.5 (low dose), 1.5 (medium dose) or 
3 mg (high dose) per mouse, applying 40H T every second day. I applied 40HT 
to tail skin, so that I could use whole mount labelling to facilitate quantitative 
assessment of the induction of new hair follicles.
After several pilot experiments I could optimise the design of the time windows to 
analyse adequately the effect of titrating the signal in both transgenic lines (see 
Figure 4.2). Given that the phenotype in the D4 mice appeared early and I had to 
sacrifice the mice at two weeks, I designed experiments with small time windows 
in order to get a better insight of the development of the D4 phenotype. In case of 
the D2 line the phenotype developed more slowly and I designed experiments 
with one-week intervals between each time point and the mice were maintained
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for up to 42 days (see Figure 4.2). I performed 4 different experiments. I first 
looked at the effects of titrating the P-catenin signal by examining Haematoxylin 
and Eosin stained tail skin sections (Figure 4.3). In the D2 line, sustained p- 
catenin induction with the medium dose of 40H T leads to the formation of 
ectopic outgrowths by 3 weeks. The epithelial projections fully resemble 
rudimentary follicles and are capable of recruiting a dermal condensate (DP). If 
the signal is prolonged, the new follicles fuse and develop structures resembling 
trichofolliculomas (Figure 4.3 C), as previously described in back skin (Lo Celso et 
al., 2004). In the D4 line, sustained P-catenin activation with the medium 40HT 
dose leads to an initial formation of outgrowths; although they increase greatly in 
size they fail to develop into a rudimentary follicle, instead forming hyperplastic 
structures resembling a tumour (Figure 4.3 F-H).
Interestingly, 40H T treatment also affected the whisker follicles (Figure 4.3 l-L) 
and the eyelid follicles in both transgenic lines (Figure 4.3 M-O). At the high dose 
of 40H T I could observe that in the whisker pad the ectopic follicles had fused 
(Figure 4.3 J-K) leading in some areas to really disorganised structures resembling 
tumours (Figure 4.3 K) with a strong dermal inflammatory infiltrates (Figure 4.3 L). 
In the eyelid follicles, the switch from a morphogenic event to tumour formation 
is particularly clear (See Figure 4.3 N-O).
4.2.2-Effects of P-catenin activation on lineage commitment in tail 
epidermis in vivo
In order to understand how ectopic hair follicles develop in tail epidermis, I 
assessed the changes in lineage commitment induced by activation of p-catenin.
I monitored the 3 differentiation pathways in the epidermis and validated the tail 
epidermis as an adequate model to study hair follicle morphogenesis.
Hair differentiation was monitored by looking at 2 hair follicle differentiation 
markers: keratin 17, an early hair differentiation marker (McGowan and 
Coulombe, 1998), CAAT displacement protein (CDP), essential for normal 
formation of the hair follicle inner root sheath (Figure 4.4; Ellis et al., 2001). In 
w ild type follicles, keratin 17 is confined to the outer root sheath cells, the IFE
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Figure 4.2- Titration of ANp-catenin-ER activation in tail epidermis in vivo.
Schematic diagram of the experimental design to look at the effects of titrating p-catenin 
activation in the D2 and D4 transgenic lines. P corresponds to postnatal day and d corre­
sponds to the day of the experiment. Note that the experiments were started at P49 when 
mice where in telogen. Days indicate the timepoint when the skin was harvested and anal­
ysed. Mice were treated with the 3 doses of 40HT, indicated by the coloured lines, every 
second day.
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and the sebaceous glands are completely negative (Figure 4.4 A), CDP is 
expressed in hair keratinocytes that are terminally differentiating at the base of 
the hair follicle (Fig 4.4 B,E). It was previously shown that induction of CDP, 
together with Lefl and keratin 17, is an early indicator of ectopic HF formation in 
dorsal skin (Lo Celso et al., 2004). In addition, I monitored sebaceous 
differentiation by using Nile Red, a lipid dye, that stains differentiated sebocytes 
(Figure 4.4 E) and early interfollicular differentiation by staining for Keratin 10 
(K10). K10 is a marker that it is expressed in basal cells that are committed to 
terminal differentiation, in the infundibulum and in the area surrounding the hair 
follicle triplet (Figure 4.4 D). Keratin 10 is also expressed in the suprabasal cell 
layers of the IFE but is not expressed in the sebaceous glands or hair follicles.
After 1 week of treatment, formation of outgrowths first occurs from the sebaceous 
glands (Figure 4.4 B and F). After one week a few clusters of cells positive for K17 
can be seen in the IFE. However only after 2 weeks they do develop into 
outgrowths positive for K17 and CDP (Figure 4.4 D,G,H). As there was an 
induction of hair markers in the sebaceous glands I wondered whether this might 
have affected the sebocyte lineages. When I performed double immunolabelling 
with the CDP marker and Nile Red, I could see clearly that the projections 
emanating from the sebaceous glands that were negative for Nile Red were 
positive for CDP (Figure 4.4 G). The induction of hair differentiation markers 
correlated with a decrease in the number of differentiated sebocytes in both lines. 
This indicates that sebaceous progenitors are driven to differentiate into hair 
keratinocytes and gradually the number of sebocytes is reduced, shown by the 
decreased areas stained with Nile Red (Figure 4.4 F and G).
As treatment progresses, the outgrowths adopt a follicle like structure and hair 
germs can be seen (Figure 4.4 G; see dotted line). After 4 weeks of treatment, the 
outgrowths and pre-existing follicles fused and formed benign tumours 
resembling trichofolliculomas (Figure 4.4 H; see dotted line), as previously 
reported (Gat et al., 1998; Lo Celso et al., 2004).
In the D4 line, after 1 day of treatment outgrowths were already apparent in the 
IFE (see Figure 4.4 I; see asterisks). After one week of treatment, the follicles were
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Figure 4.3- The levels of (3-catenin activation determine whether a morpho- 
genic or tumorigenic event is induced. (A-O) H & E stained sections of untreated (A, 
I and M) and D2 transgenic epidermis from tail (B-H), whisker pad (J-L) and eye lid ( N and 
O) treated with 40HT for the indicated time points. In A and I sebaceous glands (SG), hair 
follicles (HF) and interfollicular epidermis (IFE) are indicated. Arrows show ectopic dermal 
papillae (DP). Scale bars: 100 pm (A-C, E-O) and 50 pm (D).
Untreated —  21 Medium 40WT
Whisker HF
Untreated —  Untreated —
D
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Figure 4.4- Effects of AN[3-cateninER activation on lineage commitment.
Tail skin of untreated WT (A,B,E,M) or D2 transgenic treated for 7,14 and 21 days 
(C,D,E,F,G,H,N) and D4 transgenic treated for 1,3,6,9 days (I,J,K,L,0) treated with 1.5mg 
dose of 40HT (medium, M) dose. In A, the location of sebaceous glands (SG), interfol- 
licular epidermis (IFE) and hair follcile (HF) are indicated. (A,I,J) Double immunolabel- 
ling for keratin 17 (green) and keratin 14 (red); (B,D,L) Immunolabelling for CDP (HF 
differentiation); (C,H) Immunolabelling for K17; (F,G,K) Immunolabelling for CDP (hair 
differentiation) and staining with Nile Red (sebaceous differentiation). Note that in early 
stages of hair follicle morphogenesis (See F,G), SG are positive for hair differentiation and 
with some remnants of sebaceous differentiation. (M,N,0) Immunolabelling for K10 (IFE 
differentiation). Arrow in C indicate ectopic K17 expresion in SG. Arrow in I,F,K point to 
SG and asterisks in G,I,K indicate new outgrowths arising from IFE and SG. Dotted line 
in B demarcate HF and SG, and HF in D,N and O. In G, dotted lines demarcate newly 
arising ectopic HF; in K demarcate Nile Red positive areas and in M demarcate HF, SG 
and the parakeratotic scale negative for K10. Scale bars: 100 pm.
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very thick, probably due to the massive proliferation (Figure 4.4 I, J). Although 
rudimentary follicles formed, they did not develop to the same extent as in the D2 
line (Figure 4.4 L). The number of sebocytes was also markedly reduced (Figure
4.4 K; see dotted line). In addition, the new outgrowths induced by P-catenin in 
both transgenic lines (Figure 4.4 M-O) at the time points analysed were Keratin 10 
negative.
My observations on the effects of P-catenin activation in tail epidermis confirmed 
what has been previously reported in back skin (Lo Celso et al., 2004). Hair 
marker staining in the transgenics reveals that ectopic hair follicle formation is not 
confined in the hair follicle, but also occurs in the sebaceous glands and IFE. The 
activation of p-catenin in adult skin leads not only to stimulation of hair 
differentiation at the expense of sebaceous and IFE lineages, but also, potentially, 
to reprogramming IFE keratinocytes and sebaceous keratinocytes to differentiate 
along the hair lineage.
4.2.3-HF formation is a threshold response to p-catenin activation
To get a better insight and define the threshold for global hair follicle formation 
in tail epidermis I evaluated the dynamics of ectopic hair follicle differentiation by 
monitoring the expression of CDP in the titration experiments described in the 
previous section. As previously mentioned, the expression of CDP precedes the 
formation of epithelial outgrowths that come to express markers of the different 
HF lineages. Examples of whole mounts taken from D2 and D4 tails treated with 
different 40H T concentrations for different lengths of time are shown in Figure 
4.5, and a summary of the results is represented in the diagram in Figure 4.6.
In the D2 line, the first site of ectopic follicle formation is in the SG (Figure 4.5 B). 
Next, as the dose and the length increase follicles are induced in the IFE (Figure
4.5 C) and finally, at high and prolonged 4 OHT doses, follicles are formed from 
pre-existing HF ORS (Figure 4.5 D) resulting in the formation of trichofolliculomas 
(Figure 4.5 E). Conversely, in the D4 line the first site for ectopic HF was the IFE 
(Figure 4.5 F), followed by the SG (Figure 4.5 H). HF did not arise from the pre­
existing ORS. Instead, the ORS was thickened and positive for markers for hair 
follicle differentiation (Figure 4.5 I-M). I used the expression of keratin 17 as a
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Figure 4.5. Effects on D2 and D4 transgenic epidermis of activat­
ing AN(3-cateninER with different concentrations of 4 0 H T  for 
different lengths of time. 40HT was applied at 0.5mg (low), 1.5mg 
(medium, M) and 3mg (high, H) doses. (A-M) Representative tail whole 
mounts immunolabelled for CDP (A-l) and Keratin 17 (J-M). Transgenic lines, 
40HT doses and time of treatments (days, d) are indicated. Dashed lines 
demarcate hair follicles and sebaceous glands in A,B,E and F. Arrows in B 
indicate CDP expression from SG, in C and K a dermal papilla and in D and L 
an outgrowth arising from ORS. Arrowheads in F, G and I indicate new 
outgrowths arising from IFE. Scale bars: 100 pm.
second marker of ectopic HF differentiation for these experiments and the results 
were the same (Figure 4.5 J-M).
I took advantage of the unique organisation of tail epidermis in order to obtain 
quantitative data on ectopic HF formation (Figure 4.6) as described in the 
Materials and Methods section. In wild-type and untreated K14ANP-cateninER 
skin the hair follicles are arranged in rows and clustered in groups of three 
(triplets). As I showed in the previous Chapter one triplet and the adjacent 
interfollicular epidermis is defined as one epidermal unit, as illustrated 
schematically in Figure 4.7. First, I calculated the percentage of units in which 
ectopic expression of CDP occurred in the IFE (arrowheads in Figure 4.5 G), SG 
(arrows in Figure 4.5 B) and HF ORS (arrow in Figure 4.5 D) for each 40HT 
concentration and on each transgenic line (Figure 7 B, C). In addition, I also 
calculated the number of CDP-positive patches per positive unit (Figure 4.7 D).
In D2 mice, the dose of 40H T affected the proportion of units with ectopic CDP, 
the number of patches of ectopic CDP per unit and the time at which they 
appeared (Figure 4.7 B,D). I first observed ectopic CDP expression at day 6 with 
medium and high 40H T concentrations and at day 9 with the low dose (Figure
4.5 A,B; Figure 4.7 B). CDP was most readily induced in the SG (Figure 4.5 B). 
For instance, after 6 days of treatment with the medium dose of 40HT CDP- 
positive patches on SG were observed in 100% of units, whereas 47% had CDP- 
positive patches in the IFE, and only 17% in the pre-existing anagen HF outer root 
sheath (ORS). The HF was most refractory to induction of ectopic CDP: whereas 
CDP-positive regions of SG and IFE were achieved in 100% of units from day 9 
onwards with medium and high dose 40HT, the maximum % units with ectopic 
CDP expression in the ORS was 52% with the high dose and 34% with the 
medium dose (Figure 4.5 D). Medium dose 40HT induced a higher number of 
CDP positive patches than low dose 40HT and at all doses the number of 
positive patches per unit increased over time (Figure 4.7 D; compare Figure 4.5 
D,F). However, at the high dose the number of CDP positive patches was lower 
than at the medium dose; this was because the high dose patches were larger 
(Figure 4.7 D).
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Figure 4.6- Effects on D2 and D4 transgenic epidermis of activating A N (3 
-cateninER with different concentrations of 4 0 H T  for different lengths of 
time. 40HT was applied at 0.5mg (low), 1.5mg (medium, M) and 3mg (high, H) doses. A) 
Schematic representation of the results, showing the outer root sheath (ORS) of a single HF 
with associated SC and IFE. CDP expression is represented in green and de novo dermal 
papillae (DP) are shown in red. Arrows represent time points at which skin was analysed. 
Individual letters correspond to whole mounts shown in Figure 4.5.
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The follicular epithelium induced by P-catenin activation in K14ANP-cateninER 
mice can induce the underlying mesenchyme to form a dermal papilla (Van Mater 
et al., 2003;Lo Celso et al., 2004). The epithelium at the base of the follicles forms 
a cup-like structure that encircles the dermal papilla (see, for example, Figure 
4.9D, arrow). I also monitored the degree of 'maturity' of the ectopic hair follicles 
according whether they had recruited a DP. I could observe that the formation of 
dermal papillae occurs later than the induction of ectopic CDP (represented in red 
in Figure 4.6). In D2 mice there was a dose dependent induction of dermal 
papillae: none were formed with the low dose; and they appeared several days 
earlier in response to high dose rather than medium dose 40HT.
As reported previously, D4 (high copy number) epidermis responded to P-catenin 
activation more rapidly than D2 epidermis and by 1 day of treatment ectopic CDP 
expression was observed in IFE (Figure 4.5 F, G and 4.7 C). As previously 
mentioned, whereas in D2 mice the SGs were most susceptible to induction of 
CDP, in D4 mice the IFE was most sensitive (Figure 4.5 G and 4.7 C). D4, like 
D2, HFs were most refractory to induction of new follicles. At 14 days of medium 
40H T treatment CDP expression was observed along most of the D4 ORS; 
however, I could hardly observe the formation of distinct projections of CDP- 
positive epithelium and dermal papillae and never in HF. The correlation 
between the number of CDP-positive patches and 40HT dose and length of 
treatment was more pronounced in D2 than in D4 epidermis, largely because the 
size of the patches in D4 were larger due to individual patches merging with one 
another.
The results from the titration experiments show that by controlling the strength of 
P-catenin activation, through transgene copy number and 40H T dose, it seems 
possible to control the number and location of new hair follicles. Different regions 
of the epidermis differed in their responsiveness to P-catenin activation. SGs were 
most responsive, because they were the sites where ectopic CDP expression was 
induced most rapidly and at lowest 40HT concentrations in the lower copy 
number founder line, D2. Compared to IFE and SG, HF in both D2 and D4 mice 
were refractory to developing new follicles.
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Figure 4.7- Quantitation of p-catenin signaling in vivo. (A) The unit of tail epider­
mis used for quantitation is shown outlined in red, corresponding to three HF with associ­
ated SC and IFE. (B, C) Percentage of units with ectopic CDP expression in IFE, SG and HF 
in D2 (B) and D4 (C) lines treated for the number of days shown with low (L), medium (M) 
and high (H) doses of 40HT. (D) Average number of CDP positive patches per unit, broken 
down into IFE, SG and HF.
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Figure 4.8-. Effects of AN(3-catenin-ER activation on proliferation.
Transgenic line (D2 or D4) and days of 40H T treatment (medium dose) are 
shown. In A locations of sebaceous glands (SG), hair follicle outer root sheath 
(ORS), bulge (BG) and bulb (BL) are indicated. (A and B) Double labelling for 
Ki67 (green) and (31 integrin (red), (C and D) double labelling for BrdU (green) 
and keratin 14 (red). Arrows in B, C and D indicate clusters of proliferating 
cells in the sebaceous glands and IFE associated with ectopic HF formation. 
Scale bars: 100 pm.
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4.3-Changes in proliferation during ectopic hair follicle 
formation
I next investigated the levels of proliferation in both transgenic lines, in order to 
see whether the differences in copy number reflected also differences in 
proliferation.
In wild-type epidermis, proliferation is confined to some cells in the IFE basal 
layer, the outer layer of the sebaceous glands and in the bottom part of the hair 
fo llic le  known as the bulb (Figure 4.8 A and Braun et al., 2003). Proliferation can 
be monitored either by looking at the cell cycle marker Ki67 or by looking at 
BrdU incorporation during 1 hr-pulse prior to sacrifice (Figure 4.8 A and 3.7; 
Braun et al., 2003). Between 7 and 14 days of treatment, activation of P-catenin 
resulted in increased proliferation in clusters of cells at the sites of ectopic HF 
formation in the SG and IFE (Figure 4.8 B-D). As treatment continued these 
clusters developed into outgrowths (Figure 4.8 B-D). After one week of treatment 
of the D4 line, the follicles were very thick, probably due to the massive 
proliferation (Figure 4.8 C). In D4 epidermis the rudimentary follicles formed but 
did not develop to the same extent as in the D2 line. At three weeks in the D2 
line epithelial projections with a dermal papilla could be observed (See arrows in 
figure 4.8 D), but not in the D4 line.
In addition, I looked at pathways that are known to be involved in proliferation 
and have previously been shown to be active at early stages of HF morphogenesis 
(Jamora et al., 2005). Sites that were positive for markers of proliferation were also 
positive for an antibody detecting active pM ekl, a component of the Erk/MAPK 
pathway (Figure 4.9 A-D). In addition, it has been reported that TGFp signalling is 
also active in the early stages of HF morphogenesis (Jamora et al., 2005). I could 
also detect increased pSMAD2/3 staining in ectopic HF from SG and IFE (Figure
4.9 E-F). It has been previously shown that proliferative epidermal cells, such as 
transit amplifying cells (TAC), can be detected by expression of Fatty acid binding 
protein (FABP), another marker for TAC (see Figure 3.6 H In Chapter 3 and Figure
4.9 G-l; O'Shaughnessy et al., 2000).
The results of this section show that in D2 epidermis lineage reprogramming is 
accompanied by only local increases in proliferation, whereas in D4 epidermis
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Figure 4.9- Effects of ANp-catenin-ER activation on markers of 
proliferation signalling path way s.Transgenic mice (D2) were treated 
with 1.5 mg 40H T (medium dose) for the dates shown. (A-D) Immunola­
belling with a specific phospho-MEK1 antibody. In A locations of seba­
ceous glands (SG), hair follicle outer root sheath (ORS), bulge (BG) and 
bulb (BL) are indicated. (E and F) Labelling with pSMAD2/3 antibody. (G-l) 
Immunolabelling for Fatty Acid Binding Protein (FABP) to mark transit 
amplyfying cells (TACs). Arrows in D,F and I indicate clusters of proliferat­
ing cells associated with ectopic HF formation. Scale bars: 100 pm.
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Figure 4.9- Effects of ANp-catenin-ER activation on markers of 
proliferation signalling pathways.Transgenic mice (D2) were treated 
with 1.5 mg 40H T (medium dose) for the dates shown. (A-D) Immunola­
belling with a specific phospho-MEK1 antibody. In A locations of seba­
ceous glands (SG), hair follicle outer root sheath (ORS), bulge (BG) and 
bulb (BL) are indicated. (E and F) Labelling with pSMAD2/3 antibody. (G-l) 
Immunolabelling for Fatty Acid Binding Protein (FABP) to mark transit 
amplyfying cells (TACs). Arrows in D,F and I indicate clusters of proliferat­
ing cells associated with ectopic HF formation. Scale bars: 100 pm.
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there is more extensive proliferation and the follicles become grossly thickened.
4.4-Effects of P-catenin activation in the LRC compartment 
in vivo
Cells in all regions of the epidermis (HF, SG, IFE) are competent to respond to |3- 
catenin (Figure 4.6). Under steady-state conditions bulge stem cells give rise to 
hair fo llic le lineages (Levy et al., 2005; Ito et al., 2005) and a pulse of p-catenin 
induces bulge stem cells to proliferate, triggering the entry into the anagen phase 
of the hair growth cycle (Lowry et al., 2005). In this section I investigated the 
effects of P-catenin activation on the bulge stem cell compartment and whether 
new HF originated from this compartment or from cells in the IFE and SG.
To investigate the effect of p-catenin activation on the hair fo llic le  stem cell 
compartment I used two of the stem cell markers described previously in Chapter 
3: retention of BrdU label and expression of K15. Label retaining cells (LRC) were 
generated as described in the Materials and Methods section by giving neonatal 
mice repeated injections of BrdU and then examining the epidermis of adult 
animals after a minimum of 40 days chase-period. Mice from both lines were 
treated with the same doses as in the titration experiments. The design of the 
experiment is shown in Figure 4.10.
I monitored changes in LRC, by immunolabelling with antibodies against BrdU 
and visualising basal layer epidermal cells with an antibody against keratin 14. In 
wild-type mice and untreated transgenic mice LRC are concentrated in the 
permanent portion of the hair follicle, in the region known as the bulge, and there 
are scattered LRC in the sebaceous glands and IFE (Figure 4.11 A and G). In D2 
hair follicles treated with 40 H T  (medium dose) there was no evidence of LRC 
depletion in the bulge for up to 14 days when ectopic hair follicles were already 
formed (Figure 4.11 C). When I looked at D4 mice treated for up to 9 days l did 
not see any obvious change in numbers of BrdU positive cells (Figure 4.11 K). 
Thus at times when ectopic hair follic le formation was well advanced in IFE and 
SG (Figure 4.11) bulge LRC had not been lost and there was no evidence that they 
had moved. P-catenin activation did not trigger proliferation in the bulge (Figure
4.11 B,C,and H-
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Figure 4.10- Effects of ANP-catenin-ER activation on LRC of tail epidermis.
Schematic diagram of the experimental design to look at the effects of p-catenin activa­
tion in the LRC compartment in the D2 and D4 transgenic lines. P corresponds to postna­
tal day and d corresponds to the day of the experiment. Note that the experiments were 
started at P63 when mice were in telogen. Days indicate the timepoint when the skin was 
harvested and analysed. Mice were treated with a medium dose of 40H T every second 
day.
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K) and it was only at 28 days of treatment of D2 mice (Figure 4.11 D) and 15 days 
of treatment of D4 mice (Figure 4.11 L) that the number of LRC in the bulge had 
declined significantly.
In order to find out how BrdU positive cells were lost at late time points, I first 
looked by TUN EL labelling at whether there was an increase in apoptosis 
between the different time points (example shown in Figure 4.12 B, L, D). I did 
not observe any obvious increase in the number of TUNEL positive cells in either 
of the time points analysed in this experiment and in either lines (Figure 4.12 C, 
D).
As shown previously, activation of P-catenin resulted in local increases in 
proliferation (Figure 4.8 and 4.9). I therefore looked at whether loss of bulge LRC 
correlated with stimulation of LRC to divide. I performed double immunolabelling 
with BrdU to detect LRC and Ki67 to detect cells that were in cycle (Figure 4.12 
E-L). In wild-type epidermis LRC were confined to the bulge and scattered in IFE 
and SG, whereas proliferating cells were confined to the outer layers of the SG 
(see in red in Figure 4.12 E) and basal cells of the infundibulum and IFE (Figure
4.12 E in green). I could only detect double labelled cells in wild-type telogen 
follicles (Figure 4.12 H). During the first stages of ectopic follicle development in 
transgenics (between the first and second week of 40H T treatment) I could not 
see an increase in double positive cells (Figure 4.12 F-G; see orange or yellow 
cells). As the phenotype developed (3 weeks) I could start detecting double 
labelled cells representing LRC cells that were entering into cycle (Figure 4.12 
H,K). At later stages of the treatment (four to five weeks), when I observed the 
decrease in the number of LRC (Figure 4.12 I, J), I could detect Ki67 positive and 
non-labelled or lightly BrdU labelled cells appeared in the bulge (Figure 4.12 L). I 
conclude that on sustained activation of P-catenin LRC are lost through 
proliferation.
I next wondered whether LRC proliferation resulted in bulge compartment loss. I 
looked at Keratin 15, which is expressed in the bulge and corresponds to the zone 
of LRC (Figure 4.12 N; see Figure 3.4 in Chapter 3). Keratin 15 expression in the 
bulge was preserved in both transgenic lines, even at high 40HT concentrations
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Figure 4.11 - Effects of ANP-catenin-ER activation on LRC of tail epider­
mis. Transgenic line (D2 or D4) were treated with 40HT(medium dose) for the days 
shown. (A-L) green: BrdU; red: keratin 14. In A locations of sebaceous glands (SG), 
hair follicle outer root sheath (ORS), bulge (BG) and bulb (BL) are indicated and 
arrows show LRC. (B-L) Bulges are indicated (BG). Scale bars: 100 (im.
121
0d B > Od |C BG 14d D
*«—
c
sJ-
*
h*
VO
2
D"Os-
CO
BG BG
Nctd-FITC only --------
E > IFB- Od p
[ ' \ > J  [\
S'6 V\ A , / T  . 
BG\ :
>
14d G
^ e liF IT G .
21d I H
28d I J 32d I K  32d I
D■Dk-CO
In
cl
(0u.<u
Figure 4.12- (3-catenin activation induces LRC loss through prolifera­
tion and the bulge compartment is maintained. (A-P) Transgenic line D2 
treated with 40HT for the indicated days (d) (medium dose) are shown. A is 
untreated transgenic skin labelled with the nucleotide conjugated with FITC only 
as a negative control. (B-D) Apoptotic cells were analysed by Tunel immunolabel- 
ling. (E-L) Double labelling for Ki67 (green) and LRC (red). In E locations of seba­
ceous glands (SG), hair follicle outer root sheath (ORS), bulge (BG) and bulb (BL) 
are indicated and arrows show scattered LRC in SG and IFE. Dashed lines indicate 
the triplet (E) and the bulge in (G,H,I,L). M is wild type whole mount stained with 
secondary antibody alone, showing nonspecific SG labelling. N-P: double label­
ling for keratin 15 (red) and LRC (green). No SG remain in J, K. Note that at 28 days 
when LRC are lost there is no increase in apoptotic cells in the bulge. Scale bars: 
100 pm (A-F and J-L), 10 pm (G).
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and late time points (see examples in Figure 4.12 0,P). In D2 epidermis after 28 
days of medium dose 40H T treatment, when LRC had been completely lost from 
some bulges (Figure 4.12 P), the keratin 15 expression pattern was unchanged 
(Figure 4.12 P).
These results show that p-catenin induced HF formation could be initiated 
without involvement of bulge LRC and that even when LRC divided and lost their 
label the original bulge remained, as detected by keratin 15 expression.
Further evidence that ectopic hair follicles could originate in the IFE came from 
lineage trace analysis in triple transgenic mice (K14Cre-ERxRosa26/ K14ANP- 
cateninER), in which IFE cell progeny can be followed by LacZ expression after P- 
catenin activation. These experiments were performed by Dr Adam Giangreco 
and Dr Kristin Braun (Silva-Vargas et al., 2005). The treatments were designed so 
that transgene activation would be homogenous but the LacZ expression would 
be patchy. After 40H T treatment ectopic hair follicles originating from IFE that 
were positive for CDP, resembled the LacZ (either positive or negative) of the 
surrounding IFE (Silva-Vargas et al., 2005). These results strongly suggest that HF 
had originated from immediately adjacent epidermis rather than from 
neighbouring hair follicles and supports the notion that LRC from the bulge were 
not involved (Silva-Vargas et al., 2005).
I conclude that P-catenin activation can induce ectopic hair follicles without any 
obvious change in the number or location of bulge stem cells. After prolonged 
treatment bulge cells are induced to proliferate, however the compartment is 
maintained as bulge markers expression persists.
4.5-Characterisation of ectopic hair follicles
4.5.1-Recreation of a hair follicle niche in ectopic HF
Hair follicles constitute a very complex and dynamic niche in which several cell 
types reside and constantly go through cycles of growth and regression (Alonso 
and Fuchs, 2006). Ectopic hair follicles can recruit a dermal papilla (Figure 4.13 
A; Van Mater, et al.2003 and (Lo Celso et al., 2004). I performed an array analysis 
of genes modulated by p-catenin at 7 days that is described in Chapter 5 and 
amongst the upregulated genes were several that play a role in melanin 
biosynthesis (Table 5.1). This led me to examine whether P-catenin induced
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Figure 4.13- Ectopic hair follicles provide a niche for differentiated 
melanocytes. Whole mounts of wild-type (wt) and D2 transgenic (tg) tail skin. 
Tail skin was treated with a low (A) or medium (B-G) dose of 40H T for the 
number of days shown. Epidermis was labelled with L-Dopa (B-G) or with an 
anti-keratin 14 antibody. (A) Cuff of keratinocytes at the base of the ectopic 
follicle into which dermal papilla cells insert. In B wild type mouse is Albino, 
serving as a negative control for L-Dopa staining. Melanocytes in follicle bulb 
(red asterisk) and IFE (red arrow) are indicated in C. In E and F melanocytes in HF 
induced from SG and ORS are shown with black arrows. Insert in F shows high 
magnification view of ectopic HF arising from ORS, with melanocyte indicated 
by arrow. Scale bars: 100 pm.
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follicles were capable of providing a niche for neural crest derivatives such as 
melanocytes.
To visualise differentiated melanocytes I examined tyrosinase activity using L- 
Dopa as substrate (Nishimura et al., 2002). In order to ensure the specificity of 
this enzymatic reaction, skin from albino mice, devoid of melanocytes, was used 
as a negative control for the staining (Figure 4.13 B). In wild-type tail hair follicles 
melanocytes were concentrated at the base of the follicle (Figure 4.13 C, red 
asterisk). In adult dorsal epidermis, the differentiated melanocytes are confined to 
the hair follicles (Nishimura et al., 2002), but in the tail, small numbers of 
melanocytes were also found scattered in the IFE (Figure 4.13 C, arrows). 
Melanocytes were present in the ectopic follicles induced by P-catenin in SG 
(Figure 4.15 D, E), IFE (Figure 4.15 F) and HF (Figure 4.15 D).
In order to detect melanocyte precursors (melanoblasts), I used an antibody to c- 
Kit. In wild-type epidermis there are a few c-Kit positive cells, the putative 
melanocyte stem cells, in the bulge, as reported previously (Nishimura et al., 
2002; Figure 4.14 A, lower arrow). In addition, in tail epidermis there are also 
some c-Kit positive melanoblasts in the HF infundibulum (Figure 4.14 A, upper 
arrow; Grichnik et al., 1996). In early stages of ectopic hair follicle development 
(9 days 40HT treatment, D2 mice), c-Kit positive cells appeared in IFE 
immediately adjacent to the HF (Figure 4.14 B, arrowheads), and at later time 
points c-Kit positive cells were found in the base of the new follicles (Figure 4.16 
C).
Interestingly, the c-Kit ligand is known to act as a homing cue for melanocytes 
(Grichnik et al., 1996). Thus, l looked at the changes in the c-Kit ligand 
expression in order to understand how migration of this melanocyte population 
might have taken place. In wild-type epidermis c-Kit ligands is highly expressed 
by keratinocytes of the hair follicle, infundibulum and parakeratotic scale area of 
the IFE (Figure 4.14 D). In the transgenic skin analysed at the same time points as 
for L-Dopa, c-Kit ligand expression was no longer restricted to those areas, but 
was widely expressed, including sites where differentiated melanocytes (L-Dopa 
positive) and melanoblasts (c-Kit positive) were recruited (Figure 4.14 E).
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Figure 4.14- Ectopic hair follicles provide a niche for melano­
cyte progenitors. Whole mounts of wild-type (wt) and D2 transgenic 
(tg) tail skin. Tail skin was treated with a medium dose of 40H T for the 
number of days shown. Epidermis was labelled with anti c-Kit antibody 
to mark melanocyte progenitors (A-C) or with an anti-c-Kit Ligand anti­
body (D and E). A and B c-Kit positive cells in infundibulum (top arrows), 
bulge (bottom arrow) and in the IFE (arrowheads) are shown. Dotted lines 
in A,B demarcate HF and SC. C: dotted lines demarcate new HF. Scale 
bars: 100 pm.
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As previously mentioned, activation of P-catenin results in the formation of new 
dermal papillae, the specialised fibroblasts engulfed by the hair follicle bulb (Van 
Mater et al., 2003; Lo Celso et al., 2004). The cells encircled by the cuff of 
keratinocytes at the base of the follicle can be visualised with alkaline 
phosphatase (Lo Celso et al., 2004) and also with nestin, a marker expressed by 
neural crest derived stem cells in the dermal papilla (Toma et al., 2001); 
(Fernandes et al., 2004). In tail epidermis, nestin is also a marker of wild-type 
dermal papillae (Figure 4.15 D, arrow). In addition to the nestin positive cells in 
the DP (Figure 4.15 A), there are some nestin-positive cells with a dendritic 
morphology scattered along the length of wild-type follicles (see arrowhead in 
Figure 4.15 A). Their dendritic morphology suggested that they could be either 
differentiated melanocytes or Merkel cells, that together with sensory neurons, 
form cutaneous mechanoreceptors. Double labelling with keratin 18 indicated 
that the dendritic nestin positive cells are not Merkel cells (Figure 4.15 E,F). They 
are also L-Dopa negative (Figure 4.15 G-l), and I speculate that they are 
undifferentiated melanocyte precursors (Figure 4.15 C-l; Fernandes et al., 2004).
In conclusion, P-catenin induced follicles are capable of providing a niche for 
neural-crest derived cells such as differentiated melanocytes, melanoblasts and 
cells in the DP. These results show that even though the P-catenin transgene is 
activated in keratinocytes it has a great impact on other cell types that normally 
reside in close contact with keratinocytes. By simply activating P-catenin in basal 
layer keratinocytes, we can switch on a programme to develop a niche for other 
cell types.
4.5.2-Tail ectopic hair follicles can undergo cycles of growth and 
regression dependent of 4 0 H T
Hair follicles, in addition to providing a niche for other cell types, are very 
dynamic structures that undergo cycles of growth and regression (Alonso and 
Fuchs, 2006). Several pathways are involved in regulating the hair cycle, one 
being the Wnt pathway, which induces entry into the growth phase, anagen. The 
first response of K14ANP-cateninER epidermis to 40H T treatment is the entry into 
anagen and it was previously shown that withdrawal of 40HT caused pre-existing 
follicles to regress and enter the resting phase (Lo Celso et al., 2004).
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Figure 4.15- Ectopic hair follicles provide a niche for neural 
crest progenitors. Whole mounts of wild-type (wt) and D2 trans­
genic (tg) tail skin. Tail skin that was treated with a medium dose of 
40H T for the number of days shown. Epidermis was labelled with anti 
Nestin antibody to mark neural crest progenitors (A-D) or in combina­
tion with the Merkel cell marker keratin 18 (E,F) or with L-Dopa staining 
(G-l). Note that nestin positive cells are either clustered in the dermal 
papilla (white arrow) or scattered in ORS (A), SG (B and C) or IFE 
(D).Upper inset in D shows dendritic nestin positive cells and lower 
inset shows clustered nestin positive cells in dermal papilla of an ecto­
pic HF. Dotted lines in A-l demarcate HF and SG. Scale bars: 100 pm
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Figure 4.16. (3-catenin induced hair follicles can undergo cycles of growth and 
regression. (A) Schematic diagram of the experimental design to look at the effects of titrat­
ing P-catenin activation on cycling of the ectopic follicles. P corresponds to postnatal day 
and w corresponds to the day of the experiment when tissue was harvested. Note that the 
experiments were started at P49 when mice where in telogen. Mice were treated with the 3 
doses indicated of 40H T every second day.(B-Q) H & E stained sections of WT (B-E and J-M) 
and D2 transgenic tail (F-I) and dorsal (N-Q) epidermis treated with 40H T for 3 weeks and 
then harvested immediately (B, F, J, N) or left untreated for 3 weeks (+3w) and harvested 
(C,G,K,0) or treated with 40H T for a further 1 (+1w) (D,H,L,P) or 2 (+2w) (E,I,M,Q) 
weeks.Arrows in F-I show examples of ectopic follicles. Scale bars: 100 pm
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Therefore, it was intriguing to find out whether ANp-cateninER induced follicles 
could also undergo cycles of growth and regression.
To investigate this, I designed an experiment in which I induced ectopic follicles 
in D2 epidermis by applying 1.5mg 40H T for 3 weeks; I then stopped treatment 
for 3 weeks; and then applied 40HT for a further 1 or 2 weeks (Figure 4.16). 
Ectopic hair follicles were allowed to develop for 3 weeks (Figure 4.16 E, M) and 
then 40H T treatment was stopped. This caused ectopic follicles to regress (Figure
4.16 F,N). When 40H T was reapplied, the original follicles re-entered anagen 
(Figure 4.16 G,0); ectopic follicles re-grew and were wider than before (Figure
4.16 H-l).
Dr Giangreco in the lab measured the number of sites of ectopic CDP expression 
in order to determine whether the phenotype induced by reapplication of 40HT 
reflected re-growth of existing ectopic follicles or initiation of new ones (Silva- 
Vargas et al., 2005). Interestingly, the number of CDP positive sites increased in 
response to the first 40H T treatment; decreased when 40H T was removed; then 
on reapplication of 40H T returned to the same level as after the first treatment. 
This suggests that the original ectopic follicles re-grew (Silva-Vargas et al., 2005).
4.5.3-Ectopic hair follicles contain clonogenic keratinocytes
Given that ectopic P-catenin induced hair follicles are capable of recruiting and 
providing a niche for neural-crest stem cells and more differentiated progeny, I 
wondered if they also expressed markers for bulge cells.
To evaluate this, I first stained whole mounts with antibodies to keratin 15 and 
CD34 (Figure 4.17 A-F). As previously shown, in wild-type follicles expression of 
both markers was confined to the permanent portion of the follicle (Figure 4.17 A; 
Trempus et al., 2003; Morris et al., 2004). Both markers were retained in the 
original bulge, even after prolonged p-catenin activation (Figure 4.12 N; Figure
4.17 E, F). However, the levels of CD34 were lower in the pre-existing bulges 
(Figure 4.17 E, F; see continuous line). This is consistent with the notion that these 
cells are cycling at this late stage of treatment (Figure 4.12 E-H) and therefore not 
quiescent. In addition, expression of both markers was observed in all sites of new 
HF development in D2 epidermis from 35 days of treatment (Figure 4.17 E and F).
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Figure 4.17- p-catenin activation induces formation of keratino­
cytes that have characteristics of bulge stem cells. Whole mounts 
from tail epidermis of Wt untreated (A) or D2 transgenic mice untreated (B) 
and treated with a medium dose of 40H T (C-F) for the number of days shown. 
Whole mounts were immunolabelled with an anti-CD34 antibody (A-E) or with 
an anti-keratin 15 antibody (F). Ectopic follicles are demarcated with dotted 
lines in E and F. Inset in F shows a keratin 15 positive ectopic hair follicle. Conti- 
nous line in E, F indicate ectopic hair follicles. Red dashed lines in E and F indi­
cate pre-existing bulge. Scale bars: 100 pm
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The same observations were made for back skin at these time points (Silva-Vargas 
et al., 2005).
An additional marker for assessing bulge cell characteristics is clonal proliferative 
capacity in vitro. Recently, it has been shown that cells expressing high levels of 
CD34 and a6 integrin constitute the epidermal population that has the highest 
clonal capacity in vitro (Morris et al., 2004; Blanpain et al., 2004; Tumbar et al., 
2004; See also Chapter 3).
In order to obtain a quantitative assessment of the increase in CD34 positive cells 
and to evaluate whether or not they were capable of forming actively growing 
colonies I performed FACS analysis of disaggregated keratinocytes from back 
(Figure 4.18) and tail skin (Figure 4.19) in collaboration with Dr Adam Giangreco 
from the laboratory. CD34 is a widely expressed marker by other progenitor cells 
and not exclusively expressed on keratinocytes. In order to ensure enrichment of 
keratinocytes, we performed double labelling with antibodies to CD34 and to the 
a6  integrin subunit, which is expressed by undifferentiated keratinocytes of HF, 
SG and IFE. In addition, we further enriched for basal (small size) cells by gating 
out differentiated cells on the basis of high forward and side scatter (A, B in Figure
4.18 and Figure 4.19; Jones, et al.1995). Prior to analysis, the cell preparations 
were stained with a 7AAD dye to gate out dead cells. The majority of the gated 
cells (encircled in red in panels A and B) express the a6 integrin subunit, in both 
wild type and 40H T treated transgenic epidermis and in both, tail or back skin 
(Figure 4.18 and Figure 4.19).
In 40HT treated wild type epidermis approximately 4% of the a6 positive cells 
express high levels of both CD34 and a6 integrin and 2% are CD34 positive and 
have lower levels of a6  integrin. In D2 back epidermis the proportion that had 
high CD34/a6 integrin expression was similar (3.5%, compare C and D in Figure 
4.18), but the proportion with a CD34 positive /a6 integrin low expression 
phenotype had increased to approximately 15% (Figure 4.18 D).
Interestingly, in tail epidermis the profile was different. In wild type epidermis, the 
proportion of a6 positive cells expressing high levels of both CD34 and a6 
integrin was 3.22 %, while 0.49% are CD34 positive and have lower levels of a6
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Figure 4.18- (3-catenin activation induces formation of ectopic hair 
follicles with keratinocytes that have clonogenic capacity in vitro. FACS 
selection and culture of keratinocytes from dorsal epidermis of adult wild-type (A,C,E,F) 
and D2 transgenic (B,D,E,F) mice treated with a medium dose 40H T for 3 weeks. Cells 
isolated from epidermis were double labelled for CD34 and a6 integrin. Cells with low 
forward and side scatter characteristics (circled in A,B) were either sorted directly onto 
culture dishes (all sorted (E,F) or further fractionated into a6 single positive (green boxes 
in C,D) or CD34/a6 double positive populations (red boxes in QD). In C,D the left hand 
red boxes represent cells with lower surface a6 than the right hand red boxes. FACS 
sorted keratinocytes were cultured for 2 weeks at clonal density on a feeder layer, then 
stained with Rhodamine B to determine colony forming efficiency (E,F). The graph in (F) 
is representative of two separate experiments, in each of which cells from triplicates of 
wild-type or transgenic mice were pooled. White bars: wild-type; black bars: transgenic 
cells. Error bars represent values of standard deviation values. This experiment was 
performed in collaboration with Dr Adam Giangreco.
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Figure 4.19- P-catenin activation induces formation of ectopic hair 
follicles with keratinocytes that have clonogenic capacity in vitro in 
tail epidermis. FACS selection and culture of keratinocytes from tail epidermis 
of adult wild-type (A,C,E) and D2 transgenic (B,D,E) mice treated with a medium 
dose 40H T for 3 weeks. Cells isolated from epidermis were double labelled for 
CD34 and a6 integrin. Cells with low forward and side scatter characteristics 
(circled in A,B) were either sorted directly onto culture dishes (all sorted (E) or 
further fractionated into a6 single positive (green boxes in C,D) or CD34/a6 
double positive populations (red boxes in C,D). In C,D the left hand red boxes 
represent cells with lower surface a6 than the right hand red boxes. FACS sorted 
keratinocytes were cultured for 2 weeks at clonal density on a feeder layer, then 
stained with Rhodamine B to determine colony forming efficiency (E). The graph 
in (E) is representative of three separate experiments, in each of which cells from 
triplicates of wild-type or transgenic mice were pooled. White bars: wild-type; 
black bars: transgenic cells. Error bars represent values of standard deviation 
values. This experiment was performed in collaboration with Dr Adam 
Giangreco.
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integrin (Figure 4.19). In D2 tail epidermis the proportion that had high CD34/a6 
integrin expression was increased to 4.87%, (compare C and D in Figure 4.19). 
The proportion with a CD34 positive /a 6  integrin low expression phenotype had 
decreased to 0.092 % (Figure 4.19 D). The changes in the proportions of the 
double population were different in back and tail.
In order to test the clonal ability in vitro of these populations, I selected by FACS 
three cell fractions for back and tail (Figure 4.18 and Figure 4.19, respectively): 
the total low forward and side scatter population ('all sorted'), a6 positive/CD34 
negative cells (green gates, Figure 4.18), and all a6/CD34 double positive cells 
irrespective of whether the a6 integrin was expressed at high or low levels (red 
gates, Figure 4.18 and 4.19). After 14 days of culture without 40HT, the dishes 
were fixed and stained with Rhodamine B, revealing individual colonies of 
keratinocytes and the feeder layer on which they were cultured (see an example 
in Figure 4.18). There was no significant difference between the colony forming 
efficiency of each fraction in wild type dorsal epidermis (Figure 4.18 E, F). In 
transgenic epidermis the colony forming efficiency of the total population and the 
a6 positive/CD34 negative population was always increased but not significantly 
different from wild type. Flowever, there was a 2 fold higher proportion of 
clonogenic keratinocytes in the transgenic double positive population (Figure
4.18 F). In all three fractions the size of individual colonies tended to be larger in 
transgenic compared to wild type keratinocytes (Figure 4.18 F).
There were differences between the colony forming efficiency of each fraction in 
wild type tail epidermis (Figure 4.19 E). In transgenic epidermis the colony 
forming efficiency of the total population less than 1.5-fold compared to wild-type 
keratinocytes (Figure 4.19 E) and the a6 positive/CD34 negative population was 
slightly decreased in the transgenic compared to wild type. However, there was a 
slight increase (0.5-fold) in the proportion of clonogenic keratinocytes in the 
transgenic double positive population (Figure 4.19 E).
These results show that after prolonged P-catenin activation in dorsal adult 
epidermis, the induced HF contain cells with three characteristics of bulge stem 
cells: expression of keratin 15, expression of CD34, and clonal growth in culture.
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In dorsal epidermis there is a 1.8-fold increase in the number of clones in 'All 
sorted'. However, in tail epidermis the increase is more moderate and enrichment 
for double positives wild-type keratinocytes does not enrich for clonogenic 
keratinocytes. In addition, the intensity of CD34 levels in the double positive 
populations was lower (See Figure 4.19 D, Right Box).
4.6- Discussion
The work described in this chapter validates the whole mount system of tail skin 
as an excellent system to assess de novo hair follicle formation in three 
dimensions and to obtain quantitative and spatial data on the dynamics of hair 
formation in tail skin. In addition, it is also very informative to evaluate changes in 
the epidermal stem cell compartment. A combination between this system and 
conventional histology provides an optimal system to analyse epidermal 
phenotypes.
Hair morphogenesis is a complex patterning 'puzzle'
During development, a complex array of pathways interacts to begin the process 
of hair follicle morphogenesis as explained in the Introduction. It is interesting to 
think of the process of de novo hair follicle morphogenesis described in this 
Chapter as a recapitulation in part of the processes that occur during 
development. So starting from a single monolayer epithelium (IFE) we can induce 
a morphogenetic switch to start the programme to develop an appendage, the 
hair, by activating P-catenin in all three epidermal compartments in adult 
epidermis.
HF induction is a threshold response: from morphogenesis to tumorigenesis
The response of adult epidermis to P-catenin activation is more complex than a 
simple switching on/off de novo HF formation. With increasing p-catenin 
activation we could alter the timing and location of ectopic HF formation. 
Titration of the signal was achieved by expression of different levels of ANP- 
cateninER transgene in epidermal cells and by application of different 
concentrations of 40HT. The concept that cells exhibit a graded response to a 
gradient of P-catenin regulatory activity was previously introduced from studies of
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different APC mutations in a panel of ES cell lines (Kielman et al., 2002) which 
leads to differences in the level of activation. However, the ANP-cateninER 
transgene has the important advantage that it allows to titrate transcriptional 
activity within individual cells, both in vivo and in culture.
As mentioned in the Introduction, there are several ways to activate P-catenin and 
they differ in the outcome. When non-degradable ANP-catenin is constitutively 
activated since embryonic development (Gat et al., 1998) or when its activation is 
prolonged and sustained (Lo Celso et al., 2004) a tumour of hair follicle origin, 
known as a trichofolliculoma, is generated (Gat et al., 1998; Lo Celso et al., 2004; 
Chan et al., 1999). Interestingly, when P-catenin is activated either by the 
canonical Wnt3A ligand overexpression (Millar et al., 1999) or by Lithium, a 
GSK3P inhibitor treatment (Fathke et al., 2006) the effect is much milder. Only 
intermediate levels of P-catenin activation lead to the start of a programme to 
generate a hair follicle.
Epidermal compartments differ in their sensitivity to the p-catenin signal
This study confirms that p-catenin activation also promotes hair follicle 
differentiation in tail skin. Hair follicle lineages are promoted at the expenses of 
the other two lineages: sebaceous and interfollicular differentiation (Figure 4.4).
In addition, these compartments show different sensitivity to varying levels of p~ 
catenin. Elucidation of additional markers for each compartment w ill allow their 
isolation and this w ill enable us to profile each of these compartments. This w ill 
give insights into how the P-catenin signal is processed and interpreted by each of 
these cell types.
In both transgenic lines the ORS of existing HFs was most refractory to induction 
of ectopic HF. Although there is heterogeneous expression of Wnts and their 
receptors in adult epidermis (Reddy et al., 2001; Reddy et al., 2004) and the 
secreted Wnt antagonist Dickkopf-3 is upregulated in the bulge (Tumbar et al., 
2004; Morris et al., 2004), ANP-catenin acts downstream, bypassing their effects. 
Even though we noticed different levels of transgene expression in HF, IFE and 
SG, a more likely explanation for the refractoriness of the ORS is that Tcf3 is 
expressed in the bulge and acts as a repressor of Wnt signalling (Merrill et al., 
2001). This notion is re-inforced by the fact that the first site of ectopic hair
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follicle formation in the D4 line is the IFE, rather than the SG where there is the 
highest expression of the transgene (Silva-Vargas et al., 2005).
Effects of p-catenin activation in the LRC compartment in vivo
Previous experiments had shown that cells in all regions of the epidermis are 
competent to respond to P-catenin (Figure 4.4). However, it was not clear if new 
HF were derived from bulge stem cells or whether committed IFE progenitors 
could be reprogrammed to induce hair follicles even though they are lineage 
restricted.
Bulge stem cells are multipotent, and under steady-state conditions they respond 
to the local signals from the niche and they replenish hair follicle lineages. 
However, in situations such as wounding they are capable of giving rise to all the 
differentiated lineages of the HF, IFE and SG (Watt, et al.2006). We did not 
observe any changes in number or evidence of bulge LRC migration at early 
stages of HF formation. Even when LRC eventually divided in response to 
prolonged P-catenin activation, thereby loosing the BrdU label, expression of two 
bulge stem cell markers, keratin 15 and CD34 (Trempus et al., 2003; Morris et al., 
2004) was unchanged, indicating that the bulge stem cell compartment was 
maintained. Profiling analysis of the outcome of different levels of p-catenin 
signal in the bulge compartment and further elucidation of the effect in other 
bulge stem cell markers w ill also give insights on the phenotype.
Reconstructing a follicle niche including keratinocytes and non-epithelial cells 
that are normally resident in the hair follicle
P-catenin induced follicles were populated by melanocytes and Merkel cells and 
formed dermal papillae. The presence of Merkel cells and melanocytes is 
particularly striking since they are known to be associated with the bulge of wild 
type follicles (Nishimura et al., 2002; Szeder, 2003; Sieber-BIum, 2004). The 
expansion of these populations was correlated with a wider expression of the c- 
Kit ligand, including the keratinocytes of ectopic hair follicles. It has been shown 
that c-Kit Ligand is expressed in IFE, and by bulge LRC in the HF (Tumbar et al., 
2004). Its expression in keratinocytes supports the presence of melanocytes in 
skin (Nishimura et al., 2002). It is also intriguing that these non-epithelial cell
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types are neural crest derived and Wnt dependent. Wnt1 expression during 
embryogenesis is limited to neural crest cells; Wntl signalling is involved in the 
expansion and differentiation of melanocytes; and ablation of p-catenin in neural 
crest stem cells leads to lack of melanocytes (Dunn et al., 2004; Dunn et al., 
2000; Hari et al., 2002; Le Douarin and Dupin, 2003). It w ill be interesting if this 
global recruitment of cells onto the ectopic follicles is recapitulated when P- 
catenin activation is performed in a more restricted compartment, for instance by 
driving the transgene with the keratin 15 promoter (targeting the bulge cells) or 
with the involucrin promoter (targeting the suprabasal cells). This latter w ill be 
interesting, as these cells w ill not be in direct contact with dermal cells.
In addition, it w ill be intriguing to activate the transgene in a dermal 
compartment, if the activation of p-catenin is a global and generic switch, it might 
lead to formation of ectopic hair follicles. In this case, P-catenin activation, the 
first signal in hair morphogenesis (Schmidt-Ullrich and Paus, 2005) w ill occur in 
the dermis instead of the epidermis.
Tail ectopic hair follicles can undergo cycles of growth and regression 
dependent of 40HT and contain cells with bulge characteristics
As mentioned in the Introduction, normal follicles undergo cycles of growth and 
regression, requiring reciprocal signalling with dermal papilla cells (reviewed by 
Millar, 2002). The follicles induced by p-catenin activation can form a mature 
hair shaft (Figure 5E; Cat et al., 1998; Lo Celso et al., 2004) however they 
normally lack inner root sheath markers, such as trichohyalin (Lo Celso et al., 
2004). In addition, the re-growth phenotype observed cannot be interpreted as a 
true hair growth cycle, since it was entirely 40HT dependent. However, it is very 
interesting that although these are 'rudimentary' follicles, they are sensitive to the 
original signal, this is, P-catenin activation.
Furthermore, ectopic HF induced by P-catenin contained areas of keratin 15 and 
CD34 expression, raising the possibility that new bulge cells can be created from 
non-bulge epidermal cells with clonogenic capacity in vitro.
A role of Wnt signalling in increasing stem cell number has now been reported in 
a wide range of tissues, including the blood, mammary gland and nervous system 
(Reya et al., 2003; Megason and McMahon, 2002); Liu et al., 2004; Zhang et al.,
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2003). Previous studies have shown that P-catenin activation in cultured human 
epidermal cells increases the number stem cells (Zhu and Watt, 1999). Whether 
the appearance of cells with bulge characteristics occurs through expansion of the 
pre-existing stem cell pool, as it was originally proposed, or through generation of 
new stem cells from committed progenitors remains to be further explored 
(Pearton et al., 2004; Silva-Vargas et al., 2005). LacZ expression analyses show 
that the new follicles are not obligatory clonal. Therefore, if IFE stem cells are not 
clustered these results suggest that HF originated from the TAC compartment 
(Silva-Vargas et al., 2005). Further lineage tracing experiments w ill throw light 
into these questions. However, it w ill first be very important to further assess the 
'sternness' of these cells, for instance by looking at their reconstitutive capacity in 
vivo.
The results presented in this Chapter show that the epidermis exhibits a high 
degree of plasticity, as new hair follicles can be formed from SG and IFE, which 
normally provide sebocyte or interfollicular epidermis, respectively. Although P- 
catenin activation only occurs in basal keratinocytes, it causes the epidermis to 
induce a new dermal papilla and recruits melanocytes. This opens a new area in 
which the epidermal cells could provide a range of different cell types.
In this Chapter I wanted to analyse the process of hair follicle formation in tail 
epidermis. The results show that the levels of P-catenin activation determine the 
number and the location of ectopic hair follicles. As described in Chapter 3, wild- 
type tail skin is a highly patterned tissue. When P-catenin is activated these highly 
ordered pattern is disrupted as the different epidermal compartments become 
'permissive' and ectopic follicles arise. The levels of p-catenin activation are 
critical in determining the number and location of ectopic follicle formation. It is 
interesting to look into what pathways are downstream of P-catenin, work that is 
described in Chapters 5 and 6.
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Chapter 5- Identifying events downstream of 
the p-catenin signal during HF morphogenesis
Aims
p-catenin activation in adult epidermis results in ectopic hair follicle formation. 
The levels of activation determine the number and location of HF. Ectopic hair 
follicle formation is a threshold response: if the signal is too low hair formation 
does not occur and if it is too high tumours form. During hair follicle 
morphogenesis there are changes in proliferation, differentiation, cell-cell 
adhesion and patterning and at present it is unclear how the Wnt pathway exerts 
all the different effects. In order to find out, in this Chapter I have looked at what 
downstream pathways are modulated by P-catenin during hair follicle 
morphogenesis. I have also compared my microarray data with gene profiles of 
different cell populations in the skin that have recently been published by other 
labs.
5.1 -Profiling of p-catenin activation in vivo
In collaboration with Cristina Lo Celso, I investigated what genes were activated 
in response to P-catenin. We designed an experiment in which we treated 
triplicates 6 week-old female K14ANp-cateninER mice and transgene negative 
littermates daily with a dose of 1mg 40HT for 0, 1 and 7 days. This age was 
chosen to ensure that the hair follicles were in the resting phase of the hair cycle 
at the beginning of the experiment.
As it can be seen from the H&E staining of sections, dorsal skin from wild-type 
mice at all three time points remained in telogen (Figure 5.1 A-C). In contrast, D2 
mice had entered anagen phase after 7 days of treatment (Figure 5.1 F).
In order to evaluate changes in gene expression after P-catenin activation, we 
chose Affymetrix chip technology so that we could analyse more than18000 
transcripts, representing over 14000 established mouse genes.
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Figure 5.1- Profiling the response to P-catenin activation in 
dorsal skin in vivo. (A-F) Haematoxylin & Eosin stained sections of WT 
(A-C) and (D-F) D2 transgenic dorsal epidermis treated with 40HT for 0, 1 
or 7 days and then harvested immediately for RNA extraction.
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5.2-Microarray analysis of the P-catenin signature
We isolated RNA from whole dorsal skin of the mice and the Gene Chip facility 
(Paterson Institute, Manchester, UK) performed the hybridisation of the 
microarrays.
The raw chip data were normalised and analysed with Genespring microarray 
analysis software. In our first analysis, 40HT treated transgenics were compared 
with wild-type or untreated transgenic littermates. The graphs shown in Figure 5.2 
A represent the total number of genes for transgenic (Tg) and wild-type (Wt) that 
were statistically called 'present'. In Figure 5.2 B are shown the genes that were 
upregulated and downregulated by at least 3-fold. The majority of genes were 
modulated at 7 days (Figure 5.1 C,F). A few genes appear to be modulated by 4- 
OHT in Wt samples, and we did not consider these genes in further. Obviously 
genes upregulated or downregulated only at 7 days may not be direct 
transcriptional targets. Flowever, a lag in expression may also reflect time for 
40H T to penetrate and for activation to be maximal.
5.2.1- Genes 3-fold upregulated
We first normalised the data to identify changes in relative expression levels of at 
least 3 fold with a t-test p-value of less than 0.05. These parameters identified that 
after 7 days of 40H T treatment, 150 probe sets were up regulated >3 fold and 13 
probe sets down regulated 3 fold. Of these, 103 unique and established genes 
were up regulated and only 9 established genes downregulated after 7 days 
treatment. The full list is shown in the Appendix and a list of selected genes is 
shown in Table 5.1. The genes were classified into distinct functional groups (see 
pie chart in Figure 5.3).
29.1% of upregulated genes were involved in signalling or transcription, while 15 
% were involved in cellular metabolism and 14% were keratins. The gene that 
was (2226 fold) most up-regulated was a Riken Clone (NM_133730) that 
corresponds to the Keratin 25 gene (K25irs1). Interestingly, K25irsl is expressed in 
the Henle layer, the Huxley layer, in the IRS cuticle and also present in the hair 
medulla. Its expression extends from the bulb region up to the points of terminal 
differentiation of the three layers (Langbein etal., 2006).
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Figure 5.2.- Normalisation and filtering of the array data with 
the Genespring software. (A) The array data was quality controlled and 
normalised and the relative intensity of each probe statistically defined as 
'present' are plotted in the graph. (B) Advanced filtering was applied to the 
data set by 3-fold upregulation. The relative intensity of genes falling in this 
category is plotted in the graph.
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The list of upregulated genes included known targets of P-catenin or markers of 
hair follicle differentiation. Examples are Lef1 (upregulated 4 fold) and Cyclin D1 
(upregulated 6.28) (Tetsu and McCormick, 1999; Shtutman et al., 1999). Keratin 
17 was upregulated almost two fold and CDP 6.3 fold (see Figure 4.5 and 5.4 A- 
B). In addition to K25irs1, several other hair keratins were increased more than 20 
fold at 7 days of activation (see Table 5.1). In the signalling category, several 
pathways were upregulated such as Wnt, Sox, Ephrin, Hedgehog, Bmp, (Figures
5.3 and 5.4 and Table 5.1).
Some of the genes showing the strongest induction were members of the 
Hedgehog signalling cascade, with Shh being induced. Increased expression of 
Shh and Ptc has already been observed when P-catenin is activated in the 
epidermis (Gat et al., 1998; Lo Celso et al., 2004). In wild-type tail epidermis Gli1 
and Gli2 are mainly expressed in the cytoplasm of cells in the permanent portion 
of the HF and IFE (Figure 5.4 E,H). In response to P-catenin activation there was 
de novo expression in the SG, and relocalisation of Gli1 and GIi2 from the 
cytoplasm to the nucleus in the SG and IFE (Figure 5.4 F,G,I). Although c-Myc is 
reported to be a target of P-catenin in other tissues (He, 1998), c-Myc levels were 
not changed after 7 days of treatment, but only appeared to increase at 14 days 
(Figure 5.4 J-K). However, N-Myc, a target of Shh (Oliver et al., 2003; Kenney et 
al., 2004) was upregulated 8 fold at 7 days and continued to be highly expressed 
at 14 days (Table 5.1; Figure 5.4 L,M).
Amongst the transcription factors upregulated on the array were members of the 
SRY-related HMG box (Sox) family (Table 5.1), encoding transcription factors that 
can act both as activators and repressors (Wilson and Koopman, 2002). Sox 4 and 
5 were upregulated more than 3 fold, while Sox 6, 8, 13, 18 and 21 were 
increased 1.5 to 3 fold. I confirmed the increased expression of Sox 4 using a 
specific antibody to label epidermal whole mounts (Figure 5.4 N,0). In wild-type 
epidermis Sox4 was detectable at low levels in the cytoplasm of hair matrix cells 
and ORS (Figure 5.4 N). Sox 4 was induced exclusively in the IRS and in de novo 
follicles in response to P-catenin (Figure 5.4 O).
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|  Signalling/Transcription factors 
|  Metabolism 
Keratins 
|  Cell cycle 
|  Melanocyte 
Proteolysis 
|  DNA remodelling 
Adhesion 
|  Kinesin related 
GAP junction 
Transport 
Other
Figure 5.3.- Gene categories after normalisation and 3-fold 
filtering of the array data with the Gene Spring software. Array 
data was quality controlled and normalised. Advanced filtering was applied 
to the data set by 3-fold upregulation. The list of genes was divided into 
functional categories indicated by color coding.
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Hair Keratins:
Krtl-24 (75.5), Krt2-10 (44.5), Krt2-19 (5.6), Krt2-psl (22.0)
Other Keratins:
Krtl-4 (237.4), Krtl-c29 (193.8), Krt2-6g (80.1), Krt2-18 (74.1), Krtl-1 (41.5), Krtl-3 (37.2), Krtl-5 (3.8)
Melanin Biosynthesis:
Tyr (16.5), Si (9.7), Dct (7.6), Tyrpl (11.0), Edn3 (3.9), p (4.4)
Hedgehog Signaling:
Shh (70.6), Hhip (27.4), Gli (8.6), Ptch2 (6.6), Gli2 (3.8),Ptch (8.1)
Wnt Signaling:
Lefl (5.8), Wifi (5.4), Csnkle (3.6)
Bmp Signaling:
Bambi (6.5), Bmp7 (3.8)
Ephrin Signaling:
Ephbl (3.8)
Transcription Factors:
Dtxl (27.1), Dlx2 (5.7), Dlx3 (4.8), Hoxcl3 (4.1), Msx2 (8.5), Msxl (3.7)
Other Transcription Factors:
Sox4 (41.2), Sox5 (9.0) Nmycl (8.4), CDP (6.3), Myb (3.7), Etv4 (11.6), Tcfe2a (12.8), Bach2 (3.3), Bcllla (3.7),
Sp6 (3.9)
Cell Cycle Regulators:
Cyclin Bl (8.6), Cydin B2 (5.7), Cydin D1 (5.0), Cydin D2 (3.9), Cdc25c (22.4), Mlltl (22.7), Gsg2 (14.2), Brcal (10.1), 
Tubb3 (8.2), Np95 (8.0), Bublb (6.8), Mnsl (5.2), Mki67 (4.9)
♦Values in parenthesis are average fold induction relative to untreated transgenic or wild type littermates.
Table 5.1- Selected genes induced more than 3 Fold in 
ANp-cateninER transgenic mice following 7 day 40H T
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5.2.2- Genes 2-fold upregulated
The analysis of genes regulated ± 3 fold was published (Silva-Vargas et al., 2005). 
However, we now know that changes of less than 3 fold can be highly significant 
biologically (i.e. Jones and Watt, 1993). Therefore, I decided to repeat my analysis 
by lowering the stringency of the filtering to 2 fold induction and lower p-value 
and additional genes were revealed (see Table 5.2). These included keratin and 
keratin-associated genes such as the hair specific keratins Keratin 19 (5.9 fold), 
mK6irs (90.5 fold). Additional Wnt family members to Lef 1 and W ifi appeared: 
additional receptors like Ror2 (4.4) (Mikels and Nusse, 2006), inhibitors Dkk4 
(2.9) Dkk1 (2), Sfrpl (2.29) and canonical and non-canonical ligands Wnt5a (2.4), 
Wnt7b (2.3), Wnt10b (2.2), Fzd10 (2.1), Wnt6 (2.1), Wnt5b (3.2), Wnt7a (3.2). 
Dvl2, a pivotal downstream effector of the Wnt pathway was also up-regulated 
(3.8).
Members of genes involved in patterning during development such as the FGF, 
Bmp, Semaphorin, EGFR and Eph/ephrin family were also present in this list. 
Examples are Hgf (2.3), Ret (2.3), Fgf5 (2.4 Fgfr3 (3), Bmp8a (21.3), Edar (11.1), 
Eda (2.06), Hes5 (8.6), Hes2 (2.8), Jag1 (2.2), Sema7a (5), Nrp2 (3.3), Sema3a (2), 
Ephbl (3.8), EphA1 (3), EphB3 (2.4), Efnbl (2.3), EphA4 (2.7), EphA3 (2.3), Efnb2 
(2.2) (See Table 5.2). A selected list of additional transcription factors, such as 
Pax6 (2.6), Barx2 (2.6), Olig3 (2.6), Gata5 (2.2), Runx2 (2) and Basonuclin (2.6) 
are also shown in the Table. Basonuclin is a zinc-finger protein, found in 
stratified squamous epithelia and hair follicles (Weiner and Green, 1998) that is 
involved in the transcription of ribosomal RNA genes (Tian et al., 2001). 
Basonuclin seems to regulate the maintenance of proliferative capacity and 
prevention of terminal differentiation in keratinocytes (Tseng and Green, 1994).
It is very important to note that two candidate genes involved in asymmetric 
division were present in the list: Msi2h, Musashi, (3.4), Piwil2 (2.4). Musashi 
protein is an RNA-binding protein associated with maintenance and/or 
asymmetric cell division of progenitor cells. Recent studies suggest that Musashi 
functions not only in the asymmetric division of early progenitor cells but also in 
the differentiation of IRS cells during HF development and hair cycle progression 
(Sugiyama-Nakagiri et al., 2006). Piwil2 is a member of the argonaute family. 
Family members are defined by conserved PAZ and Piwi domains and play
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Cytoskeleton
Trio (9.94), Dvl2 (3.8), Gripl (2.63), Rac3 (2.49), Wasfl (2.45), Arhgapl3 (2.75), Krt2-17 (2.8), Tiam2 (2.1), Rhpn2 (2.08), 
Racgapl (3.37), Rhobtb3 (3.24)
BMP/TGFp signalling
Bmp8a (21.3), Edar (11.1), Tgfb3 (2.6), Eda (2.06), Smad7 (2.48), Bmprlb (2.15), Tgfbli4 (2.08), Edaradd (2.1), Ect2 (3.49)
Notch signalling
Hes5 (8.614), Hes2 (2.823), Hey2 (2.54), Jagl (2.163)
Semaphorin signalling
Sema7a (4.996), Nrp2 (3.24), Sema3a (2.002), Pxn (2.521)
Wnt signalling
Ror2 (4.365), Wnt5b (3.219), Wnt7a (3.176), Dkk4 (2.867), Wnt5a (2.376), Wnt7b (2.291), WntlOb (2.2), FzdlO (2.056), Wnt6 
(2.057), Dkkl (2.032), Sfrpl (2.201)
Eph/ephrin signalling
Ephbl (3.785), EphAl (3.008), Ephb3 (2.402), Efnbl (2.304), Epha4 (2.672), Epha3 (2.273), Efnb2 (2.158)
Transcription factors
Sox5 (5.237), Sox3 (5.222), Soxl3 (2.436), Soxl8 (2.549), Pax6 (2.57), Barx2 (2.552), Olig3 (2.529), Gata5 (2.119), Runx2 
(2.019),
Runx3 (1.98), Slit2 (2.71), Foxml (3.209), Vdr (3.08), Foxnl (2.11), Rxra (2.144), Nfkbl (2.143), Lmycl (2.092), Lhx5 (2.754), 
Lhx2 (1.855), Tcf7l2 (1.6530, Irx2 (3.47), Irx4 (2.85)
RNA/DNA processing
Msi2h (3.371), Piwil2 (2.385), Bnc (2.516). Tert (2.712), Hmgb2 (2.509)
ECM/Adhesion remodeling
Itgbl (4.325), Tnc (3.335), Lamrl (3.232), Mmpl4 (3.191), Adaml5 (2.898), Adam34 (3.199), Itgb6 (2.59), Lambl-1 (2.575), 
Tnn (2.385), Fnl (2.309), Mmpl9 (2.653), Cldnl3 (3.16), Cldn9 (2.462), CldnlO (2.334), P-cadherin (4.19), K-cadherin (2.9), 
Hmmr (3.1)
Other signalling
Casp9 (2.78), Spry4 (4.049), Madh6 (2.989), Bd2 (2.07), Tle3 (3.197), Fgfr3 (2.982), Edil3 (2.998), Hgf (2.272), Ret (2.302),
Fgf5 (2.418), Cckar (2.758), Ptgds (2.701), Dgkb (2.865), Diap3 (2.848), Areg (2.756), Plczl(2.07), Drd4 (2.08)
Gpr2 (2.402), Gpr37 (2.563), Gpc3 (2.462), Dnm2 (2.466), Gsdm (2.005), En2 (2), Lrp8 (2.462), Ngfa (2.248), Egfr (2.167), Ctsb 
(2.042), IKK-beta (3 .2 ll)
♦Values in parenthesis are average fold induction relative to untreated transgenic or wild type littermates.
Table 5.2- Selected genes induced more than 2 Fold in AN£- 
cateninER transgenic mice following 7day 40H T  treatment.
149
important roles in stem-cell self-renewal, RNA silencing and translational 
regulation in various organisms (Lee et al., 2006b). Piwi has recently been shown 
to be a nuclear protein involved in gene silencing of retrotransposons and 
controlling their mobilization (Saito et al., 2006). In addition, Piwi proteins 
interact with small RNAs, constituting a new family of regulatory molecules with 
diverse functions in eukaryotes (Cheng et al., 2005).
Interestingly, in addition to activating expression of genes involved in proliferation 
and hair differentiation, |3-catenin activation leads to changes in cell adhesion and 
ECM genes, leading to remodelling of the stem cell niche. For instance, the 
following genes are upregulated: Integrin |3-1 (4.3), Tenascin C and N (3.3, 2.4), 
Lamininrl (3.2), Mmp14 (3.2), Adam15 (2.9), Adam34 (3.2), Itgb6 (2.6), Lamb1-1 
(2.6), Fn1 (2.3), Mmp19 (2.7) and Hmmr (3.1). P-catenin activation also leads to 
changes in expression of genes encoding cytoskeletal proteins, for example: Trio 
(10), Gripl (2.7), Rac3 (2.5), Wasfl (2.4), Arhgap13 (2.7), Krt2-17 (2.8), Tiam2 
(2.1), Rhpn2 (2), Racgapl (3.4) and Rhobtb3 (3.2).
From the genes that are upregulated at least two fold in the arrays it becomes 
clear that at early stages of hair follicle development changes in proliferation and 
early hair differentiation are accompanied by cytoskeletal rearrangements, 
changes in adhesion and ECM. This suggests that changes in the nature of the 
stem cell niche allow hair morphogenesis to take place in adult epidermis.
5.2.3-Dissecting the p-catenin program by looking at genes 
associated with distinct hair follicle cell populations
Although proliferation is one of the hallmarks of cells in the HF matrix (see Figure 
1.4) they also express a number of signalling proteins and transcription factors that 
specify each of the six programs of differentiation in the IRS and HS. Recently, the 
molecular signature of several cell populations resident in the bulb has been 
elucidated. Rendl and colleagues have combined multicolour tagging with cell 
specific promoters and surface marker labelling to distinguish between ORS, 
matrix, dermal fibroblasts, dermal papilla and melanocytes. I reclassified our 3- 
fold gene list into categories representing these hair follicle populations (Table
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3-Fold Analysis Hair Follicle Populations
Gene name Matrix ORS DF DP Me
Keratin associated
Krtape-1 (64.8), Krtap9-1 (16.7), Krtapl2-1  
(8.9), KrtapS-1 (4.6  
Hair keratins
Krtl-24 (76.2), Krt2-10 (64.9), Krt2-psl 
(25.0), Krt2-19 (6.4)
Other keratins
Krtl-4 (46.4), K rtl-3  (42.8), K rtl-5  (3 .9)
K r t l-4 , K r t l-  
C29, K r t l-3 ,  
K rtl-5 ,  K r t l-2 4 ,  
Krt2-19
K rt l-4 ,
Krt2 -19
Krt2-19 K r t l-4
Melanocyte biosynthesis
Tyr (16.9), Tyrpl (10.1), Si (9 .5), Oct (7 .4), P 
(4 .4 )
T y rp l, Si , 
Oct
Tyr, T y rp l,  
Si, Oct
Tyr , T y rp l, Si , 
Oct
Hedgehog
Gil (8 .4), Hhip (6.8), Ptch2 (6 .6), Shh (4.8), 
GII2 (3.6)
W nt
W lfl(5.4 ), Lefl (4.0)
BMP
Bambi (6 .4), Bmp7 (3 .8)
Homeobox genes
Msx2 (8 .5), Dlx2(S.4), 01x3 (4 .8), Hoxcl3 
(4 .0 ), M s x l (3 .5 )
01x2. MSX2, 
Dlx3, H oxc l3
W if i
Bambi, Bmp7
01x2,
Msx2,
01x3,
HOXC13
Bmp7
01x2
Hhip
W ifi
Msx2
Hhip
W if i
Bambi, Bmp7
Transcription factors
Sox4 (33.0), NM yd (8 .3), SoxS (7.2), CDP 
(6 .3), Tcfeaa (7 .9), Sp6 (3 .9 ') ,  B d lla  (3.8), 
Myb (3 .7), Bach2 (3.3)
Sox4, NMyCl, 
Sox5, CDP, 
Tcfeaa, Sp6, 
B d l la ,  Myb, 
Bach2
SOX4, 
N M ycl, 
SoxS, CDP, 
Tcfeaa, 
B d l la ,
Sox4,
NM ycl,
Tcfeaa
Tcfeaa,
Bach2
SoxS, B d l la
Cell cyde regulation
CydlnBl (8 .6), Cydin B2 (5 .7), CydlnDl (5.0), 
Cydin02 (3 .8), Tubb3 (8 .6), Np95 (7.1), Mnsl 
(5 .1), Mkl67 (4.9)
C y d in B l, 
CydinB2, 
C y d in D l, 
C yd in 02 , 
Tubb3, M n s l, 
Mld67
C yd inB l,
CydinB2,
C y d in O l,
C yd in02 ,
M nsl
Mki67
CydinD2,
M nsl
Tubb3 Tubb3
Receptors
GprcSd (82.1), Cxcr4 (6 .9), Cntfr (4.1)
GprcSd GprcSd
Cxcr4
Cxcr4 Gprc5d
Cxcr4
Kinase activity
Me Ik (8.5)
Melk Melk Melk
Other signalling
Fbn2 (27.0) 
Racgapl (4 .7) 
Baspl (3.8)
Uhrfl
Racgapl
U h rf l
Racgapl, 
B a s p l,
Uhrf
Fbn2,
Racgapl,
U h rf l
Fbn2, Basp l Baspl
Kinesin-related
Kif2c (7 .7), Kif22-ps (7 .4), K ifll (5.0)
IQ f2c , K i f l l Kif2c,
IQ f l l
K i f l l
Adhesion
C o llla l (11.2), Hmmr (5 .0), A k a m  (3 .6), 
Ncaml (3.4}
Hm m r, Alcam N cam l,
Hmmr,
Alcam
N cam l,
C o l l l a l ,
Hmmr
N cam l,
C o l l l a l
N cam l,
C o l l la l l ,H m m r
Proteolysis
Ctse 12.1, Lrp4 (5 .8), Lap3 (4 .5), Capn8 (3 .2)
Ctse, Lrp4, Lap3 Ctse, Lap3 Ctse Lrp4
Vesicle transport
Syt4 (44.8), V tilb  (7.5)
V t i lb Syt4 Syt4 S y t4 , V tilb
Gap juntion
G)b2 (29.9), G)b6 (23.9), G jal (4.3)
DMA/Chromosome
Xrccl (24.3), Hlstlh2ae (17 .7 ), Rad51apl 
(17.3), Hcapg (5 .6), Smc4ll (5 .3), Top2a (4 .8)
R a d S la p l,
X rcc l
R a d S la p l,
X rcc l
R a d S la p l
Metabolic
Gnmt (179.3), S100a3 (48.4), Padi3 (32.2), 
Fbpl (18.6), A lp6vlbl (17.6), Hsdllb2 (16.8), 
Padil (14.7), Upp (11.9), Ggll (8 .6), Trpm l 
(7.7), Has3 (6 .3), Fads2 (4 .9), Slcl6a7 (4.8), 
Aro2 (4.7). Bdh (3.4). Aloxl5b (3.1)
T rp m l
Others
Cryba4 (170.2), Crym (29.7), Ly6g6d (16.1), 
Spag5 (13.4), Edr (11.9), Rex3 (4.8), Peg (4.5)
Peg, Rex3 Peg, Rex3 Peg Rex3
Downregulated
Cyp2el (0 .07), Cdt (0.13), Mpz 
(0.13), Asbl4 (0 .13), Lep (0.17), 
D s a ll l  (0.19), Mai (0.20), Tm4sf3 
(0.20), Mbp (0.24)
C yp2el C yp2el, 
Cck, Mpz, 
A sb l4 , 
Lep, Mai, 
D s c r l l l ,  
Mbp
C yp2el, Mai, 
D s c r l l l ,Mbp
Cck, A s b l4 , Lep
Table 5.3- Selected genes induced more than 3 Fold in 
ANp-cateninER transgenic mice following 7day 4 0 H T  
treatment. These genes were re-classified into HF populations 
defined in Rendl, et al.2005. These genes are in red letters when their 
highest expression in the compartment or in black letters when they 
are simply expressed in wild-type skin.
5.3) to see what hair populations were expanded by p-catenin activation. It is 
striking that all the genes downregulated at 7 days lie into the dermal fibroblast 
category. Interestingly genes with highest expression in the DP such as W ifi, 
Hhip, Bambi, are inhibitors of Wnt, Shh and BMP. Apart from proliferation genes, 
most of the genes that lie in the matrix category are homeobox genes and 
keratins, together with Gpr5d, N-Myc, CDP and Bach2. The ORS signature is also 
highly upregulated, for instance Sox4, Bcl11a, Myb, CDP, Bach2, Melk and 
RacGapI genes. Interestingly, most of the genes in my list fall into one of the 
categories defined by Rendl et al. This suggests that P-catenin activation promotes 
proliferation and differentiation of bulb cell lineages, where normally the pathway 
is active during the anagen phase.
5.2.4-Comparison between the profile of bulge cells after P-catenin 
activation and the profile of the hair germ during development
Some of the targets from our array matched genes isolated in a study profiling the 
bulge compartment after P-catenin activation. Sox4 is an intriguing example. 
Lowry and co-workers show that it is a protein that is specifically up-regulated in 
the SC niche during the follicle growth phase and also expressed in proliferating 
TA progeny (Lowry et al., 2005). In addition, Sox4 has been pinpointed as a 
putative marker of intestinal stem cells, although this has not yet been 
demonstrated. These findings further validate our array data and put Sox4 as a 
candidate for TA amplification and the transition to terminal differentiation. 
Further studies w ill give insights into the emerging roles of member of the HMG 
box superfamily of transcription factors in skin and hair biology.
It has been suggested that Wnt signalling has sequential roles temporally 
regulating the follicle SC lineage. Firstly, P-catenin stabilisation promotes SC 
maintenance (Zhu and Watt, 1999; Lowry et al., 2005). Then, it promotes 
activation and proliferation (Lowry et al., 2005). Lastly, a more sustained Wnt 
signal promotes the transition from proliferation to differentiation (Gat et al., 1998; 
DasGupta and Fuchs, 1999; Huelsken et al., 2001; Merrill et al., 2001; Millar, 
2002; Braun etal., 2003).
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Keratin 17 Keratin 17
Figure 5.4- Validation of P-catenin target genes. Tail whole mounts from 
untreated wild-type (wt) or D2 transgenic mice were treated with a medium dose 
of 40HT for the number of days shown and were labeled with antibodies to the 
proteins shown. Arrows and arrowheads indicate ectopic HF outgrowths in IFE and 
SG, respectively. G is an enlargement of the box in F. Dashed lines demarcate SG 
in A,H,M; HF with SG in C,D and I and ORS in N,0. Scale bars: 100 pm.
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Recently a new approach to isolating and profiling hair germs during skin 
development has yield the signature of the hair germ population (Rhee et al., 
2006). Interestingly, many of the genes highly upregulated in the hair germ are 
also highly upregulated in our array at 1 or 7 days. These include W ifi, H h ip l, 
Shh, Syt4, N-Myc, Eda, Bach2, Neuropilin2, Foxcl, Runx2, Runxl, Glypican3, 
Dkk4, Nfat, Sema3b, Basonuclin, Wnt5a, Frasl, VDR, Tcf7, Zfp365, RasGef13, 
Ltbpl and Ncam. It w ill be of great interest to investigate some of these genes 
further as they are likely to be involved in the early stages of hair morphogenesis.
5.2.5-Genes upregulated more than 2-fold at 1 day
Whereas there were very few changes in 3-fold genes at day 1, when I looked at 
the profile of genes upregulated 2-fold at 1 day I could see that a whole of battery 
of transcription factors are upregulated (See Table 5.4). A few that were 
upregulated at 1 day also remained upregulated at 7 days including Bach2, Sox5, 
Runxl, Phox2b, Zfp346 3.277 and Foxpl. At 1 day, there also seems to be some 
rearrangements of ECM and adhesion with changes seen in several 
metalloproteinases, Adams, collagens, Frasl and integrin p i . At 1 day there are 
also changes in cytoskeletal genes such as alpha-eaten in, kaiso and Rockl. At this 
early time point changes are seen in Wnt ligands and receptors like Lrp6, Rora2 
and Wnt7b, Wnt9b, Wnt9a and intermediate members like Casein kinase-b and 
Ape. The Hedgehog pathway is also active at this stage with Shh, NMyc and Hhip 
upregulated. Members of the BMP and Semaphorin pathways and several Hes 
genes downstream of the Notch pathway are also upregulated (see Table 5.4). 
Interestingly, both RNA remodelling genes Piwi and Musashi are upregulated at 
dayl (see Table 5.4). It w ill be of great interest to investigate some of these genes 
further as they are likely to be very important in setting up the morphogenetic 
programme to make a hair.
The analyses I have presented in this Chapter are 'backwards', starting with the 
most stringent lists of genes modulated at 7 days by 3-fold and comparing it with 
a set of genes modulated by 2-fold. These filtering settings have allowed me to 
unveil a set of genes whose expression is modulated at 1day.
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Transcription factors
Phox2b (10.650, Dlgh (8.831), Pou4f3 7.71, Foxal7.433, Zfp96 5.49, Mixll 4.566, Nkx2-6 4.535, Nr2el4.028, Hoxa43.988, 
Barhll3.593, Pou6fl3.503, Bach23.437, Hoxal03.419, Zfp346 3.277, Foxpl 2.7, Hoxdl 2.571, Runxl 2.424, Tbx5 2.38, 
Sox30 2.329, Pou2f2 2.249, Trim25 2.226, Hmx3 2.175, Myf5 2.132, SoxlO 2.1, Sox5 2.027
ECM/Adhesion remodeling
Cldn 18 6.036, Timp2 5.306, Adam 7 5.19, Pcdhb4 4.827, MyolO 4.325, FGF22 4.14Col9a3 4.321, Col24al 4.092, 
Col5a32.873, Hmmr2.85, Coll9al 2.637, Frasl 2.487, Adam26 2.486, Trygnl6 2.367, Itgbl 2.231, Ncanr>2 2.143, Gpc6 
2.121 Col9a3 2.119, Ela3b 2.103, Adam34 2.085, Timp2 2.045
Wnt Signalling
Lrp6 3.827, Rora2.717, Klfl2 2.6, Csnb 2.471, Ape 2.404, Wnt7b 2.301, Wnt9b 2.283, Wnt9a 2.106
Notch Signalling
Hes 5 6.81, Hes3 2.393, Hes2 2.383, Hes7 2.105, Notch2 2.066
ONA/RNA remodeling
Hmgnl 5.779, HdaclO 4.846, Nup210 4.046, Mnt(max binding repressor) 3.07, Piwill 2.629, Msi2h 2.382, Histlh4h 2.334, 
Smarcbl 2.29
Semaphorin signaling
Sema6b3.587, SemaSa 3.49, Sema3b 2.501
BMP/TGFb signaling
Tgfbli4 2.383, Tgfbrl 2.26, Bmprlb 2.133, Bmp8a 2.039
Cytoskeleton
Alpha-catenin 1 3.101, Kaiso 3.015, Cdh82.719, Ctsf 2.524, Cdh3 2.263, Krtl-19 2.117, Rockl 2.077, Cldn7 2.044
Other signalling
Grpr 7.003, Srd 5a2 6.448, Fnbp2 6.181, Rassfl 6.076, edr 5.732, Tshb 5.49, Gpr22 5.416, Gys2 5.19, Syt4 4.848, Ccr3 
4.191, lfnal3.988, Umod3.937, Nfatc2ip 3.816, Trpm5 3.745, Magea6 3.594, Uspl5 3.461, Jak3 3.438, Nekl3.431, 
Apom3.415, Tnfsfl3b 3.398, Rdh7 3.347, Epsl5-rs3.182, Spill3.138, Vil2.831, Lrp22.79, Lrp2bp-pending2.773, Ang42.765, 
Gfral2.734, Samhdl2.733, Pdgfd2.722, Gpr63 2.646, Bd7a 2.56, Ppp3rl 2.44, I l l r l  2.433, Bcl2l2 2.399, Fgf5 2.382, Ngfa 
2.371, Camk2d 2.37, Pacsinl 2.346, Nr5a2 2.315, Trfr2 2.274, Rab27b 2.212 Tnfsfl4 2.212, Ptch 2.196, Prkcn 2.194, 
Caspase-3, Igf2bp3 2.145, Pin 2.136, Cyp26al 2.129, Igfbp5 2.125, Nrg3 2.091, Lrp4 2.08, Hhip 2.063, Igf2bpl 2.007
♦Values in parenthesis are average fold induction relative to untreated transgenic or wild type littermates.
Table 5.4- Selected genes induced more than 2 Fold in AN|3- 
cateninER transgenic mice following 1 day 4 0 H T  treatment.
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Several profiling analysis of distinct HF cell populations have been published after 
I had analysed the array data. This prompted me to set out a further analysis of 
our array data and I went back to re-analyse my data and compare it with the 
signatures of several HF populations.
The arrays gave us important information about which pathways act downstream 
of P-catenin to promote ectopic HF formation. The laboratory has focused on 
three: Notch, Hedgehog and Eph/ephrin. Dr Estrach and Dr Ambler in the lab 
have focused on the Notch pathway while I have looked at the others.
5.3-Hedgehog drives proliferation during HF morphogenesis
It has been shown in previous studies that Shh is upregulated upon P-catenin 
activation (Gat et al., 1998; Van Mater et al., 2003 and Lo Celso et al., 2004). As 
shown in the previous section, in addition to Shh, several components of the 
Hedgehog signalling pathway were upregulated on P-catenin activation (See 
Table 5.1 and Figure 5.4). The activation of Hedgehog signalling was confirmed 
in tail skin by looking at G lil and Gli2 expression (Figure 5.4 E,H and 5.5 B-D). In 
order to monitor activation of the pathways we looked for nuclear localisation of 
G lil (Figure 5.5). G lil and 2 were nuclear at sites of ectopic hair follicles (Figure
5.4 G, I).
Given that P-catenin activation results in local increases in proliferation (see 
Figure 4.5 in Chapter 4) and that Shh drives proliferation during normal hair 
follicles anagen (Callahan and Oro, 2001) I investigated the role of the Hedgehog 
pathway downstream of P-catenin during ectopic hair follicle formation. For this, I 
designed an experiment in which I treated K14ANp-catenin transgenic mice with 
the Hedgehog antagonist Cyclopamine at the same time as 1mg 40HT (See 
experimental design in Figure 5.5). Cyclopamine is a pharmacological inhibitor 
that blocks Hedgehog signalling by binding to Smoothened (van den Brink et al.,
2004). The dosage that we used in these experiments did not cause any 
phenotype in wild-type skin (Silva-Vargas et al., 2005). In order to validate that 
the drug was working, I used the whole-mount tail system to look at G lil 
localisation (Figure 5.5 B-D). As previously mentioned, in untreated epidermis 
G lil is mainly located in the cytoplasm of most cells and a
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D2 D4
P49 P50 P52 P55 P58 P61 P64 
Od Id  3d 6d 9d 12d 15d
Telogen
P49
Od
P56
7d
P63
14d
Telogen
High Dose 3mg 
Medium Dose 1.5 mg 
Low Dose 0.5 mg
Cyclopamine
B Gli1 C Glil I  D Glil
Untreated ______ I 40HT I 40HT+Cyclopamine
Figure 5.5- Cyclopamine blocks the Hedhehog pathway in tail epidermis.
(A) Diagram shows the experimental design to look at the effects of blocking Shh path­
way by Cyclopamine treatment in p-catenin induced ectopic hair follicle formation. P 
corresponds to postnatal day and d corresponds to the day of the experiment. D2 and D4 
mice were either treated with 40HT alone or with 40HT and Cyclopamine for up to 2 
weeks. (B-D) Tail whole mounts from D2 transgenic mouse were labelled with antibod­
ies to G lil. Arrow in B indicates Glil nuclear staining in untreated epidermis. The panels 
in B,C and D show a high magnification of SG. Scale bars: 50 pm.
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4 OHT + cyclopamine 4 OHT + cyclopamine
Figure 5.6- Hedgehog signalling is required for P-catenin-induced hair 
follicle formation. D2 and D4 mice were either treated with 40HT alone or with 
40HT and cyclopamine for up to 2 weeks. Sections of dorsal (A,B) or tail (C-H) 
epidermis stained with hematoxylin and eosin. (I-L) Tail whole mounts were labelled 
with antibodies to keratin 14. Scale bars: 100 pm.
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few cells in SG have nuclear G lil (Figure 5.5 B), which it has been shown to be 
downstream of Ihh (Niemann et al., 2003). After 40HT treatment there was a 
marked increase in the number of cells with G lil positive nuclei (Figure 5.5C), 
consistent with the location of GIi2 (Figure 5.4 I). However, when P-catenin was 
activated in the presence of Cyclopamine, G lil remained cytoplasmic (Figure 5.6 
D), establishing that the conditions of Cyclopamine application were effective at 
inhibiting Hedgehog signalling.
Examination of skin by conventional histology showed that Cyclopamine blocked 
the induction of anagen in D2 and D4 hair follicles, the earliest response to P- 
catenin activation in K14ANP-cateninER epidermis (Figure 5.6). Cyclopamine 
also reduced the appearance of ectopic HF (Figure 5.6 B,D). Interestingly, when 
we treated D2 and D4 skin with high levels of 40HT for short periods, 
Cyclopamine reduced the thickness of hyperproliferative IFE in D2 and D4 and 
allowed the appearance of ectopic hair follicles (Figure 5.6 F-H).
I also analysed the effects of Cyclopamine by visualising whole mounts. The 
treatment with Cyclopamine could convert the D2 medium dose phenotype to 
wild type, blocking most new follicle formation in SG, HF and IFE (Figure 5.6 l-L). 
However, Cyclopamine did not revert completely the tumourigenic D4 
phenotype, but instead it converted it to a morphogenic D2 phenotype (Figure 5.6 
L). In Cyclopamine treated D4 epidermis the new follicles became more 
pronounced and dermal papilla formation was stimulated (Figure 5.6 H).
I confirmed the morphological observations by staining whole mounts with a 
range of antibodies. Keratin 17 expression induced by P-catenin in the IFE and SG 
(Figure 5.7 A) was largely inhibited and Keratin 17 expression was confined to the 
ORS (Figure 5.7 B), as in wild-type epidermis. Ectopic expression of CDP in D2 
epidermis (Figure 5.7 E) was also inhibited by Cyclopamine (Figure 5.7 F). In D4 
epidermis the size of the ectopic CDP patches was reduced (Figure 5.8 D).
I also looked at whether the effects of Cyclopamine correlated with a reduction of 
proliferation. When l evaluated Ki67 staining I could confirm that proliferation 
was decreased in Cyclopamine treated skin (Figure 5.7 C, D and 5.8 A,B).
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Figure 5.7- Hedgehog signalling is required for p-catenin 
induced hair follicle formation in the D2 line. D2 mice 
were either treated with 40H T alone or with 40H T and cyclopa­
mine for up to 2 weeks. Tail whole mounts were labelled with anti­
bodies to keratin 17 (A,B), Ki67 (C,D) or CDP (E,F). Dashed lines 
outline SG (B), ORS (C,E,F) or HF with SG (D). Scale bars: 100 pm.
Keratin 17 Keratin 17
40HT 40HT+ Cyclopamine
1 6 0
40HT 40HT+ Cyclopamine
Figure 5.8- Blocking Hedgehog signalling reduces (3- 
catenin induced proliferation and promotes hair follicle 
morphogenesis in the D4 line. D4 mice were either treated 
with 40H T alone (A,C) or with 40H T and cyclopamine for up to 
2 weeks (B,D). Tail whole mounts were labelled with antibodies to 
Ki67 (A,B) or CDP (C,D). Dashed lines outline HF with SG (A-D). 
Scale bars: 100pm.
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5.4- Eph/ephrin superfamily, candidates for positioning 
signals of ectopic hair follicles
Additional analysis of the p-catenin profile revealed that members of the family of 
Ephrin receptors (Ephs) and their membrane-bound ligands (Ephrins) are 
upregulated by P-catenin in skin. This family has been shown to act downstream 
of P-catenin in controlling stem cell maintenance, proliferation and niche 
architecture in several tissues including the intestinal epithelium (Batlle et al., 
2002; Sancho et al., 2003). Several Ephs and Ephrins were upregulated between
1.5 and 3 fold on activation of P-catenin in the epidermis: EphB1 (3.8), EphA1 (3), 
ephrin-B2 (2), ephrin-B1 (2), EphA4 (2), EphB3 (2), EphA3 (2) and EphA7 (3).
I validated several of these genes by immunofluorescence staining of tail skin 
(Figure 5.9 A-F). The ligand ephrin-B1 is expressed predominantly in the hair 
matrix and the lower portion of the ORS in early and late anagen wild-type 
follicles (Figure 5.9 C). In response to P-catenin activation EphrinBI was induced 
in the IFE and SC (Figure 5.9 D), coinciding with CDP expression (Figure 5.9 F). 
The upregulation of EphrinBI correlated with increased expression of one of its 
receptors, EphB3 (Figure 5.9 B). In addition, EphA4, which is normally expressed 
in the bulge area (See Chapter 3; Tumbar et al., 2004), was upregulated in ectopic 
hair follicles (Figure 5.9 E). This is of interest because it has been shown that 
EphA4 is expressed in the feather placode together with Bmp7 and 8 and 
FolIistatin (McKinnell et al., 2004a). In the next Chapter, I w ill discuss the role of 
Eph/ephrin signalling in patterning the mammalian epidermis.
5.5- Discussion
In this chapter I have described the P-catenin signature in whole skin. The 
signature list includes established and expected Wnt target genes, and it is 
characterised with proliferation-associated genes, signalling molecules and 
transcription factors involved in ORS, matrix and DP lineage determination. An 
important aspect is that components of signalling pathways include activators and
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EphB3
'wt
EphB3
D D2 14d
ephrin-B1 ephrin-B1
EphMA
D2 21d
ephrin-B1/
Figure 5.9- Eph/ephrin family is induced during ectopic hair follicle 
formation. Tail whole mounts from untreated wild-type (wt) or D2 transgenic 
mice treated with a medium dose of 40HT for the number of days shown were 
labeled with antibodies to EphB3, ephrin-B1 and EphA4. Arrows in D indicate 
ectopic HF outgrowths in IFE . Asterisks in A indicate nonspecific staining of SG. 
Dashed lines demarcate ORS in C, HF with SG in D,E. Note that the ectopic follicle 
arising from the IFE shown in F is ephrin-B1 and CDP positive. Scale bars: 100 pm.
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inhibitors providing a tight and controlled activation that allows the formation of 
ectopic HF to be formed. P-catenin signature also leads to changes in adhesion 
and ECM reflecting remodelling of the stem cell niche during this process. Finally, 
the array data have allowed me to identify what pathways are downstream of p- 
catenin during early phases of HF morphogenesis.
p-catenin activation leads to the induction of proliferation and hair 
differentiation
Our array data set was validated by the presence of known targets of P-catenin or 
markers of hair follicle differentiation in the list of upregulated genes. Examples 
are Lefl, Cyclin D1, Shh and several hair keratins previously reported in skin. 
P-catenin activation selectively up-regulated the expression of a large proportion 
of genes encoding for proteins involved in proliferation and cell cycle progression 
and hair differentiation. The induction of these genes allows hair follicle 
morphogenesis to start, promoting the amplification of TA and in the transition of 
the TA cell to a committed hair lineage (see Figure 5.10).
A big surprise from the array is the lack of overlap between p-catenin and Myc 
regulated epidermal genes (Frye et al., 2003). In intestinal epithelium Myc is a p- 
catenin target gene (He et al., 1998) and c-Myc plays a central role in progenitor 
maintenance downstream of the P-cateninATcf4 complex (van de Wetering et al., 
2002).
However, the picture is quite different in skin. Myc induces exit from the stem cell 
compartment by inducing cell adhesion and ECM remodelling related genes, 
promoting sebocyte rather than hair follicle differentiation (Arnold and Watt, 
2001; Waikel et al., 2001; Frye et al., 2003) and in the epidermis, p-catenin 
activation causes localised increases in proliferation and hair differentiation and 
does not upregulate c-Myc at the time points analysed. Nevertheless, N-Myc is 
upregulated. It has been shown that N-Myc is downstream of Shh and that N-Myc 
modulates GSK3P (Mill et al., 2005), adding an additional level of regulation by 
P-catenin activation. It is tempting to suggest that perhaps in skin N-Myc is the 
Myc member that is downstream of P-catenin. Further analysis w ill be important 
in determining whether it is a direct target and its role of in skin.
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NicheProliferation Differentiation Positioning . ...remodelling
Hedgehog Notch TGFb/BMP Eph/ephrin PCP
i
HF morphogenesis
Figure 5.10 - Intersection of signalling events downtream of (3- 
catenin during HF formation. Diagram representing the main signal­
ling pathways activated by p-catenin. For simplification, only selected path­
ways are indicated in this diagram. The relationship between them and how 
they feedback to P-catenin is a main focus on analysis.
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Negative feedback versus signal amplification of the P-catenin signal
Hedgehog and Wnt signalling interact during embryonic development (Reya et 
al., 2003 and Taipale and Beachy, 2001) and inappropriate activation of Wnt or 
Hedgehog signalling is associated with a range of epidermal cancers in humans 
and mice (Gat et al., 1998;Chan et al., 1999; Callahan and Oro, 2001;Niemann 
et al., 2003; Lo Celso et al., 2004; Takeda et al., 2006). This study shows that Shh 
and other members are upregulated in response to p-catenin activation in 
K14ANp-cateninER epidermis and inhibition of Shh with Cyclopamine reduces P- 
catenin induced HF formation. This data puts Hedgehog antagonists as useful 
tools in the treatment of epidermal tumours in which either Wnt or Hedgehog 
signalling is activated (Reya et al., 2003; Taipale and Beachy, 2001; Niemann et 
al., 2003).
It is interesting the notion that P-catenin activation in addition of activating the 
Bmp, Shh and Wnt pathways, it also leads to upregulation of several Shh, Wnt 
and Bmp inhibitors (for example Hhip, W ifi, DKK1 and 4 and Bambi) (Figure 
8.11). This might explain why K14ANp-cateninER mice only develop tumours 
after prolonged or high level activation (see Figure 1.9; Lo Celso et al., 2004). In 
order to trigger a morphogenetic event, in D2 epidermis, lineage reprogramming 
is accompanied by only local increases in proliferation, whereas in D4 epidermis 
there is greater proliferation and the follicles become grossly thickened triggering 
a tumorigenic-like event. Therefore, the fact that Cyclopamine lowers the 
proliferation induced by p-catenin activation converting the D4 to the D2 
phenotype shows that in order to de novo follicle formation to occur there must 
be an appropriate signal strength leading to a balance between Wnt and Shh 
signalling activation and inhibition (Figure 8.1).
Wnt pathway and niche remodelling
Several Wnts are induced upon p-catenin induction. These ligands are normally 
expressed in discrete domains in the bulb area of the follicle (Millar, 2002) and 
are known to activate the canonical Wnt pathway via P-catenin (Wnt7a, Wnt6, 
Wnt10b) and non-canonical pathway via the Planar Cell Polarity (PCP) pathway
16S
p-catenin
SIGNAL INHIBITION
W ifi ,DKK1 ,DKK4,Sfrp1
BAMBI, Smad7 
HHIP
SIGNAL AMPLIFICATION
Wnt5 b, Wnt5a, Wnt7 a, 
Wnt7b,Wnt10b,Fzd10
BMP7, BMP8, Edar,Ect2
Shh.Ptc.Gli1 ,GII2
HF morphogenesis
Figure 5.11 - Negative feedback versus amplification of the (i- 
catenin signal . Diagram representing genes of the Wnt, BMP and Hedgehog 
pathways that are activated by b-catenin that either promote or inhibit the activa­
tion of the pathway. Note that a balance between the two must be acheived in 
order for HF to be formed.
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and (Wnt5a, Wnt11, Wnt5b). This is of importance as the two pathways have 
different downstream effectors leading to different outcomes and are active during 
hair follicle differentiation. For instance, Wnt11 functions in gastrulation by 
controlling cell cohesion through Rab5c and E-cadherin. (Ulrich et al., 2005) 
Intriguingly, the Wnt11 receptor Frizzled-7 (Fz-7) (Djiane et al., 2000) is required 
for tissue separation during Xenopus gastrulation (Winklbauer et al., 2001), 
suggesting that non-canonical Wnt signalling controls cell migration by 
modulating cell adhesion. Several cytoskeletal proteins and activators of GTPases 
are upregulated upon p-catenin activation, further suggesting that the PCP is 
active also (Figure 5.10). It is not well understood how they cross-talk in 
epidermis and during hair follicle morphogenesis and it w ill be very important to 
pursue this question.
It is striking that all the genes down-regulated at 7 days, lie into the dermal 
fibroblast category (Rendl et al,. 2005). It w ill be worth following these findings as 
it might give new insights into the early crosstalk between epidermal 
keratinocytes and dermal cells that goes on after initial Wnt activation in the 
epidermis.
Novel pathways interactions downstream of p-catenin
These studies have revealed that several pathways are activated downstream of P- 
catenin activation to promote ectopic HF formation. As previously mentioned, 
members of the Hedhehog, BMP, TGFp and Notch pathways are upregulated 
already at very early stages of HF morphogenesis, after 1 day of P-catenin 
activation. These pathways have been reported active during embryonic HF 
morphogenesis (Schmidt-Ullrich and Paus, 2005). However, how they are related 
to P-catenin and how these are regulated is the focus of current investigation.
In addition, new pathways, such as Eph signalling and Sox, not previously 
described in skin are also up-regulated.
Sox genes were amongst the transcription factors upregulated in response to P- 
catenin activation in the epidermis. Recent studies have put Sox9 in the list for 
new markers of the bulge stem cell population (Vidal et al., 2005). It is intriguing 
that Sox9 is induced by P-catenin in intestine (Blache et al., 2004) and in
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embryonic lung (Okubo and Hogan, 2004). In the lung P-catenin activation 
results in stimulation of proliferation and a switch in lineage commitment from 
lung to intestinal cell types (Okubo and Hogan, 2004). Interestingly, some of the 
targets from our array matched genes isolated in a study profiling the bulge 
compartment after P-catenin activation. Sox4 is an intriguing example. Lowry and 
co-workers show that is a protein specifically up-regulated in the SC niche during 
the follicle growth phase and also expressed in proliferating TA progeny (Lowry et 
al., 2005). In addition, Sox4 has been pinpointed as a putative marker of intestinal 
stem cells. These findings further validate our array data and put Sox4 as a 
candidate for the TA amplification and transition into committed differentiation. It 
w ill be interesting to investigate epidermal Sox function further, given the physical 
interaction of p-catenin with certain Sox proteins (Zorn et al., 1999). This w ill give 
insights into the emerging roles of member of the HMC box superfamily of 
transcription factors in skin and hair biology.
In intestinal epithelium p-cateninATcf regulates the expression of EphB2, EphB3 
and EphrinBI and thereby controls cell positioning (Batlle et al., 2002). Our 
screen of genes regulated by p-catenin revealed a modest increase in expression 
of several members of the Eph/ephrin family. Components of this family (ephrin- 
B1, EphA4, ephrin-B2) are also upregulated in bulge LRC (Tumbar et al., 2004). In 
addition, EphA4 is expressed in the feather placode (McKinnell et al., 2004a). It is 
therefore tempting to speculate that in the epidermis, as in the intestinal 
epithelium, Eph/ephrin expression may couple stem cell self-renewal and 
differentiation to cell position. Analysis presented in Chapter 6 w ill attempt to 
unravel how Eph/ephrins pattern mammalian epidermis and might contribute to 
determining ectopic hair follicle positioning in part by modulating P-catenin 
signalling.
It is of particular interest the appearance of two genes, Musashi and Piwil2 
involved in RNA remodelling and gene silencing during asymmetric stem cell 
division. It is very important to follow up these two proteins during hair follicle 
morphogenesis and in other processes regulated by p-catenin. It w ill be 
important to unveil the mechanism of action of how P-catenin regulates small 
RNAs, known as regulatory molecules that provide a new mechanism of
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regulation (Kim, 2006), also in the skin (Yi et al., 2006). A very recent study has 
shown that sRNAs are crucial for ORS identity and maintenance (Andl et al., 
2006).
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Chapter 6- EphB/ephrin-B signalling determines 
hair follicle patterning
Aims
As discussed in previous Chapters, p-catenin activation controls hair follicle 
formation in adult and embryonic skin (Silva-Vargas et al., 2005; Lowry et al.,
2005). Little is known about how pattern is controlled in mammalian skin: the 
placing of individual follicles within the epidermis, and the distribution of 
undifferentiated and differentiated cells along the hair follicle outer root sheath. I 
found that several Eph receptors and ephrin ligands are upregulated in response to 
P-catenin activation in adult epidermis (see Chapter 5). These findings prompted 
me investigate whether Eph/ephrin signalling plays a role in epidermal patterning.
6.1- Analysis of expression of EphB/EphrinB expression in 
wild-type skin
To address the question as to where ephrin-B and EphB receptors might interact to 
control patterning in the epidermis, I first looked at their expression patterns.
I analysed where ephrin-B and EphB receptors are expressed in adult epidermis 
by labelling tail whole-mounts and conventional back skin sections with specific 
antibodies (Figures 6.1, 6.2 and 6.3). As negative controls I used skin from ephrin- 
B1, EphB2 and EphB3 null mice or omitted primary antibodies during staining 
(See Figure 6.1 and 6.2). It was not possible to reach any conclusions about 
expression of ephrin-B and EphB proteins in the sebaceous glands of tail 
epidermal whole mounts because of high levels of non-specific staining (asterisks, 
Figure 6.1 A, C, D).
Three B-type ligands were expressed. Ephrin-BI expression was highest in the 
bulb (base) of growing anagen hair follicles (Figure 6.1 A, B, F; Figure 6.2 C,G and 
6.3; Tumbar et al., 2004). Ephrin-B2 was highly expressed in the zone where the 
hair follicle becomes continuous with the IFE, called the infundibulum, and also 
in the neighbouring IFE, which in tail skin is known as the parakeratotic scale
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Figure 6.1- Expression pattern of EphB receptors and ephrin-B ligands in 
adult wild type tail epidermis. (A-L) Immunolabelling of tail skin whole mounts 
of wild type epidermis with antibodies to the proteins indicated. I and J are enlarge­
ments of the boxes in H. L is an enlargement of K. As a negative control either omission 
of primary antibody or tissue from ephrin-B1 null (EfnblKO ), EphB2 null (Ephb2KO) 
and EphB3 null {Ephb3KO) was used. Asterisks indicate SG non-specific staining. 
Scale bars: 100 pm.
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Figure 6.2- Expression pattern of EphB receptors and ephrin-B ligands in 
adult wild type dorsal epidermis. (A-H) Immunolabelling of dorsal skin sections of 
w ild type epidermis with with antibodies to the proteins indicated. As a negative control 
either omission of primary antibody or tissue from ephrin-B1 null {E fnb lKO), EphB2 null 
(Ephb2KO) and EphB3 null (Ephb3KO) were used. Asterisks indicate SG non-specific 
staining. Scale bars: 100 pm.
174
Infundibulum
BULGE EphB3 (High),EphB1,EphB4(High); ephrin-B1 ( low )
EphB2 (High),ephrin-B2 (High),EphB3(Low),EphB4(Low)
EphB3(High)
EphB3(Medium),ephrin-B1 (Medium), ephrin-B2,(High) EphA4(High)
EphB3(Medium),ephrin-Bl (Medium), EphB4(Middle) 
EphB3(High/Low),ephrin-Bl (High/Low), EphB4(High) and  ephrin-B2(Medium)
ephrin-B3(High)
Figure 6.3- Expression pattern of EphB receptors and ephrin-B ligands in 
wild type epidermis. Schematic summary of high expression of ephrin-B ligands 
and EphB receptors in different epidermal regions. DP: dermal papilla. ORS: outer 
rooth sheath, IFE: Interfollicular epidermis and SG: sebaceous glands.The relative 
levels of expression are indicated by High,Medium and Low.
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(Schweizer and Marks, 1977;Lopez-Rovira et al., 2005). In addition, it is 
expressed at lower levels in the HF bulge and the bulb (Figure 6.1 D, 6.2 B, F and 
6.3). Ephrin-B3 was mainly detected in the dermal papilla, the specialised 
mesenchymal cells at the base of the hair follicles (Figure 6.1 and 6.3;Rendl et al., 
2005).
I also examined the expression of the B-type Eph receptors. EphB3 was most 
highly expressed in the bulb of anagen hair follicles, but could also be detected in 
the hair follicle bulge, the infundibulum, sebaceous glands and IFE (Figure 6 1C,
E, 6.2 D,H and 6.3). Within the HF bulb, EphB3 and its ligand ephrin-B1 were 
expressed in complementary cell layers (Figure 6.1 E, F and 6.3). This mutually 
exclusive expression pattern has been reported for several Ephrin ligands and their 
receptors (Poliakov et al., 2004). EphB2 expression was restricted to the 
infundibulum, as judged both by antibody staining and by p-galactosidase 
expression in mutant mice in which the region of the EphB2 gene encoding the 
cytoplasmic domain has been replaced by a |3-galactosidase gene (Henkemeyer et 
al., 1996; Figure 6.1 G). The pattern of EphB4 expression was similar to that of 
EphB3 (Figure 6.1 H,l,J), while EphB1 was mainly expressed in the IFE. EphA4, 
which can bind B-type ligands, was expressed in the bulge area of the hair follicle 
(Figure 6.3; Tumbar et al., 2004). I did not look at the expression of other A-type 
ligands or receptors; however, EphA7, 4 and EphrinAI were detected in the arrays 
thus they might be also expressed (See Table 5.1 in Chapter 5).
6.2-Macroscopic and Histological analysis of Eph null gross 
phenotype
In order to study the in vivo function of ephrin-B1 and its cognate receptors, 
EphB3 and EphB2, in epidermal patterning, I analysed the skin of mice in which 
the ephrin-B1 (Compagni et al., 2003), EphB2 (Orioli et al., 1996) and EphB3 
(Orioli et al., 1996) genes had been deleted by homologous recombination. None 
of the mice exhibited obvious hair loss. Ephrin-B 1 null mice had no macroscopic 
skin phenotype. EphB3 null mice had greasy skin and ruffled fur that was 
associated with abnormal clumping of the follicles. The same phenotype was
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Figure 6.4- Histological changes in ephrin-B/EphB mutant skin (A-l) Hema­
toxylin and Eosin stained sections of dorsal skin of wild type, ephrin-B1 {Efnbl KO), EphB2 
(Ephb2KO) and EphB3 (Ephb3KO) null epidermis. Mice analysed were from 6 months old 
to 1 year old (See Table 6.1 for details). Scale bars: 100 pm.
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Figure 6.5- Histological changes in Eph/ephrin mutant tail skin
(A-G) Hematoxylin and Eosin stained sections of dorsal skin of Wild type, 
ephrin-B1 null (EfnblKO), EphB2 null (Ephb2KO) and EphB3 null (Ephb3KO) 
epidermis. Mice analysed were from 6 months old to 1 year old (See Table
6.1 for details). Scale bars: 50 Jim.
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D .
Infundiburum cyst SG duplication
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HF clumping
IFE hiperthickening
MetanoCyte recruitment
Spontaneous wounding
Figure 6.6- Histological changes in EphB3 mutant skin (A-G) 
Hematoxylin and Eosin stained sections of dorsal skin of EphB3 (Ephb3KO) 
epidermis. Mice analysed were from 6 months old to 1 year old (See Table
6.1 for details). Scale bars: 50 pm.
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occasionally seen, in milder form, in EphB2 null mice. A summary of the defects 
in adult epidermis and the details of the mice analysed are shown in Table 6.1.
In order to monitor if hair re-grew over time we shaved by hair clipping the dorsal 
skin. In both, wild type and mutant back skin follicles entered anagen, indicating 
that the hair growth cycle was not inhibited (Figure 6.4 A-D). In all three mutants 
the IFE was thicker than in wild type mice (Figure 6.4 E-H, N); this was the only 
abnormality detected in ephrin-B1 null skin (Figure 6.4 F). By looking at the 
histology in the tail I could observe the appearance of infundibulum cysts (see 
Arrows, Figure 6.5; Table 6.1). In dorsal skin, EphB3 null animals showed the 
most pronounced phenotype. Spontaneous wounds developed in the IFE (Figure
6.6 G) and melanocytes accumulated in the dermis (Figure 6.6 F). Enlargement 
and duplication of sebaceous glands occurred (Figure 6.4 G, C; table 6.1). In 
some cases, two or three hair follicles shared a common infundibulum (Figure 6.6 
A). Another characteristic lesion in dorsal skin was also the expansion of the 
infundibulum and the formation of infundibulum cysts (Figure 6.4 G, 6.5 E and
6.6 B; Table 6.1). We also observed sebocytes intermingled with infundibulum 
keratinocytes (Figure 6.6 B; Table 6.1). All of the changes observed in EphB3 null 
skin were also seen in EphB2 null skin, albeit with lower frequency and severity 
(Figure 6.4 H, I and 6.5 D).
When I looked at skin of double mutants (EphB3/EphB2KO homozygous) the 
severity of the phenotype was more severe (Figure 6.7). There were patches of 
hyperthickened epidermis (Figure 6.7 A), and cells in the basal layer were more 
invasive, and less polarised (Figure 6.7). Intermingling of sebocytes and 
keratinocytes was more frequent (Figure 6.7 G, H). Hair clumping, SG duplication 
and enlargement were also observed (Figure 6.7 l-L). One of the four mice 
analysed had a small papilloma (Figure 6.7 E-F).
6.3- Changes in patterning of hair follicle and interfollicular 
epidermis
In order to dissect in more detail the patterning defects observed by conventional 
histology of back skin (Figures 6.4, 6.5, 6.6 and 6.7), I used the tail skin whole
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Genotype Phenotypes
HF Triplets IFE HF SG
Ephb3KO
J o "  (n = 2 0 )
(6 months -1.5 year)
NO
(18)
Very thick 
(12)
Duplicated (14) 
Infundibulum 
cyst
Ruffled hair (11)
Enlarged (15) 
duplicated 
Greasy skin
Ephb2KO 
J o *  (n= 11)
(6 months -1.5 year)
YES
(11)
Thick
(5)
Infundibulum (7) 
cyst 
Ruffled hair 
(5)
Enlarged ^  
duplicated 
Greasy skin
Efnbl KO YES Normal/Thick HF thickness (g) Enlarged (4)
(n = 11)
(6 months -1.5 year)
(11) (5) duplicated
Ephb2/3KO NO Very thick Hair duplication (4) Enlarged (4)
(4) Invasive patches Ruffled hair duplicated
(n =4 ) 
(1 year) ( 4 )
(3) Greasy skin
Table 6.1- Summary of the defects in adult mutant epidermis. The number 
of affected mutants for each phenotype is given together with the total number of 
animals analysed (in parentheses).
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Figure 6.7- Histological changes in EphB3/EphB2 double mutant skin (A-L) 
Hematoxylin and Eosin stained sections of dorsal skin of wild type (A) and 
Ephb3/Ephb2 KO epidermis (B-L). (A-D) Close-ups of IFE (3 mice). (E) One of the mice 
developed a papilloma in the upper side of the back. (F) High magnification of the 
window in (E). (G) Sebocyte intermingled in the infundibulum. (H) Magnification of the 
window in (G). Total of three 6 months old animals were analysed (See Table 6.1 for 
details). Scale bars: 50 pm.
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Figure 6.8- Loss of ephrin-B/EphB leads to abnormal triplet pat­
terning within the epidermis. (A-D)Tail epidermal whole mounts of wild 
type (A), EphB3 (B), EphB2 (C) and ephrin-B1 null mice were immunolabelled 
with a keratin 14 antibody. Individual hair follicles arranged in triplets are 
numbered 1,2,3 (A,C,D). (B) Shows a row of 5 follicles. (E) Follicle number was 
counted per epidermal unit of a total of 24 different pieces ofW T or Ephb3 null 
epidermis (n= 25 units per piece) and the distribution was plotted as percent­
age values of counted follicles per unit over the total number of units per piece 
analysed. Scale bars: 100 pm.
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mount system, which allows a three-dimensional assessment of changes occurring 
in large areas of skin. The epidermis of the tail is highly patterned, as can be 
appreciated in whole-mount preparations (Schweizer and Marks, 1977; Braun et 
al., 2003 and see Chapter 3). As discussed in previous Chapters, in wild type skin, 
hair follicles are arranged groups of three (triplets) and are organised in rows, such 
that the hair follicle triplets in one row are staggered relative to those in the rows 
on either side (Figure 6.8 A, E, see Chapter 2).
In ephrin-B1, EphB2 and EphB3 null tail skin the follicles were arranged in rows 
and the spacing between rows was maintained (Figure 6.8 B-D). In ephrin-B1 or 
EphB2 null epidermis the follicles were generally grouped in triplets (Figure 6.8 C, 
D). However, in EphB3 mutants the triplet organisation was completely disrupted, 
such that follicles were found either individually or in groups of up to 7 (Figure
6.8 E). The distribution of the number of follicles per epidermal unit was 
calculated by counting the number of follicles/ epidermal units (see Chapter 5) of 
a total of 24 pieces corresponding to 18 EphB3KO mice and each piece 
containing about 25 epidermal units. 5 % of units contain groups of 1 hair follicle 
(HF), 15 % of units contain 2 HF, in 35% of units the triplets are maintained, in 
30 % of units groups of 4 HF are present, 15 % of units contain groups of 5 HF, 5 
% had groups of 6 HF, 2.5 % had groups of 7 HF and 2% had groups of 8 HF (See 
Figure 6.8 E). In wild-type epidermis the 95 % of units contained HF in triplets 
(Figure 6.8 E). Quadruplets also are present in epidermal units but at much lower 
frequency (4%) and 1% of units contain very rare sextuplets or duplets (See Figure
6.8 E).
Within tail IFE, two types of differentiation can be distinguished (see Chapter 2; 
Lopez-Rovira et al., 2005). I have found that the IFE that encircles each hair 
follicle triplet, known as the parakeratotic scale, does not express keratin 10 
(Figure 3.5 E, Q) but does express caspase 14 (Figure 3.5 B,C,D,E). The remainder 
of the tail IFE is keratin 10 positive and caspase 14 negative (Figure 3E, I, Q).
In all three mutants IFE differentiation was disturbed (Figure 6.9). In EphB3 null 
epidermis expression of caspase 14 was normal (Figure 6.9 E), but keratin 10 was
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Figure 6.9- Loss of ephrin-B/EphB leads to abnormal patterning 
within the epidermis (A-L) Tail epidermal whole mounts of wild type (A-C), 
EphB3 (D-F), EphB2 (G-l) and ephrin-B1 (J-L) null mice were immunolabelled with 
the antibodies shown or stained for L-Dopa. Dashed lines demarcate parakeratotic 
scales (A^/QDjGJ). Scale bars: 100 pm.
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expressed throughout the IFE (Figure 6.9 D). Keratin 10 was also expressed 
throughout EphB2 null tail epidermis (Figure 6.11 G), and caspase 14 expression 
was reduced or absent (Figure 6.9 H). Conversely, in ephrin-B1 null epidermis, 
the IFE was keratin 10 negative, expression being confined to the hair follicle 
infundibulum (Figure 6.9 J). In ephrin-B1 null epidermis, caspase 14 expression 
was normal (Figure 6.9 K).
The loss of boundaries within the IFE observed with K10 and caspase 14, 
correlated with a loss of boundaries in the distribution of differentiated 
melanocytes (Figure 6.9 C, F, I, L). In wild type tail IFE, differentiated melanocytes 
are confined to the parakeratotic scales and can be visualised by L-Dopa 
reactivity in whole mounts (Figure 6.9 C; Figure 3.8) In EphB2 null epidermis, L- 
Dopa positive melanocytes were no longer confined to the parakeratotic scales, 
but were more widely scattered throughout the IFE (Figure 6.9 I). This effect was 
less pronounced in EphB3 null epidermis (Figure 6.9 F). Conversely, there was a 
marked decrease in the number of melanocytes in ephrin-B1 null epidermis 
(Figure 6.9 L). The changes in the distribution of melanocyte population 
correlated with changes in expression of the c-kit ligand known to act as a cue for 
melanocyte homing (Figure 6.13; Tumbar et al., 2004).
I conclude that EphB3 loss disrupts the normal triplet pattern of hair follicles in 
tail epidermis, and that loss of EphB2, EphB3 or ephrin-B1 disturbs the pattern of 
IFE differentiation and the localisation of melanocytes within the IFE.
6.4- Changes in patterning along the hair follicle axis
Having established that disruption of ephrin-B/EphB signalling led to changes in 
hair follicle position and patterning of the IFE, I examined whether it also affected 
patterning along the length (proximo-distal axis) of the hair follicles, including the 
sebaceous glands (Figure 6.10, 6.11, 6.12). I thought it is likely that patterning 
was disturbed because H&E staining revealed intermingling of sebocytes with 
infundibulum keratinocytes, as well as hair follicles with abnormal morphology 
(Figures 6.4, 6.6.).
In wild type epidermis, keratin 17 is expressed along the length of the outer root 
sheath but not in the infundibulum (Figure 6.10 A, D, G, J). CDP is highly
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Figure 6.10- Loss of ephrin-B/EphB leads to abnormal patterning 
along the hair follicle. Tail epidermal whole mounts of w ild type (A-C), 
EphB3 (D-F), EphB2 (G-l) and ephrin-B1 (J-L) null mice were immunolabelled 
with the antibodies shown . Dotted lines demarcate HF and SG (B,E,H,K) and 
SG and infundibulum (C,F,I,L). Arrow in J shows thickened bulge. Scale bars: 
100 pm.
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expressed in the bulb of anagen follicles (Figure 6.10 B). The infundibulum is 
specifically labelled with antibodies to phosphorylated Akt in telogen follicles 
(pAkt; Figure 6.12 C; Alonso et al., 2005).
The hair follicle outer root sheath in ephrin-B1, EphB2 and EphB3 null epidermis 
was keratin 17 positive (Figure 6.10 A, D, G, J). Keratin 17 staining did, however, 
reveal abnormalities in follicle morphology that were consistent with the changes 
seen in back skin (Figure 6.4). In addition, keratin 17 expression extended into the 
infundibulum in EphB3 and EphB2 null epidermis (Figure 6.10 D and G). It has 
been shown that Keratin 17 is upregulated in proliferative skin, and the increase 
may be due to increased proliferation or Bmp and TGF(3 upregulation. For 
instance, Tenascin expression is a marker of the ORS that could be used instead. 
CDP expression was normal in EphB3 and EphB2 null tail follicles (Figure 6.10). 
However, in ephrin-B1 follicles CDP positive cells were not confined to the bulb, 
but were also present in the inner root sheath (Figure 6.10 B,K), correlating with 
an increase in proliferating, Ki67 positive cells (See Figure 6.14 J-L).
The location of phosphoAkt positive cells was not normal in ephrin-B1 null 
epidermis (Figure 6.10 L). In EphB2 null, and to a lesser extent in EphB3 null, 
epidermis phosphoAkt was no longer detected in the infundibulum, but instead 
was present in the outer root sheath below the sebaceous glands, in the region 
corresponding to the bulge (Figure 6.10 I, F).
In wild type tail follicles, the differentiated, L-Dopa positive, melanocytes are 
confined to the bulb (Figure 6.11 A). This was also the case in ephrin-B1 null 
follicles (Figure 6.11 D). However, in EphB3 null follicles L-Dopa positive 
melanocytes were also found in the bulge (see red asterisks in figure 6.11 B ). In 
EphB2 follicles L-Dopa positive melanocytes were absent from the bulb and 
present in the infundibulum (see red line in Figure 6.11 C). The changes in the 
distribution of melanocytes correlated with changes in expression of the c-Kit 
ligand (Figure 6.11 E-H; (Tumbar et al., 2004; Nishimura et al., 2002). In 
EphB3KO and EphB2KO skin c-Kit ligand was widely localised in the epidermis.
185
L-DOPA c-Kit
Figure 6.11- Loss of ephrin-B/EphB leads to abnormal pat­
terning of melanocytes along the hair follicle. Tail epidermal 
whole mounts of wild type (A, E), EphB3 (B, F), EphB2 (C, G) and 
ephrin-B1 (D, H) null mice were stained for L-Dopa (A-D). Dotted 
lines demarcate HF and SG (E,G). Asterisks in B indicate the bulge and 
in C indicate the infundibulum. White asterisks in E-H indicates non­
specific staining of the SG. Scale bars: 100 pm (A-H).
188
Figure 6.12- Loss of ephrin-B/EphB leads to abnormal pattern­
ing of the SG. Tail epidermal whole mounts of wild type (A), Ephb3 (B), 
Ephb2 (C) and ephrin-B1 (D) null mice were stained with Nile Red . Dotted 
lines demarcate HF and SG (A-D). Scale bars: 100 pm.
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Figure 6.13- Eph/ephrin signalling control patterning in tail skin. (A)
Summarises schematically the data presented in Figure 6.9. In A grey arrows are 
hair follicles; parakeratotic scales are demarcated by dotted lines. Green: caspase 
14; Blue stripes: keratin 10. (B) Summarises schematically the data presented in 
Figure 6.10 and 6.11; In A and B stripes indicate co-expression.
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In Efnbl KO skin there was a decrease consistent with a reduction of melanocytes 
(Figure 6.11 H).
The lipophilic dye Nile Red provides a specific marker of sebocytes (Figure 6.12). 
Sebaceous glands were normal in ephrin-B1 null epidermis (Figure 6.12 D), but 
were enlarged in EphB3 null tail epidermis (Figure 6.12 B). In both EphB3, EphB2 
and in double null epidermis Nile Red staining extended into the infundibulum, 
consistent with the appearance of sebocytes in the infundibulum of back skin 
(Figure 6.4, 6.6 and 6.7).
These results show that disruption of EphB/ephrin-B signalling not only disturbs 
IFE patterning and hair follicle spacing (Figure 6.9), but also changes the location 
of marker expression in the SG along the length of the follicles (Figure 6.10, 6.11, 
6.13).
6.5- Changes in proliferation
Proliferative cells are normally confined into discrete areas of the epidermis. They 
are normally concentrated in the infundibulum, the outermost layer of the SG, the 
bulb of anagen follicles and scattered in the IFE (Figure 6.14 C). To determine if 
Eph receptors and ephrin ligands affect proliferation, I looked at proliferation in 
the bulge stem cell compartment in mutant skin. Ki67 staining showed an 
expansion of proliferating cells in the portion above the bulb in the ORS of 
EphB3KO and Efnbl KO skin (Figure 6.14 H, I, K, L). There was also an increase in 
proliferating cells in the IFE of EphB3KO and EphB2KO (Figure 6.14 F, I). The 
same changes were observed in dorsal epidermis (Figure 6.14 A,D,G,J).
6.6- Changes in the bulge stem cell compartment
To investigate whether the changes in epidermal patterning correlated with 
changes in the bulge stem cell compartment, I analysed two markers of bulge 
stem cells, keratin 15 and CD34 (Lyle et al., 1998; Trempus et al., 2003). In 
whole mounts of wild type tail epidermis keratin 15 expression is restricted to the 
bulge, the sebaceous glands staining non-specifically (Figure 6.15 A, see Figure 
4.12 in Chapter 4). In the three mutants, keratin 15 was co-expressed with CD34,
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Figure 6.14- Changes in proliferation in ephrin-B/EphB 
mutant skin (A-L) Immunolabelling of sections of dorsal skin 
(A,B,D,E,G,H,J,K) or tail skin whole mounts (C,F,I,L) of wild type, ephrin- 
B1 {EfnblKO), EphB2 (Ephb2KO) and EphB3 {Ephb3KO) epidermis with 
an anti-Ki67. (M) Graph shows Ki67 positive cells that were counted from 
conventional back sections. Scale bars: 100 pm.
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Figure 6.15- Loss of ephrin-B/EphB leads to changes in the bulge com­
partment (A-D and J) Immunolabelling of tail epidermal whole mounts with anti­
keratin 15. (E-H and I) Immunolabelling of tail epidermal whole mounts with anti- 
CD34. In (B,I,J) dotted lines indicate the bulb of the HF and asterisks show the domain 
positive for keratin 15. Dotted lines in (E-H) demarcate the SG and HF. Scale bars: 100
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another bulge marker (Figure 6.15 E-H). In EphB3 null epidermis there was an 
additional population of keratin 15 positive cells, lying just above the bulb (Figure 
6.15 B, asterisks); these cells did not, however, express CD34 (Figure 6.15 l-J). In 
EphB2 null epidermis, there was a second keratin 15 positive population, but it 
was located in the infundibulum (Figure 6.15 C, asterisks). In ephrin-B1 null 
epidermis, keratin 15 expression was confined to the bulge, but the bulge was 
enlarged and it contained more keratin 15 positive cells than in wild type 
epidermis (Figure 6.15 D).
To obtain a quantitative measure of changes in the second bulge stem cell 
marker, CD34, I isolated cells from back skin and double labelled for CD34 and 
the a6 integrin subunit, a marker of undifferentiated basal keratinocytes in all 
epidermal regions (Figure 6.16 A-D; Blanpain et al., 2004). In EphB3 null and 
EphB2 null epidermis there was a decrease in the proportion of cells expressing 
the highest levels of CD34 (R4; Figure 6.16 B, C). In contrast, in ephrin-B1 null 
epidermis the proportion of cells with the highest levels of CD34 (R4) was 
markedly higher than in wild type epidermis (Figure 6.16 D). In all three mutants, 
there was an increase in a6 integrin levels, which was most striking in the case of 
ephrin-B1 (Figure 6.16 A-D). This experiment is representative of three
independent experiments in which at least 2 mice were pooled.
As a further means of evaluating the stem cell compartment (see Chapter 5), I 
isolated keratinocytes from normal and mutant dorsal skin and plated equal 
numbers in culture at clonal density on a J2-3T3 feeder layer (Figure 6.17). 
Ephrin-B 1 null keratinocytes had three times the colony forming efficiency of wild 
type keratinocytes (Figure 6.17 A, E). EphB3 null keratinocytes also showed
increased colony formation (Figure 6.17 B, E). In contrast, EphB2 null
keratinocytes had less than half the colony forming efficiency of wild type
keratinocytes (Figure 6.17 C, E). The high colony forming efficiency of ephrin-B1 
null keratinocytes correlated with thickening of the hair follicle bulge (Figure 6.16 
D).
I conclude that disruption of EphB/ephrin-B signalling changes the size of the 
stem cell compartment and disturbs expression of stem cell markers. It is 
particularly striking that in EphB3 null follicles there were cells that were keratin
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Figure 6.16- Loss of ephrin-B/EphB leads to changes in the bulge 
populations. Flow cytometry of basal keratinocytes (gated on basis of FSC 
and SSC) labelled with antibodies to CD34 and a6 integrin. (A) Wild type; (B) 
EphB3 null; (C) EphB2 null; (D) ephrin-B1 null.(E) The values for the CD34 
High and Low populations were plotted from 3 experiments and are shown 
in the graph. This is representative of three separate experiments, in each of 
which cells from at least two wild-type or mutant mice were pooled.
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Figure 6.17- Loss of ephrin-B/EphB leads to changes in 
colony forming capacity in vitro. Colony forming efficiency of 
FACS sorted CD34/a6 double positive keratinocytes on J2-3T3 feeder 
layer. A-D: individual dishes stained with Rhodamine B. (E) Quantita­
tion of data (mean ± S.D.) from three separate experiments, in each 
of which cells from triplicate wild-type or mutant mice were pooled. 
Values are standardised relative to a wild type value of 1.
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15 positive and CD34 negative, and that whereas EphB2 and EphB3 null 
epidermal cells had similar CD34 expression there were marked differences in the 
colony forming efficiency. Thus, three well-established epidermal stem cell 
markers are not obligatorily co-expressed.
6.7- Eph/ephrin signalling modulates keratinocyte integrin 
levels in vivo
To investigate possible mechanisms by which EphB/ephrin-B signalling could 
alter epidermal patterning, I initially looked at integrin expression in vivo.
Analysis by whole mount labelling showed that the levels of the two main 
integrins expressed in basal keratinocytes, a6 integrin and pi integrin, are 
increased in all three mutants (Figure 6.18). Loss of ephrin-B1 did not have a 
major effect on cell surface pi integrin levels (Figure 6.18 L). However, loss of 
EphB3 led to a massive increase in |31 integrin expression (Figure 6.19 J) and 
EphB2 loss led to a more modest increase (Figure 6.18 K). Double labelling for 
Ki67 confirmed that proliferation was increased in the IFE of mutant epidermis 
(Figure 6.18 l-L).
6.8- Integrin expression levels correlate with abnormal 
localisation of pSMAD2/3 in mutant skin
It has been previously shown that missexpresion of a6|34 leads to impaired 
localisation of pSMAD2/3 (Owens et al., 2003). This prompted me to look at 
downstream effectors of TGF|3, pSMAD2 and 3, which are also known to be 
involved in skin homeostasis and development Oamora et al., 2005). The 
pSMAD2 and 3 are effectors of non-canonical TGF|3, and in mouse skin are 
expressed throughout all the compartments in the basal layer (Figure 6.19). 
However, in the SG and bulb their localisation is cytoplasmic, whereas in the 
bulge and IFE it is nuclear (Figure 6.19 A, E). Interestingly, in EphB3 and EphB2 
mutants all the pSMAD2/3 is localised in the cytoplasm, and the levels are 
increased in EphB2 mutants (see Figure 6.19 B, C, F-H). This does not occur in the 
ephrin-B1 mutant, which shows normal localisation (Figure 6.19 D, I). In 
addition, the pSMAD2/3 positive SG population is misslocalised and appears
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Figure 6.18- EphB/ephrin-B signalling modulates keratinocyte integrin levels in
v ivo . Tail epidermal whole mounts labelled with anti-a6 integrin (A-H) or anti-(31 integrin 
(green) and Ki67 (red) (I-L). Scale bars: 100 pm (A-D,l-L), 50 pm (E-H).
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Figure 6.19- Loss of ephrin-B/EphB leads to abnormal pSMAD 2/3 
expression. Tail epidermal whole mounts of wild type (A,E), EphB3 (B,F), EphB2 
(C,G,H) and ephrin-B1 (D,I) null mice were immunolabelled with a pSMAD2/3 
antibody . Note in (E) that pSMAD2/3 in WT is localised to the nucleus (arrow) in 
most IFE basal keratinocytes, whereas, in the SG it is localised in the cytoplasm 
(arrowhead).(G) Enlargement of the box in (C). (E) Enlargement of the box in (A), 
(F) Enlargement of the box in (B). (G,H) Enlargement of the box in (C) and (I) 
enlargement of the box in (D). Note that in H the original settings shown in G are 
lowered. Scale bars: 100 pm.
intermingled with IFE keratinocytes (Figure 6.19 B, F), coinciding with changes 
observed in sebocytes that are miss-localised (See Figure 6.6, 6.12). Further 
experiments are required to determine whether or not the changes in pSMAD2/3 
are a direct consequence of altered integrin expression in this model.
6.9- Discussion
EphB receptors and ephrin-B ligands are expressed in distinct domains in skin
I have shown that EphB receptors and ephrin-B ligands are expressed in distinct 
domains in IFE and along the HF. As discussed earlier, the first step of HF 
morphogenesis after P-catenin activation is to "disturb" the existing boundaries, 
altering therefore the "balance" between proliferation and differentiation, and 
then the boundaries need to be re-established after the new hairs have been 
developed. In addition, the hair cycle progression also requires that patterning 
along the HF axis to be very dynamic. So in these two programmes, Eph/Ephrin 
signalling needs to be dynamically modulated. One or two cells are expressed at 
the most distal tip of the hair placode (E15.5) during development (Amelia 
Compagni, personal communication). It w ill be important to study further the 
pattern of expression of Eph and ephrin during embryonic hair formation to 
understand further how the pattern is set during early stages and look in the 
mutants to understand when the phenotypic defects arise.
EphB/ephrin-B signalling controls patterning in tail skin
The experiments described in this chapter show that EphB/ephrin-B signalling 
controls three types of patterning in mouse tail epidermis: hair follicle spacing, 
cell position along the proximo-distal follicle axis, and the location of cells 
undergoing different programmes of IFE differentiation. These phenotypes not 
only occurred in tail skin, but also in back skin. Disruption of EphB/ephrin-B 
signalling alters the localisation of melanocytes, both within the epidermis and 
the dermis, causes the appearance of sebocytes within the infundibulum and 
increases epidermal proliferation.
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Loss of Eph/ephrin signalling: are changes cell-autonomous or niche related?
These changes may either be a direct consequence of disturbed signalling, or a 
response of cells to being placed in an abnormal environment. It is quite 
remarkable that when Eph/ephrin signalling was disrupted the tissue was still 
functional, the hair cycle continuing normally, even though patterning along the 
follicles was disturbed and the size and location of the stem cell compartment 
were altered. As the expression of these molecules is redundant, single deletions 
have a milder effect than when more than one gene is deleted. When I analysed 
the double mutant (EphB3/EphB2KO) I could clearly see that the phenotype was 
much more severe as it has been previously reported in the intestine (Batlle et al., 
2002). Further studies addressing if there is compensation w ill be needed to 
clarify this issue.
There were different effects on deleting the ligand (ephrin-Bl) or the receptors 
(EphB2 or 3, EphB3 deletion being more severe). In ephrin-B1 null tissue, the 
increase in proliferation is correlated with expansion of the bulge and of the CDP 
positive bulb population, possibly reflecting a failure of cells to migrate from these 
locations. In EphB3 null epidermis the increase in proliferation is correlated with 
a decrease in bulge cells, at evidenced by reduced numbers of CD34 positive 
cells, possibly reflecting increased departure from the niche.
The differential effects on CD34, keratin 15 and clonogenicity demonstrate that 
these three bulge stem cell markers do not co-segregate obligatorily, and that the 
epidermis can be maintained with greater or fewer stem cells. This calls into 
question whether the bulge stem cells have inherent stem cell characteristics or 
whether they are responding to their unique niche (Rendl et al., 2005). I can 
speculate that ephrin-B1 promotes differentiation while EphB3 preserves the stem 
cell compartment.
The changes in proliferation observed in the EphB3 and in the ephrin-B1 null skin 
are in agreement with data from the nervous system that Eph/ephrin signalling 
regulates proliferation (Holmberg et al., 2005; Conover et al., 2000). There are a 
number of possible mechanisms for increased proliferation, including the 
upregulation of integrins that occurs when EphB/ephrin-B signalling is disrupted.
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In human IFE high |31 integrin expression is a marker of stem cells Qones et al., 
1995) and high levels of (31 integrins are required to maintain the human 
epidermal stem cell compartment in vitro (Zhu et al., 1999). Nevertheless, 
overexpression of (31 integrins does not result in increased proliferation in mouse 
epidermis (Gebhardt et al., 2006).
The parallel between integrin overexpression and pSMAD2/3 localisation is 
intriguing. It was previously shown that suprabasal expression of a6|34 leads to 
increased sensitivity to chemical carcinogenesis and the mechanism involving 
inhibition of pSMAD2/3 translocation to the nucleus (Owens et al., 2003). The 
Eph/ephrin mutant mice provide an important new approach to analysing the 
mechanisms linking a6|34 to impaired TGF|3 sensitivity.
My results have close parallels with studies of intestinal epithelium. In the 
epidermis disruption of EphB/ephrin-B signalling affects the position of large 
groups of cells (entire hair follicles and parakeratotic scales), whereas in the 
intestine the effects are at the level of single cells (Batlle et al., 2002). The changes 
in proliferation and differentiation could be, in part, a secondary consequence of 
placing cells in different niches. However, it is clear that this is not the only 
mechanism as there are also cell autonomous consequences of altering Eph/ 
ephrin signalling. In the next chapter I w ill describe experiments with cultured 
keratinocytes in which I investigate the mechanism of action of Eph/ephrin 
signalling in controlling epidermal patterning.
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Chapter 7- Mechanisms of Eph/ephrin 
signalling
Aims
In this Chapter I investigate possible mechanisms by which EphB/ephrin-B 
signalling could alter epidermal patterning, including effects on integrin 
expression and cell-cell adhesion. I also demonstrate that Eph/ephrin signalling 
modulates canonical Wnt signalling.
7.1- EphB/ephrin-B signalling modulate integrin expression
Analysis by whole mount labelling showed that the levels of the two main 
integrins expressed in basal keratinocytes, a6 integrin and pi integrin are 
increased in all three mutants (Figure 6.18 in Chapter 6). In order to get 
quantitative data of these changes I performed flow cytometry analysis that 
confirmed that a6 integrin expression was increased in mutant epidermis (Figure 
7.1), the effect being most dramatic in ephrin-B1 null keratinocytes (Figure 7.1 C). 
The loss of ephrin-B1 did not have a major effect on cell surface p1 integrin 
levels, whether judged by flow cytometry (Figure 7.1 F) or whole mount labelling 
(Figure 6.18 L). However, loss of EphB3 led to a massive increase in p1 integrin 
expression (Figure 6.18 J) and EphB2 loss led to a more modest increase (Figure 
6.18 K). Double labelling for Ki67 confirmed that proliferation was increased in 
the IFE of mutant epidermis (Figure 6.18 l-L). It is interesting to note that in 
addition to the increase in the membrane levels of integrins (Figure 7.1), there 
were increased cytoplasmic levels, as revealed by immunofluorescence (Figure 
6.18).
7.2- EphB/ephrin-B mutants have abnormal morphology
In order to investigate how EphB/ephrin-B signalling affected keratinocyte 
adhesion, I generated spontaneously immortalised keratinocyte lines from ephrin- 
B1, EphB3 and EphB2 null mice. Mutant keratinocytes displayed abnormal 
morphology, being very elongated with several lamellopodial protrusions
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Figure 7.1- EphB/ephrin-B signalling modulates keratinocyte 
integrin levels. (A-F) Flow cytometry of basal keratinocytes (low 
forward side scatter (FSC) and small side scatter (SSC) were labelled 
with antibodies to a6 (A-C) or (31 (D-F) integrins. Wild type keratino­
cytes are shown in black (A-C) or green (D-F); mutant keratinocytes are 
shown in red (A-C) or black (D-F).
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Figure 7.2 - EphB/ephrin-B mutants have abnormal morphology 
and motility. (A-C) Phase contrast micrographs of adherent cultured kerati­
nocytes from wild-type (WT), EphB3 null (Ephb3KO) and ephrin-Bl null 
(EfnblKO) mice. (D,E) Interference reflection microscopy (IRM) micrographs 
of adherent cultured keratinocytes from WT and Ephb3KO mice. (F-K) These 
pictures are stills of movies that recorded the motility of WT and Ephb3KO 
keratinocytes seeded at low density on collagen coated dishes for several 
hours. In order to compare between the motility of WT and Ephb3KO kerati­
nocytes, and example is shown, in which the position of a cell of each type is 
indicated with a red dot and tracked in the time points at 0 min, 5 min and 15 
min indicated. Scale bars: (A-C) 100jim, (D-E) 50pm
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Figure 7.2 - EphB/ephrin-B mutants have abnormal morphology 
and motility. (A-C) Phase contrast micrographs of adherent cultured kerati­
nocytes from wild-type (WT), EphB3 null (Ephb3KO) and ephrin-B1 null 
(EfnblKO) mice. (D,E) Interference reflection microscopy (IRM) micrographs 
of adherent cultured keratinocytes from WT and Ephb3KO mice. (F-K) These 
pictures are stills of movies that recorded the motility of WT and Ephb3KO 
keratinocytes seeded at low density on collagen coated dishes for several 
hours. In order to compare between the motility of WT and Ephb3KO kerati­
nocytes, and example is shown, in which the position of a cell of each type is 
indicated with a red dot and tracked in the time points at 0 min, 5 min and 15 
min indicated. Scale bars: (A-C) 100pm, (D-E) 50pm
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compared to wild-type keratinocytes (see Figure 7.2 A-E). They did not spread to 
the same extent as wild type keratinocytes; they formed elongated membrane 
protrusions (Figure 7.2), they had fewer contacts with the plate as indicated by the 
IRM micrographs (Figure 7.2). In addition, they exhibited increased motility. An 
example is shown in the stills of movies shown in Figure 7.2.
7.3- EphB/ephrin-B activation in keratinocytes in vitro
In order to look at the effects of the forward and reverse signalling, I set up an 
assay to activate Eph signalling in keratinocytes (Figure 7.3). Treatment of wild- 
type keratinocytes with recombinant ephrin-B1 Fc and EphB3Fc proteins showed 
that activation of either forward or reverse signalling led to F-actin reorganisation, 
as described for intestinal cells (Figure 7.3; Batlle et al., 2002). Treatment with Fc 
only did not induce any changes in morphology and F-actin, which remained 
mainly cortical (Figure 7.3 A-C).
Stimulation of reverse signalling via treatment with EphB3Fc promoted cell 
detachment, with lamellopodia and fillopodia formation in wild-type cells (Figure 
7.3 D-F). This was similar when forward signalling was stimulated with ephrin- 
B2Fc (Figure 7.3 J-L). In contrast, when forward signalling was activated with 
ephrin-B1 Fc, cells formed lamellopodia in the first 10 min, but after 30 min they 
appeared to cluster (Figure 7.3 G-l).
To validate this assay I monitored receptor or ligand clustering upon stimulation. 
Two examples are shown in Figure 7.4 and 7.5. Cells were either treated with the 
ligand or the receptor and were then immunolabelled for either the receptor or 
the ligand that was being activated (see Figures 7.4 and 7.5). No clustering was 
observed when cells were stimulated alone with Fc or non-clustered ligand or 
receptor (see Figure 7.4 A and 7.5 A). Small clusters were observed when cells 
were stimulated (Figure 7.4 B, F and C and 7.5 C, D). Interestingly, when I 
activated p-catenin either via Wnt3A or activating ANp-cateninER with 40HT the 
degree of clustering seemed much increased, and some internalisation was 
observed (see Figure 7.4 C, D, E and 7.5 E-C).
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Figure 7.3- EphB/ephrin-B signalling induces keratinocyte F-actin 
remodelling and changes in cell shape. (A-L) Wild type keratinocytes 
plated at low density on Collagen I coated tissue culture dishes and left to attach 
overnight. Cells were stimulated with either FC alone (A-C), pre-clustered recom­
binant EphB3Fc (D-F), pre-clustered recombinant ephrin-B1 FC (G-l) or recombi­
nant ephrin-B2FC (J-L) for 10 min (A,D,E,G,J) or 30 min (B,C,E,F,H,I,K,L). Cells 
were fixed and then stained with Phalloidin-TRITC. Scale bars: 100 pm.
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Figure 7.4- Stimulation with ephrin-B1 Fc induces EphB3 clustering 
in keratinocytes. Wild type (A-C,F) or AN(3-cateninER (D,E) keratinocytes 
were stimulated with either FC alone (A), pre-clustered recombinant ephrin-b1 Fc 
alone (B,C), or in combination with 40HT (D,E) or in combination with Wnt3A 
(F) for 2 days. Cells were fixed and then immunolabelled with anti-EphB3 anti­
body (Green) and Phalloidin-633 (blue).
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Figure 7.5- Stimulation with EphB3Fc induces ephrin-Bl clustering in 
keratinocytes. Wild type keratinocytes (A-D) or ANp-cateninER keratinocytes 
(E-H) were stimulated with either FC alone (A,B), pre-clustered recombinant 
EphB3Fc alone (C,D), or in combination with 40HT (E-H) or 10x more concen­
trated EphB3Fc with 40HT (G,H) for 2 days. Cells were fixed and then immunola- 
belled with anti-ephrin-B1 antibody. Red corresponds to ephrin-B 1 expression, blue 
correspond to the nuclear counterstain DAPI and green show EGFP expression. 
Scale bars; 50pm.
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7.4- p-catenin drives expression of EphB 3 and ephrin-B1
In Chapter 5, the array analysis of P-catenin activation signature genes showed 
that ephrin-B1 was up-regulated 2.3 fold, and EphB3 was 1.6 fold. I was intrigued 
by the notion that P-catenin might control cell positioning in the epidermis by 
controlling the expression of Eph receptors and Ephrin ligands. To test whether p- 
catenin does indeed upregulate Eph/ephrin, I looked at the expression of ephrin- 
B1 and EphB3 in P-catenin driven hair formation in vivo. The first response of P- 
catenin is to drive proliferation. I could observe clusters of proliferative cells at 
early stages of p-catenin activation (see Figure 4.8 and 4.9 in Chapter 4). When I 
looked at the expression of ephrin-BI and EphB3 with conventional sections or 
whole-mount immunolabelling, I could see that at initial stages of p-catenin 
activation, there was increased expression of ephrin-B1 and EphB3. As treatment 
progressed, I could observed that the initial bumps, or clusters, of proliferating 
cells contained cells with high expression of ephrin-B1 (Figure 7.6 B, D) and 
EphB3 (Figure 7.6 A, C). As I had observed previously (Figure 5.9), as hair 
formation continues, the expression of both the receptor and the ligand are 
expanded along the new follicles (Fig 7.6 E, F).
7.5- Loss of ephrin-B/EphB signalling leads to abnormal P- 
catenin levels
I next wondered whether Eph signalling modulates Wnt responsiveness. I first 
looked at the localisation of P-catenin in mutant epidermis. In wild-type skin, P- 
catenin is localised mainly to cell-cell borders (Figure 7.7 A,B) and nuclear p- 
catenin is only detectable in a subpopulation of keratinocytes in the matrix at the 
base of the hair follicles (Figure 7.8 A; DasGupta and Fuchs, 1999; Niemann et 
al., 2002). Interestingly, I observed that the levels of membrane-associated p- 
catenin were higher in both the EfnblKO and EphB3KO follicles than wild-type 
follicles (Figure 7.7 D and H). In EfnblKO  keratinocytes the increased levels of P- 
catenin were largely cytoplasmic or in the nucleus (Figure 7.7 C, D, 7.8 D, 7.9 D, 
E). In the case of EphB3KO follicles, I could observe high levels at the membrane
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Figure 7.6- P-catenin stimulation induces ephrin-B1 and EphB3 
expression in sites of ectopic hair follcile formation. Sections of dorsal 
skin (A-B) or tail whole-mounts (C-F) of K14ANP-cateninER mice were treated for 
the indicated days with a 1.5 mg dose of 40HT. Immunolabelling with anti- 
EphB3 (A,C,E) or anti-ephrin-B1 (B,D,F) antibodies. Scale bars: 100pm
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Figure 7.7- Loss of ephrin-B/EphB leads to abnormal P-catenin levels in IFE.
Sections of dorsal skin of wild type (A,B), ephrin-B1 null (EfnblKO) (C,D), EphB2 null 
(Ephb2KO) (E,F) and EphB3 null (Ephb3KO) (G,H) mice were immunolabelled with a P- 
catenin antibody. Blue corresponds to DAPI positive nuclei, green corresponds to p- 
catenin and red corresponds to F-actin stained with Phalloidin TRITC. (B,D,F,H) Enlarge­
ments of boxes in A,C,E,G respectively showing a high magnification of the IFE. Scale bars: 
100 pm.
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Figure 7.8 - Loss of ephrin-B/EphB leads to increased p-catenin 
levels in the hair follicle bulb. Sections of dorsal skin of wild type 
(A,B), ephrin-B1 null (EfnblKO) (D), EphB2 null (Ephb2KO (E) and EphB3 
null (Ephb3KO) (C) mice were immunolabelled with a p-catenin antibody. 
Blue corresponds to DAPI positive nuclei, green corresponds to p-catenin 
and red corresponds to F-actin stained with Phalloidin TRITC.Scale bars: 
100 Jim.
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Figure 7.9 - Loss of ephrin-B/EphB leads to increased p-catenin levels 
in the hair follicle bulge. Sections of dorsal skin of wild type (A), ephrin-B1 null 
(EfnblKO) (D,E), EphB2 null (Ephb2KO) (F) and EphB3 null (Ephb3KO) (6 ,0  mice 
were immunolabelled with a p-catenin antibody.Blue corresponds to DAPI positive 
nuclei, green corresponds to P-catenin and red corresponds to F-actin stained with 
Phalloidin TRITC. (E) is an enlargement of the box in D. Scale bars: 100 |im.
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(Figure 7.7 G, H; 7.8 C and 7.9 B,C). The same effects were seen in immortalised 
cells cultured from mutant epidermis (see Figure 7.10).
7.6- EphB/ephrin-B signalling modulate P-catenin 
transcriptional activity
To investigate whether loss of Eph/ephrin resulted in increased P-catenin 
dependent transcriptional activity, I transfected keratinocytes with the TOPFLASH 
reporter, in which an enhancer with multiple LeflATcf binding sites drives 
luciferase expression (van de Wetering et al., 1997). 1 activated P-catenin by 
treating the cells with recombinant Wnt3A. Since the cells had not been 
transfected with exogenous Lef/Tcf or activated p-catenin (Zhu and Watt, 1999; 
Niemann et al., 2002), there was only a small increase in luciferase activity in 
wild type keratinocytes treated with Wnt3A, as reported previously (Lowry et al.,
2005). However, in both ephrin-B1 and EphB3 null keratinocytes transcriptional 
activation by Wnt3A was significantly increased (Figure 7.10 A).
Interestingly, when I stimulated either reverse (EphB3-Fc) or forward (ephrin-B1 
Fc) signalling in the mutant keratinocytes there was a super induction of 
TOPFLASH activity (See Figure 7.11).
These results show that the increased levels of p-catenin in mutant keratinocytes 
correlate with an increase of the p-catenin transcriptional activity. In addition, 
Eph/ephrin signalling can modulate p-catenin transcriptional responsiveness.
7.7- Effects of EphB/ephrin-B signalling on P-catenin 
induced proliferation
In order to start dissecting what part of the p-catenin response was modulated by 
Eph signalling, I first analysed proliferation of stimulated cells, for a period of 7 
days. As expected, Wnt3A-treated wild-type cells show increased proliferation 
(Figure 7.12). Interestingly, proliferation was reduced in cells co-stimulated with 
Wnt3A and EphrinB1-FC and EphB3-Fc. This may explain why p-catenin can 
either drive proliferation or differentiation. In this case, it appears that Eph/ephrin 
signalling reduces the p-catenin induced proliferation in wild-type.
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Figure 7.10- Abnormal levels of P-catenin in mutant keratinocytes 
lead to increased transcriptional activity. (A) Cultured keratinocytes from 
wild-type (WT), EphB3 null (Ephb3KO) and ephrin-B1 null (EfnblKO) mice were 
transiently transfected with TOPFLASH in the presence or absence (Mock) of 
Wnt3A. Relative light units (RLU) are shown. Bars represent means of at least 3 
replicate samples in up to 4 experiments ± S.D. (B-M) Wild type (B-E), Ephb3KO 
(F-l) or EfnB1 KO Q-M) keratinocytes were stimulated with either FC alone 
(BjQFjGJ/K), or with Wnt3A (D,E,H,I,L,M) for 2 days. Cells were fixed and then 
immunolabelled with an anti-p-catenin antibody (green), DAPI (blue) and phal- 
loidin (red). C,G,K,E,I,M Enlargements of boxes in B,F,J,D,L, respectively. Scale 
bars: 50pm
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Figure 7.11 - Eph/ephrin signalling modulates p-catenin transcriptional 
activity in keratinocytes. Cultured keratinocytes from wild-type (WT) (blue), 
EphB3 null (yellow) and ephrin-B1 null mice (red) were transiently transfected with 
TOPFLASH in the presence of (Mock of CHAPS buffer), ephrin-B1Fc, EphB3Fc, 
Wnt3A (diluted in CHAPS buffer) alone or in combination. Relative light units (RLU) 
mean values are shown. This experiment was performed twice.
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Figure 7.12- Eph/ephrin signalling modulates (3-catenin 
induced proliferation in keratinocytes. Cultured keratinocytes 
from wild-type (WT) were plated in equal numbers in the presence or 
absence (Mock), ephrin-B1Fc, EphB3Fc, Wnt3A, alone or in combina­
tion. Cells were counted at the timepoints indicated with a colorimetric 
assay at 490 nm. This experiment was performed twice and the data 
shown in this figure is from one experiment
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7.8- EphB/ephrin-B signalling modulates keratinocyte mixing
To see whether the changes in cell-cell interaction and adhesion and P-catenin 
levels would affect cell patterning in vitro, I introduced a retroviral vector 
encoding GFP into wild type and mutant cells and then performed mixing 
experiments with GFP positive and negative populations, as described in the 
Materials and Methods section (Figure 7.13). When wild type GFP positive cells 
were mixed with wild type GFP negative cells, the two populations were 
completely intermingled (Figure 7.13 A). I consistently observed 75 % of the cells 
intermingled and 25% of the rest were next to one or two GFP positive cells (see 
Figure 7.4 13,F). In contrast, when cells of differing EphB/ephrin-B1 status were 
mixed, they always sorted out (96%), cells of the same genotype clustering 
preferentially with one another (Figure 7.13 B-D, F). Interestingly, when a single 
mutant cell was surrounded by wild-type cells this was large and flattened and 
tend to repulse from the other populations (Figure 7.13 E).
These results show that disruption of EphB/ephrin-B signalling changes the 
adhesive properties of the cells, such that populations that differ in EphB/ephrin-B 
expression (Figure 7.13) w ill tend to segregate from one another. This in turn 
could explain the effects of EphB/ephrin-B1 ablation on epidermal patterning.
7.9- Effects of Eph/ephrin signalling on 0-catenin induced 
cell mixing
If Eph/ ephrin signalling plays a role in determining the sites of p-catenin induced 
HF formation, I would expect to see effects in mixing experiments in culture. I 
therefore mixed cell lines previously generated from the ANp-catenin ER mice and 
wild-type keratinocytes. I observed that when activated p-catenin with 40HT the 
responding cells clustered more with each-other in a dose-dependent fashion 
(Figure 7.14 A-D).
I next combined P-catenin activation (via 40HT treatment or Wnt3A treatment) 
and activation of reverse (with EphB3Fc) or forward (with ephrin-B1Fc) signalling. 
Activation of reverse signalling led to an enhanced P-catenin response (cell 
clustering) (Figure 7.14 C, D) that coincided with enhanced EphrinBI clustering
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WT L1K0 R3K0 L1K0/R3K0
Figure 7.13- EphB/ephrin-B signalling modulates keratinocyte 
mixing. Cell sorting was examined by mixing GFP transduced and unla­
belled keratinocytes of the genotypes shown. Polymerised actin was 
detected with Phalloidin-Alexa 594 (red). (F) Cell grouping was calculated 
by scoring 500 cells per condition as either being next to a GFP cell (green) 
or not (red). These results represent four independent experiment in tripli­
cate are shown. Error bar indicates the SD values per condition. Scale bars: 
100 pm (A-E).
2 2 0
on the cell membrane (see Figure 7.5). The same response was also observed 
when cells were treated with Wnt3A (Figure 7.4).
In order to validate these observations, I performed the same experiment with 
Efnb lKO and EphB3KO cells and wild-type or AN|3-cateninER cells (Figure 7.14 
and look at the summary of the experiments shown in Table 7.1). As previously 
observed, cells with different 'ephrin status' segregated from one another, with 
either EfnblKO  or EphB3KO cells tending to segregate from WT cells (see Figure
7.14 E and G; Table 7.1). When I treated a mixture of EphB3KO and WT cells 
with Wnt3A, WT cells clustered as previously described (Figure 7.13). However, 
the EphB3KO cells did not clustered and were generally found as single cells with 
enlarged morphology (Figure 7.14 F and J; Table 7.1). The same phenomenon 
was observed when reverse signalling was activated with EphB3Fc (see figure
7.14 J; Table 7.1). When I performed the same experiment with Efnbl KO cells, I 
could still observe cell clustering, but the clusters were larger and less compacted 
compared to wild-type cells (Figure 7.14 G, H, I; Table 7.1).
7.10- Discussion
EphB/ephrin-B signalling modulate adhesion and cell shape
I have shown that activation of either forward or reverse signalling in primary 
mouse keratinocytes leads to changes in F-actin organisation and cell shape 
changes, predominantly formation of lamellopodia and fillopodia. In turn, I have 
found that loss of Eph/ephrin signalling leads to changes of cell shape and 
spreading. These changes are reminiscent of situations in which the activity of 
Rho GTPases is being modulated, in particular Rac1, Cdc42 and RhoA (Hall, 
2000). These results in keratinocytes are in agreement with previous reports 
showing a role of Eph/ephrin in cystoskeletal remodelling and GTPase activation 
(Batlle et al., 2002; Noren and Pasquale, 2004). Further analyses of changes in 
Rho GTPases activity are required to elucidate the molecular mechanism of these 
changes.
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D4 ANB-cateninEGFP W T D4 ANB-cateninEGFP WT D4 AN|i-cateninEGFP W T D4 AN^-cateninEGFP WT
EfoMKOEGFP/ H
O  «r_.'
'/pfi63KOEGFP/WT
Efnbl KO EphB3K0
Li
LIFc R3Fc Wnt3A Wnt3A+ Wnt3A+ 
LUFc R3Fc
R3Fc Wnt3A Wnt3A+ Wnt3A+ 
L11Fc R3Fc
Figure 7.14- p-catenin modulates keratinocyte mixing in vitro.
Cultured keratinocytes infected with EGFP from wild-type (WT), ANp- 
cateninER (D4), EphB3 null and ephrin-B1 null mice were mixed and 
plated with equal numbers with non-CFP infected cells. Cells were either 
treated with FC alone, or with Wnt3A for 2 days. Cells were fixed and then 
stained with DAPI (blue) and phalloidin (red). Cell grouping was calculated 
by scoring an average of 500 cells per condition as either being next to a 
GFP cell (green) or not (red). These results represent 2 independent experi­
ments that were counted.
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+ p-catenin activation
Treatments: FC only ephrin-B1-Fc EphB3-Fc FC only ephrin-B1-Fc EphB3-Fc
WT/ p-catenin YES(95%)
YES
(85%)
YES
(85%)
YES
(85%)
YES
(85%)
YES
(85%)
WT/WT NO NO NO NO NO NO
(85%) (85%) (85%) (85%) (85%) (85%)
Ephb3KO/ YES YES YES YES YES YES
WT (80%) (40%) (60%) (50%) (70%) (70%)
Efnbl KO/ YES YES YES YES YES YES(90%) (90%) (90%) (75%) (90%) (90%)
WT
Table 7.1- Summary of the keratinocyte mixing experiments. This table 
summarises the results of mixing experiments shown in Figures 7.13 and 7.14. The 
phenotype indicated is the ability of two cell populations that are initially mixed to 
segragate from one another. YES indicates that the two populations do not intermingle 
and NO that cells remained intermingled in a mixed population. The percentages 
values are also shown.
Phenotypes
EphB/ephrin-B signalling is important for cell-cell interaction and boundary 
formation
As mentioned in the introduction, Eph/ephrin signalling is bidirectional. This is 
the expression of ephrin-B ligand on one cell population leads to activation of 
forward signalling on neighbouring EphB expressing cells, and also to activation 
of reverse signalling on ephrin-B expressing cells. This allows the formation of a 
boundary separating cells of different identities, the boundary being maintained 
because cells on either side differ in their adhesive properties and sort from one 
another (Watt, 1984; Cooke et al., 2005). This notion is supported by the mixing 
studies, in which I have shown that the 'Eph/ephrin status' of a cell population 
determines whether or not cells w ill intermingle or segregate from one another. 
This provides a dramatic demonstration of the power of Eph receptors and ephrins 
as patterning molecules (Pasquale, 2005). The fact that loss of Eph/ephrin 
signalling in vivo leads to changes in two critical basal integrins important for 
anchorage to the BM, further supports the role of Eph/ephrin molecules in 
determining the adhesion status of a cell and thus its fate. In Chapter 6, I have 
shown that ephrin-B1 and EphB3 are expressed in distinct "domains". I speculate 
that the formation of these boundaries might be coupling the processes of 
migration, differentiation and proliferation. The specific expression of ephrin-B 
ligands or Eph receptors of a cell population also correlate with the differentiation 
and proliferation status and also allow or not intermingling with other populations 
by modulating cell adhesion, migration, etc.
EphB/ephrin-B signalling modulates Wnt responsiveness
I have shown that |3-catenin activation drives the expression of EphB3 and ephrin- 
B1 during ectopic HF formation. As mentioned in the Introduction, hair follicle 
and feather formation have an absolute requirement for reciprocal Wnt signalling 
between the ectoderm and the underlying mesenchyme (Millar, 2002; Chang et 
al., 2004; Yu et al., 2004). It is intriguing that EphA4 is expressed during early 
feather placode formation and that modulation of its levels in a chicken culture 
system showed that EphA4 signalling is required for proper induction and 
maintenance of the feather bud and this occurs in part via RhoB (McKinnell et al.,
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2004a). This suggests that Eph/ephrin signalling downstream of the Wnt pathway 
might be evolutionary conserved in skin appendage formation.
I have shown that keratinocytes in IFE and HF of mutant skin have increased 
levels of p-catenin and that loss of EphB3 or ephrin-B1 resulted in increased P- 
catenin levels and transcriptional activity. The mechanism by which loss of 
EphB/ephrin-B upregulates P-catenin could be via increased expression of Cdc42, 
as it has been shown that Cdc42 protects p-catenin from degradation (Wu et al., 
2006; Miao et al., 2005). In addition, I have shown in Chapter 6 that pSMAD 2/3 
is misslocalised in mutant skin. Altered TGFp sensitivity could also be 
contributing to altered p-catenin levels, as it has been recently shown that 
SMAD7 directly interacts and regulates the levels of P-catenin by targeting it to 
proteosomal degradation. This having a big impact on the p-catenin levels and p- 
catenin directed lineage commitment (Han et al., 2006). p-catenin increased 
levels observed in mutant skin are likely to impact on the increased proliferation 
observed, as p-catenin activation can stimulate proliferation of epidermal cells 
(Zhu and Watt, 1999; Silva-Vargas et al., 2005 and Lowry et al., 2005).
While I propose that EphB/ephrin-B signalling influences proliferation via its 
effects on p-catenin, the effects on integrin expression, cell shape and motility are 
also likely to control epidermal pattern. These functions have been well described 
in vitro (Miao et al., 2005), but my results are the first to document dramatic 
effects on integrin expression in vivo.
Eph/ephrins not only modulate Cdc42 activity, but also the activity of the Rho 
GTPases, Rac1 and RhoA (Noren and Pasquale, 2004; Tanaka et al., 2003; Miao 
et al., 2005) and this will impact on the adhesive properties of epidermal cells 
and also affect the size of stem cell compartment (Benitah et al., 2005; Wu et al.,
2006). These are not only pleiotropic effectors of Eph/ephrin, integrin and growth 
factors signalling but they are also key regulators of the non-canonical Wnt also 
known as planar cell polarity (PCP) pathway.
In addition, I have shown that Eph/ephrin signalling modulates the effects of p- 
catenin on transcriptional activity, proliferation and cell mixing.
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It is intriguing, that Ephrin-Bl and EphB2 can bind to Dishevelled (Tanaka et al., 
2003; Lee et al., 2006a) and could therefore alter the balance between canonical 
and non-canonical (PCP) Wnt signalling (Poliakov and Wilkinson, 2006). It will 
be very important to test this hypothesis in vitro and in vivo, as it w ill open a new 
avenue of understanding the interaction between canonical and non-canonical 
Wnt pathway in epidermis. The effects observed in the IFE of the mutants also 
suggest that this mechanism might be at place and P-catenin may play a role in 
IFE, perhaps in the process in which basal cells detach from the BM and start the 
programme of differentiation, in which CDC42 and the PAR complex has recently 
been shown to be involved (Lechler and Fuchs, 2005).
The in vitro assay for activating Eph/ephrin signalling in wild-type keratinocytes 
and the mutant keratinocytes described in this Chapter w ill provide a very good 
tool to elucidate which of these downstream effectors are modulated in order to 
start dissecting further the mechanism at the molecular level. It w ill also give an 
insight to dissect further whether activation of Eph/ephrin in keratinocytes leads to 
repulsive and/or adhesive signals contributing to the formation or not of a 
boundary.
EphB/ephrin-B signalling and tumorigenesis
In both intestine and epidermis inappropriate activation of Wnt pathway is 
associated with tumour formation (Radtke et al., 2006; Cat et al., 1998; Chan et 
al., 1999; Lo Celso et al., 2004). Recent studies suggest a role of Eph/ephrin 
signalling as a tumour supressors (Batlle et al., 2005; Noren et al., 2006; Guo et 
al., 2006). This would be consistent with the observation that Eph/Ephrin may 
negatively regulate P-catenin responsiveness. A good way to test this hypothesis in 
skin in vivo would be to cross the mutants with the K14ANp-cateninER mice. I 
could then examine whether P-catenin activation would lead to increased tumour 
formation in an EphB/ ephrin-B null background.
Model of ephrin-B/EphB signalling in epidermis
I propose that ephrin-B1 acts as a ligand of the EphB3 receptor expressed in 
neighbouring cells. The expression of ephrin-B1 in one cell population leads to
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activation of forward signalling on neighbouring EphB3 expressing cells, and also 
to activation of reverse signalling on ephrin-B1 expressing cells. This leads to: 1- 
activation of forward signalling on EphB3 expressing cells, leading to the 
modification of p-catenin (proliferation/cohesiveness) and 2- activation of reverse 
signalling on ephrin-B1 expressing cell that tells the cell to (differentiate, migrate, 
so determining the fate of the cell), and these together 3- leading to the formation 
of a boundary on one side cells that are committed to differentiate and on the 
other the progenitors. It is tempting to speculate that EphB/ephrin-B signalling 
might regulate the abundance of progenitor and differentiated cells, and perhaps 
restrict undifferentiated cells to regions where Eph signalling is kept to a specific 
level (Pasquale, 2005). This notion w ill be important to keep in mind in further 
analyses to conclude that this is the case in the skin.
In the absence of EphB3, the ligand does not activate EphB3 receptor; therefore P- 
catenin response is not modulated and there is a massive increase of p1 integrin 
and a6 integrin. In this case, the pathway activated downstream of ephrin-B1 
(reverse) is favoured leading to increased proliferation/differentiation. So leading 
to an enhancement of the p-catenin response. In the absence of ephrin-B1, again 
the receptor is not activated so P-catenin response is not modulated with a large 
increase in a6 integrin and a moderate increase in p i. In addition ephrin-B1 
downstream signalling upon EphB3 ligation is not activated, so no 
differentiation/migration occurs.
I propose that EphB/ ephrin-B signalling acts primarily to determine boundary 
formation. The changes in proliferation and differentiation could be, in part, a 
secondary consequence of placing cells in different niches or reflecting an 
increase of a population that 'got stuck' at some point of their development or 
migratory pathway. However, it is clear that there are also cell autonomous 
consequences of altering Eph/ ephrin signalling (Foo et al., 2006) in particular the 
changes in integrin and p-catenin levels that could have a direct role in tumour 
development.
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Chapter 8- Final Discussion
8.1 -HF morphogenesis is a threshold event
In this thesis I have analysed the effects of titrating the levels of P-catenin activity 
in adult epidermis by using a drug inducible model, N-terminally truncated p- 
catenin fused to a mutant estrogen receptor (K14ANp-cateninER transgenic mice) 
that allowed me to control the levels of activation.
The results presented in Chapter 4 show that levels of p-catenin activation 
induces de novo hair follicle formation from sebaceous glands and IFE, while only 
sustained, high-level activation induces hair follicles in pre-existing hair follicles. 
Even though the expression of the K14ANp-cateninER transgene is homogenous 
not all the cells generate follicles. The three different compartments have different 
sensitivity to P-catenin activation. It will be important to elucidate the molecular 
basis of the differences in interpreting the p-catenin signal.
My results show that P-catenin activation in adult tail epidermis is enough to be 
The first signal' to trigger a morphogenetic process to generate a hair. However, 
this has to be within a fine threshold of P-catenin activation: very low levels 
promote bulge stem cell maintenance, medium levels activate the stem cells 
without any changes in the compartment (Lowry et al., 2005) and induce the 
entry into anagen already reported (Gat et al., 1998; Van Mater et al., 2003; Lo 
Celso et al., 2004, Silva-Vargas et al.,2005). My results also show that within this 
threshold of signal a HF niche will form or not (see Figure 8.1; Silva-Vargas et al., 
2005). When the levels are too high, a tumour is formed instead (Figure 8.1; Lo 
Celso et al., 2004; Gat et al., 1998). This raises the question as to whether it is 
important or not in which skin compartment the first signal 'to make a hair' is 
made. If p-catenin activation is a 'global switch' to make an appendage then if we 
use a dermal specific promoter we should obtain similar results. This w ill be 
intriguing to find out.
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8.2- Adult epidermis is a very plastic tissue
The experiments discussed in Chapter 4 show that the ectopic hair follicles that 
arise from the IFE originate from this compartment, and not by migration or 
division of bulge stem cells (Silva-Vargas et al., 2005). The results place adult 
epidermis with a remarkable flexibility when it comes to generating new 
appendages. This suggests that given the right stimulus, any epidermal cell might 
contribute to the formation of a hair.
Next, it will be very important to characterise and to unveil how IFE stem cells are 
arranged and establish whether transit-amplifying cells are a discrete cell 
population. If indeed stem cells are not clustered in the interfollicular epidermis, 
these observations raise the intriguing possibility that interfollicular epidermal 
transit-amplifying cells have the potential to become hair follicle stem cells. 
Although it is generally believed that the progression from stem cells to transit- 
amplifying cells is irreversible and unidirectional, there are precedents in 
Drosophila for suggesting that transit-amplifying cells can convert into stem cells 
in some circumstances (Kai and Spradling, 2004). This w ill be a concept worth 
pursuing.
De novo hair follicles induced from the interfollicular epidermis provide a niche 
for neural crest cell populations and contain cells with characteristics of bulge 
stem cells: K15 and CD34 expression, and clonal growth in culture.
It will be important to test the 'sternness' of these new populations. Several groups 
are using as an in vivo assay the capacity of a cell population to generate HF 
when transplanted together with dermal fibroblasts onto nude mice. The use of 
these in vivo assays is already very informative but raises the issue of using mixed 
populations. In the future, as new markers are revealed, it w ill be important to 
improve these assays and to clarify the epidermal stem cell hierarchy. Studies of 
new populations in skin might reveal new populations with perhaps the capacity 
to make up for the two compartments needed to generate a hair, keratinocytes 
and dermal fibroblasts, thus allowing to perform an in vivo assay of hair 
regeneration with a single population.
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8.3- Modelling P-catenin activation in skin
The study presented in this Thesis clearly shows that the timing, location and 
strength of the Wnt signal is critical, and this opens the question on how the 
pathway exerts all the different responses. From the analyses presented in Chapter 
5 it becomes clear that at early stages of hair follicle development changes in 
proliferation and early hair differentiation are also accompanied by cytoskeletal 
rearrangements, changes in adhesion and ECM remodelling. This change in the 
nature of the 'adult niche' thus allows for hair morphogenesis to take place in 
adult epidermis. Some of the genes are the same as those active during embryonic 
development, however the adult niche is different than the dynamic changes that 
undergo during embryonic hair development. This might account with some 
differences observed.
My array analysis provides with new data to help the discovery of new P-catenin 
target genes and regulatory pathways. It w ill be of great interest to investigate 
further some of the candidate genes elucidated in this study, as they are likely to 
be very important in setting up the morphogenetic programme to make a hair. In 
addition, it w ill be important to profile the p-catenin signal at the single cell level. 
Using an in vivo reporter for p-catenin activity would allow us to follow the 
dynamics of p-catenin activation during ectopic HF formation in real time. This 
will allow single cell isolation and we w ill be able to profile at the single cell 
level what the p-catenin signal means.
8.4- Intersection of the p-catenin/Wnt pathway with other 
signalling families
Another important aspect will be to elucidate alternative transcriptional partners 
of P-catenin in skin and to study the intersection between Wnt and other 
pathways. We can think of the Wnt pathway as part of a spider's web, in which 
different pathways intersect in many different ways: touching the web at any point 
will impact on multiple threads (Watt et al., 2006).
For example, two of the pathways that intersect with the Wnt pathway in 
epidermis are the Notch and vitamin D pathways. It has been shown that both
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pathways are essential for postnatal hair follicle development and homeostasis, 
since the Notch deletion in epidermis results in almost complete hair loss 
followed by cyst formation (Vauclair et al., 2005) and loss or mutations of the 
vitamin D receptor (VDR) are associated with hair loss in mice and humans (Watt 
et al., 2006). In the case of the VDR, the molecular basis of the binding of P- 
catenin to ligand-activated VDR has recently been elucidated (Shah et al., 2006) 
and although, the physiological relevance has not yet been described, it seems 
likely that Tcf/Lef-independent transcriptional activation by P-catenin is important 
in regulating hair follicle growth and differentiation (Watt et al., 2006). In the case 
of the Notch pathway, in vitro studies highlighted this intersection with the Wnt 
pathway. Devgan et al. have shown that Wnt4 is negatively regulated by p21, a 
direct transcriptional target of Notch activation (Devgan et al., 2005). The in vivo 
consequences of the intersection of the two pathways have recently been 
elucidated. Estrach et al, have shown that the Jagged! ligand is a direct target of 
P-catenin in skin (Estrach et al., 2006). The Notch pathway is required for 
maintenance of HF cycling and ectopic HF formation (Estrach et al., 2006). This is 
of interest as Notch pathway has been shown to regulate Eph/ephrin signalling in 
the vascular system (Hainaud et al., 2006) and it will be very important to test if 
this is also occurring in skin, in particular during HF morphogenesis.
8.5-Wnt and tumorigenesis
Mutations in members of the Wnt pathway have been usually associated with 
stabilisation of p-catenin and transcriptional activation of Lef/Tcf transcription 
factors leading to inappropriate activation and formation of epidermal tumours 
(Chan et al., 1999). These benign tumours have a high degree of hair 
differentiation and in humans have been associated with activating mutations of 
p-catenin (Chan et al., 1999). In addition, prolonged activation of P-catenin in 
adult epidermis leads to the formation of trichofolliculomas, although these can 
regress when P-catenin activation returns to normal levels (Lo Celso et al., 2004). 
A big surprise was a recent report showing for the first time a human-associated 
sebaceous gland tumour harbouring a mutation in the Lef1 gene that inactivates 
the Wnt pathway (Takeda et al., 2006). The Lef 1 gene's mutation impairs the 
binding of Lef1 protein to P-catenin and its transcriptional activity and determines
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the sebaceous nature of the tumours, as assessed by an increased sebaceous 
differentiation programme (Takeda et al., 2006). This brings an interesting notion 
that Lefl can contribute to tumour formation via a P-catenin independent 
mechanism (Watt et al., 2006).
Interestingly, the array analysis revealed that for each set of activators of a given 
pathway, the expression of a number of inhibitors is also induced (Figure 8.1). 
The balance of these opposing signals allows for HF to occur. Therefore, if the 
balance were lost it would lead to abnormal morphogenesis giving rise to tumour 
formation. In this line, one of the pathways upregulated by P-catenin activation in 
the epidermis is Sonic hedgehog (Shh) signalling. It has been shown very recently 
that Wnt inhibitors directly regulate the activity of Shh during neural tube 
formation (Lei et al., 2006), indicating that this model also applies for members of 
different pathways. Furthermore, in addition to the Wnt signalling, Shh signalling 
is also inappropriately activated in epidermal tumours.
Another pathway that I have described downstream of P-catenin is the family of 
Eph/ephrin and in Chapter 7 l show that Eph/ephrin signalling modulates the Wnt 
responsiveness in keratinocytes. I propose that this mechanism might be 
important for understanding the development of skin tumours. This hypothesis has 
been already tested in breast and colon tumour development (Clevers and Batlle, 
2006; Batlle et al., 2005; Noren et al., 2006). And a very recent report supports 
the idea and shows that EphA2 may be involved in the susceptibility to develop 
skin tumours (Guo et al., 2006). It will be important to test this hypothesis.
8.6- Tail skin whole mount is a good system to solve 
'patterning problems'.
The results shown in this Thesis validate the whole mount system of tail skin to 
assess de novo hair follicle formation in three dimensions and to obtain 
quantitative and spatial data on the dynamics of hair formation in tail skin. It is 
also very informative to characterise markers of LRC and their committed progeny 
and evaluate changes in the epidermal stem cell compartment.
I have shown three types of patterning in mouse tail epidermis: hair follicle 
spacing, cell position along the proximo-distal follicle axis, and the location of
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cells undergoing different programmes of IFE differentiation in parakeratotic 
scales. The whole mount system will allow to test new markers in the future and 
help unveil for example how IFE stem cells are distributed whether they are 
clustered or scattered randomly.
The expression pattern domains and their boundaries that I have described are 
reminiscent of the Drosophila imaginal disks, one of the classical examples to 
study planar cell polarity (Saburi and McNeill, 2005). HF formation is a complex 
process and it is intriguing that the downward growth of the follicular cells is 
carried out at a precise angle relative to the plane of the epidermis, which also 
dictates the angle of the outgrowth. Frizzled 6, expressed in the adjacent 
epidermis seems to be in charge for the parallel orientation of HF. It w ill be 
interesting to investigate if the rules of PCP can be applied to HF morphogenesis 
(Barrow, 2006).
I have established that EphB/ephrin-B signalling controls three types of patterning 
in mouse tail epidermis: hair follicle spacing, cell position along the proximo- 
distal follicle axis, and the location of cells undergoing different programmes of 
IFE differentiation. In addition, it also controls localisation of melanocytes, both 
within the epidermis and the dermis, causes the appearance of sebocytes within 
the infundibulum, and increases epidermal proliferation. The in vitro model that I 
present in Chapter 7 w ill be important to further dissect the proposed mechanism 
of action of Eph/ephrin signalling in vitro.
We can use the whole mount system for understanding patterning and given that 
we can quantify events it will be important to apply the biological data into 
mathematical models to further understand and predict new patterns (Reeves et 
al., 2006).
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Figure 8.1 - A model for p-catenin action during hair follicle formation.
Hair follicle formation is a threshold response to p-catenin activation and results from 
a balance between negative feedback versus amplification of the P-catenin signal. This 
leads to a balanced modulation of proliferation, differentaition, positionning and niche 
remodelling, which are all required for HF formation.This diagram indicates that genes 
of the Wnt, BMP and Hedgehog pathways are activated by p-catenin that either 
promote or inhibit the activation of the pathway. Note that a balance between the two 
must be achieved in order for HF to be formed. If there are more activators than inhibi­
tors it could lead to tumour development, instead if there are more inhibitors than acti­
vators no HF will be formed. For simplification, only selected pathways are indicated 
in this diagram. The relationship between them and how they feedback to P-catenin is 
a main focus on analysis.
8.7- Concluding remarks and future prospects
Future analyses to understand how P-catenin signal is interpreted will be very 
important and will shed on how p-catenin intersects with other pathways and 
how these are integrated to generate a message to make a hair. It is of particular 
interest the relationship between the canonical Wnt and the PCP pathways and to 
test if Eph/ephrin signalling is at their intersection.
The Wnt pathway and function is highly conserved through evolution. It is 
intriguing that the Cnidarians genomes encode a diversity of 11 of the 12 Wnt 
genes described in man. How the Wnt gradients are arranged in the HF and the 
process of HF morphogenesis highly resembles the process of head formation in 
the Hydra model (Galliot et al., 2006), hyperactivation of p-catenin leads to 
ectopic head formation. In addition, the process of inducing ectopic HF in the 
multilayered adult epidermis is a problem similar to adult epithelial regeneration 
in which Wnt inductive signals are reactivated and have to overcome the 
inhibitory signals from multilayered epitheliums, for example the chick limb (He 
and Axelrod, 2006). It w ill be important to compare these situations in the future. 
Perhaps when looking at complex patterning programmes we should always keep 
an eye open on how ancient ancestors give rise to their appendages (He and 
Axelrod, 2006).
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